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Ultrasound was used to develop particle systems based on phospholipids 
and protein materials. This technique has proven to be a very effective method of 
nano and microstructured materials production. 
Owing to the variety of the application fields of such particles (nanomedicine, 
drug delivery, cosmetics, etc.), and as existing nano and microparticles are now 
available, a thorough knowledge of the formulating processes (and their 
potentialities) is essential in order to achieve the given purposes and needs for 
research. Based on this approach, it is necessary to develop or optimize 
methodologies that can fulfill all the requirements to create devices with delivery 
ability. 
In this work, to obtain large unilamellar vesicles (LUVs) from 
dipalmitoylphosphatidylcholine (DPPC), it was necessary an extensive 
characterization of ultrasound, namely power input, distance from ultrasound tip 
to base of reactor and treatment time, in order to control the maximum cavitation 
events. Results indicated a dependence on cavitation events that are a function 
of power input, and consequently on the position of the probe within the reaction 
vessel and the wave behaviour. Short treatment times were required to achieve 
nanosized vesicles in anti-nodal (/4; 19 mm) reactor geometries. In this wave 
point the cavitation phenomenon is more pronounced when compared to the 
nodal point (/2; 38 mm). The acknowledgment of this was also helpful for the 
incorporation of peptides in phospholipids aggregates. The developed systems 
were characterized in terms of morphology, zeta-potential, particle size and size 
distribution. 
Studies were also performed in order to investigate the mechanism of protein 
microspheres formation by ultrasound sources using different proteins bovine 
serum albumin (BSA), human serum albumin (HSA) and silk fibroin (SF) as well 
as diverse peptide constructions. The microspheres were produced by means of 
ultrasonication of two-phase starting mixture, consisting of protein solution and 
organic solvent or natural oils. Several parameters, namely protein concentration, 
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ratio of aqueous/organic phase were tested to study their influence in the 
physico-chemical properties of the developed particles. It was conclude that the 
particles size decrease with the use of higher protein concentration (5.0 g.L-1 and 
10.0 g.L-1 for BSA and SF, respectively) and with lower percentage of organic 
phase (5%). The use of different proteins along with different peptides 
constructions allowed us to prove that the main mechanism of protein 
microspheres formation is the mass transport effects, promoted by ultrasound, 
which led to a change in protein entropy system and, consequently, to an 
enhancement of hydrophilic and hydrophobic interactions forming a closed ring, a 
microsphere. 
The performance of several stabilizers in microspheres formulation was 
determined. The results demonstrate that the polyvinyl alcohol (PVA) is the most 
efficient for these protein devices and that 8% was the amount required to obtain 
smaller sizes and a monodispersed population [≈ 260 nm of size diameter and  
≈ 0.060 of polydispersity index (PDI)]. The developed protein-based systems 
were also characterized regarding their ability to be used as release systems. 
Two categories of bioactive agents - natural oils and anti-inflammatory drug - 
were incorporated within protein microspheres. The results demonstrated that 
they are non-cytotoxic in a certain range of microspheres concentration. 
Additionally, the developed materials were able to incorporate and to release, 
with a defined profile, molecules pertaining to two different groups of bioactive 
agents (natural oils and anti-inflammatory drugs). 
The sonochemical method has been further extended to the application of 
these microspheres containing piroxicam, onto cotton and nonwoven gauzes. A 
sustained release of piroxicam was observed over time, greatly supporting their 
application for textile-based wound dressings. 
In summary, the results of this work show that it was possible to develop 
liposomes and protein microspheres with ultrasound sources, whose 
characterization showed their ability to incorporate and deliver different bioactive 
agents. 
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A técnica de ultra-sons foi usada no desenvolvimento de sistemas de 
partículas a partir de fosfolipídios e proteínas. Esta técnica provou ser um 
método muito eficaz na produção de nano e micro-materiais estruturados. 
Devido à variedade de áreas de aplicação de tais partículas (nano-medicina, 
libertação controlada de medicamentos, cosméticos, etc.), e ao grande número 
de nano e micropartículas existentes, um conhecimento profundo dos processos 
de formulação (e suas potencialidades) é essencial para alcançar os objectivos 
pretendidos e as necessidades de investigação. Com base nesta abordagem, 
mostra-se necessário desenvolver e optimizar metodologias capazes de 
satisfazer todos os requisitos indispensáveis à criação de dispositivos com 
capacidade de libertação controlada. 
Neste trabalho, para obter vesículas unilamelares grandes (LUVs), a partir 
do dipalmitoilfosfatidilcolina (DPPC), foi necessária uma extensa caracterização 
dos ultra-sons, nomeadamente a potência, a distância da sonda de ultra-sons à 
base do reactor e o tempo de tratamento, de forma a controlar os fenómenos de 
cavitação máxima. Os resultados obtidos indicaram que os fenómenos de 
cavitação, para além de dependerem da energia aplicada dependem ainda da 
posição da sonda dentro do recipiente de reacção e do comportamento da onda. 
Para atingir vesículas nanométricas no ponto antinodal (/4; 19 mm) do reactor 
foram suficientes tempos de tratamento de curta duração. Naquele ponto da 
onda, o fenómeno de cavitação é mais acentuado quando comparado com o 
ponto nodal (/2; 38 mm). A confirmação desta ocorrência foi também útil para a 
incorporação de péptidos em agregados de fosfolipídos. Os sistemas 
desenvolvidos foram caracterizados em termos de morfologia, potencial zeta, 
tamanho de partícula e distribuição de tamanho. 
Foram também realizados estudos para investigar o mecanismo de formação 
de microesferas de proteína por fontes de ultra-sons utilizando diferentes 
proteínas como a albumina serum bovina (BSA), albumina serum humana (HSA) 
e a fibroína da seda (SF), bem como diversas construções peptídicas. As 
microesferas foram produzidas através da sonicação de uma mistura com duas 
fases, que consiste em uma solução de proteína e solventes orgânicos ou óleos 
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naturais. Vários parâmetros, nomeadamente a concentração de proteína, as 
relações de fase aquosa/orgânica foram testadas para estudar a sua influência 
nas propriedades físico-químicas das partículas desenvolvidas. Verificou-se uma 
diminuição no tamanho das partículas com o uso de maior concentração de 
proteína (5.0 g.L-1 e 10.0 g.L-1 para BSA e SF, respectivamente) e com menor 
percentagem de fase orgânica (5%). A utilização de diferentes proteínas, 
juntamente com diferentes construções peptídicas permitiu concluir que o 
principal mecanismo de formação de microesferas de proteína são os efeitos de 
transporte de massa, promovido pelos ultra-sons, que leva a uma mudança na 
entropia da proteína e, consequentemente, a um aumento de interacções 
hidrofílicas e hidrofóbicas, formando um anel fechado, a microesfera. 
O efeito de estabilizadores nas várias formulações de microesferas foi 
também determinado. Os resultados demonstram que o polivinil álcool (PVA) é o 
mais eficiente para estes dispositivos de proteína e 8% é a quantidade 
necessária para obter tamanhos menores e populações monodispersas  
[≈ 260 nm de diâmetro e ≈ 0.060 de índice de polidispersão (PDI)]. Os sistemas 
desenvolvidos baseados em proteína também foram caracterizados quanto à 
sua capacidade para serem aplicados como sistemas de libertação. Duas 
categorias de agentes bioactivos - óleos naturais e anti-inflamatórios - foram 
incorporados no interior das microesferas de proteína. Os resultados revelaram 
que estas não são cito-tóxicas em determinadas concentrações. Além disso, os 
materiais desenvolvidos demonstraram ser capazes de incorporar e libertar, com 
um perfil definido, moléculas pertencentes a dois diferentes grupos de agentes 
bioactivos (óleos naturais e fármacos anti-inflamatórios). 
O método sonoquímico foi ainda utilizado na aplicação das microesferas 
contendo piroxicam, em gazes de algodão e não-tecido, para obter uma 
libertação controlada de piroxicam ao longo do tempo, apoiando 
extraordinariamente a sua aplicação no desenvolvimento de novos depósitos de 
ferida baseados em materiais têxteis. 
Em resumo, foi criada evidência sobre a possibilidade de desenvolver 
lipossomas e microesferas à base de proteínas através de sistemas de  
ultra-sons, cuja caracterização traduz a sua capacidade de incorporar e de 
libertar diferentes agentes bioactivos. 
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Over the past few decades, there have been demands to develop several 
devices for delivery purposes. In parallel, there was a need to optimize or 
develop new techniques to produce them. 
The main aim of this thesis is to develop nano and microparticles, based on 
phospholipids and protein materials, using high energy of ultrasound. The 
specific objectives intend to verify the influence of sonochemical method to 
produce these systems and at the same time, evaluate the physico-chemical 
parameters of the developed devices and their ability for delivery purposes. 
In agreement with the aims of the present thesis, this dissertation research is 
divided in four parts containing ten chapters, with one of them experimental. The 
contents of each one are summarized below. 
 
1st part - Theoretical considerations related to the topics of thesis outline. 
 
- Chapter I: give an overview of the state of the art of the sonochemical 
methodology to prepare two different delivery devices, namely liposomes 
and polymeric particles. Special focus is devoted on the novel 
applications and recent work involving sonochemical methodology in the 
fields of nano and microparticles. Some remarks on the main concepts of 
those systems to form the nano and microparticles and their applications 
as delivery systems (DS) is performed. Finally, relates to their uses and 
potential for textile-based wound dressings. 
 
2nd part- Materials and methods. 
 
- Chapter II: contains in detail the materials and the experimental 
procedures used for the development and characterization of nano and 
microparticles. 
INTRODUCTION TO THE THESIS FORMAT 
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3rd part - Major results in the scope of this thesis (Chapter III to IX). 
 
- Chapter III: Effect of ultrasound parameters for unilamellar liposome 
preparation, describes the characterization of ultrasound system 
providing a guideline for further preparation of unilamellar vesicles. 
 
- Chapter IV, Incorporation of peptides in phospholipid aggregates 
using ultrasound, reports the use of ultrasound to prepare liposomes 
incorporating one of the two different synthesized peptides and their 
physico-chemical properties. 
 
- Chapter V, Insights on the mechanism of protein microspheres 
formation, was designed to investigate the mechanism of proteinaceous 
microspheres formation by sonochemical method, using bovine serum 
albumin (BSA) and silk fibroin (SF). Different experimental conditions 
were investigated to study their influence in microspheres formation, and 
in their physico-chemical properties. 
 
- Chapter VI, Mechanisms of the formation of proteinaceous 
microspheres - Highlights from peptide size and sequences, reports 
deeper studies on the mechanism of protein microspheres formation, by 
sonochemical method. For that, new engineered peptides with a different 
range of sizes and sequences were used and further characterized. 
 
- Chapter VII, Sonochemical proteinaceous microspheres for wound 
healing, exploits the benefits of BSA, human serum albumin (HSA) and 
SF microspheres, incorporating three different organic solvents  
(n-dodecane, mineral and vegetable oil), for wound healing. 
 
- Chapter VIII, Protein microspheres as suitable devices for piroxicam 
release, describes the use of a sonochemical method to produce 
microspheres of BSA and HSA incorporating piroxicam. Besides 
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microspheres characterization, it was also analysed the release profile of 
piroxicam from these devices. 
 
- Chapter IX, Cotton and nonwoven gauzes bandages: A support for 
proteinaceous microspheres, reports the application of BSA-piroxicam 
microspheres attached onto cotton and nonwoven gauzes using two 
different methodologies: incubation and sonochemical methodology. 
 
4th part: General discussion, final remarks and future perspectives. 
 
- Chapter IX: contains the general conclusions regarding the overall work 
carried out under the scope of this thesis, as well as some final remarks. 
The future perspectives part describes the future work that can follow this 
thesis outline. 
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Chapter I 
Chapter I -  Sonoproduction of particles for delivery purposes* 
ABSTRACT 
The development of nano and micro delivery systems (DS), so small in size, 
is growing in importance. In an era where nano is the new trend, micro and nano 
materials are in the forefront of progress. These systems can be produced by a 
diversity of methods. However, the use of high intensity ultrasound offers an easy 
and versatile tool for nano and microstructured materials that are often 
unavailable by conventional methods. Similarly to the synthesis methods that can 
be used, several starting materials can be applied to produce particulate 
systems. In this review, the recent strategic development of DS is discussed with 
emphasis on liposomes and polymer-based, specially protein-based, 
nanomedicine platforms for drug delivery. Among the variety of applications that 
materials in the particulate form can have, the control release of drugs is probably 
the most prominent one, as these have been in the forefront line of interest for 
biomedical applications. The basic concepts of sonochemical process pertaining 
to DS are summarized as well as the role of sonochemical procedure to their 
preparation. The different applications of these systems wrap up this review. 
 
 
                                            
*
 This chapter is based on the following publication: 
Silva R; Ferreira H, Cavaco-Paulo A, Sonoproduction of particles for delivery purposes, 
submitted. 
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 GENERAL INTRODUCTION I-1.
Nano and microparticles are particulate delivery systems (DS) of nanometre 
or micron size ranges, respectively, and can incorporate therapeutic agents, such 
as small drugs or even macromolecules [1]. The term microparticle refers to 
spherical particles with diameters range between 0.1 and 100 µm. Particles with 
diameter below 0.1 µm are called nanoparticles [2]. 
The promising significance of nano and microparticles in the biomedical field 
and the needs of materials with biocompatibility, biodegradability and non-toxicity 
have propelled the efforts for developing and optimizing new materials. Various 
types of particles like solid lipid nanoparticles [3], micelles [4], liposomes [5], 
dendrimers [6] and polymers [7] have been reported as DS to encapsulate drugs 
and other bioactive agents (Figure I-1). 
 
Figure I-1:  Types of nano and microtechnology used for delivery purposes. The major 
components are either lipids or polymers. The black and grey axis 
represents the diameter of technology (Adapted from Couvreur, P. and 
Vauthier C. [8]). 
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Over the past few decades, significant advances have been made in delivery 
technology. Drug delivery, which takes into consideration the carrier, the route of 
administration and the target, has evolved into a strategy of processes or devices 
designed to enhance the efficacy of therapeutic agents through controlled 
release. This may involve enhanced bioavailability, improved therapeutic index 
(ratio between the efficacy of the drug and its undesirable side effects), or 
improved patient acceptance or compliance. In fact, the administration of a drug 
in a DS influences their parameters, in particular concerning the 
pharmacokinetics, pharmacodynamics and biodistribution, which, in turn, affect 
their therapeutic index [8, 9]. Thus, the DS can increase the bioavailability of 
drugs and decrease their toxic effects, leading to an increase in therapeutic index 
(Figure I-2). Additionally, they can vehicular and release the drugs in a target cell, 
thereby decreasing the dose required to observe certain action minimizing the 
side effects [10]. 
 
Figure I-2: Release profile of conventional formulation and drug delivery systems 
(DDS) over time (Adapted from Liechty et al. [11]). 
The need of developing new DS at nano and microscaled materials is 
paralleled by attempts to optimize or develop new techniques to produce them. 
Therefore, numerous protocols exist for synthesizing nano and microparticles 
based on the type of drug used and the desired delivery route. Among a variety 
of approaches, the utilization of ultrasound for materials synthesis has been 
extensively studied, and now is positioned as one of the most powerful tools in 
nano and micro structured materials synthesis [12]. Once a protocol is chosen, 
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the parameters must be tailored to create the best possible characteristics for the 
developed particles. 
In this review, the most successful ultrasound-assisted synthetic methods 
(sonochemistry) will be discussed to provide a fundamental understanding of 
their basic principles and to demonstrate the powerful and unique aspects of 
ultrasound in nano and micro structured materials synthesis. This review also 
focuses on the materials-based drug delivery platform, highlighting the use of 
phospholipids and proteins. Finally, it will be pointing out to areas requiring 
focused effort to arrive at an understanding of applications of these devices for 
textile-based wound dressings. 
 SONOCHEMISTRY I-2.
Chemistry deals with the interaction between energy and matter, and 
chemical reactions, require some form of energy (e.g. heat, light, radiation, 
electric potential, etc.) to proceed [12, 13]. In large part, the properties of a 
specific energy source determine the course of a chemical reaction. 
Sonochemistry is the research area in which molecules can undergo a 
chemical reaction due to the application of powerful ultrasound radiation 
(20 kHz-10 MHz) [14]. Considering typical sound velocities in liquids of  
≈ 1500 m.s-1, acoustic wavelengths range from 10 to 10-4 cm, which is far above 
molecular and atomic dimensions [15]. Thus, no direct molecular level interaction 
between ultrasound and chemical species take place. Instead, acoustic 
cavitation, driven by high intensity ultrasound, accounts for the chemical effects 
of ultrasound [16]. 
Ultrasonic irradiation differs from traditional energy sources in duration, 
pressure and energy per molecule [17]. Cavitation occurs over a very wide range 
of frequencies, from tens of Hz to tens of MHz; above that frequency regime, the 
intrinsic viscosity of liquids prevents cavitation from occurring. Most high intensity 
ultrasonic horns operate at 20 or 40 kHz, most cleaning baths near 40 kHz, and 
there is specialized equipment available in the few hundred kHz to few MHz 
regime [14, 18]. 
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In general, physical effects of ultrasound (e.g. emulsification and surface 
damage) are more dominant at lower frequencies, whereas cavitational heating 
of collapsing bubbles occurs over the full frequency range. Acoustic cavitation 
appears in the liquids at high and moderate intensities of ultrasonic irradiation. 
The minimum power intensity required for ultrasonic cavitation increases with the 
increase of the frequency of ultrasound [19]. When sonicating liquids at high 
intensities, the sound waves that propagate into the liquid media result in 
alternating high-pressure (compression) and low-pressure (rarefaction) cycles, 
with rates depending on the frequency. The liquid expands during the expansion 
by the sound field („„negative pressure‟‟, low-pressure). This results in rapid 
growth of the weak sites of the liquid predominantly containing dissolved gases 
(„„cavitation nuclei‟‟) thus producing vapour - and gas-filled cavities or 
microbubbles [20]. Then, the liquid compresses during the compression phase of 
the sound field („„positive pressure‟‟, high-pressure). The bubbles continue to 
grow during the negative/positive cycles of the ultrasound until reaching a critical 
diameter (Figure I-3), which depends on ultrasound frequency and nature of the 
liquid. This „„critical‟‟ bubble is mostly filled with gases and vapour and thus 
unable to provide stiffness. The compression of bubbles occurring during 
cavitation is more rapid than thermal transport and generates localized hot-spots. 
The compression of bubbles during cavitation leads to the enormous 
concentration of energy within the small volume of the collapsed bubble. The 
oscillating bubbles can accumulate ultrasonic energy effectively while growing to 
a certain size (typically tens of mm) [21]. 
Under the right conditions, a bubble can overgrow and subsequently 
collapse, releasing the concentrated energy stored in the bubble within a very 
short time (with a heating and cooling rate of >1010 K.s-1). This cavitational 
implosion is very localized and transient with a temperature of ≈ 5000 K and a 
pressure of ≈ 1000 bar [22]. 
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Figure I-3: Schematic representation of transient acoustic cavitation (Adapted from 
Bang J. H. and Suslick K. S [23]). 
The chemical effects of ultrasound were explored for many years, specially in 
water [24-28]. Ultrasonic irradiation of aqueous liquids generates free radicals, 
and the formation of free radicals by sonolysis of water has been particularly 
well-studied. Primary sonolysis products in water are hydrogen radicals (H•) and 
hydroxyl radicals (•OH) [Equation I-1 (1)] [23]. These radicals can recombine to 
return to their original form or combine to produce hydrogen (H2) and hydrogen 
peroxide (H2O2) [Equation I-1 (2) and (3)]. They can also produce hydroperoxyl 
radicals (HO2
•) by combination with oxygen (O2). These strong oxidants as well 
as the reductants are used for various sonochemical reactions in aqueous 
solutions. 
 
OHHOH  2  (1) 
 2
HHH  
 (2) 
 22OHOHOH 

 (3) 
Equation I-1: Chemical reactions of sonolysis of water (Adapted from Bang J. H. and 
Suslick K.S. [23]). 
I-2.1. Sonoproduction of nano and microstructured materials 
The ultrasonic irradiation, compared to traditional energy sources, provides 
rather unusual reaction conditions (a short duration of extremely high 
temperatures and pressures in liquids) that cannot be realized by other methods 
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[20]. Major developments in nanotechnology have been achieved, by 
sonochemistry methodology, synthesising different nano and microstructured 
materials. A diverse set of applications of ultrasound have been explored to 
obtain such different materials. 
Table I-1 summarizes the most frequently used materials for the synthesis of 
nano and microstructures by sonochemical method. 
Table I-1:  Overview of the materials used to achieve different nano and microstructure 
by sonoproduction. (Information compiled, in the scope of this review, from 
references [17, 29-89]) 
Material Type Reference 
Phospholipids 
Liposomes (small 
unilamellar vesicles 
and large unilamellar 
vesicles) and solid 
lipid nanoparticles 
[29-43] 
Polymers (proteins, chitosan, 
polyglutamate/polyethyleimine/polyacrylic 
acid, polyvinyl alcohol, polyallylamine 
hydrochloride/polystyrene sulfonate, gum 
acacia and starch) 
Nano and 
microparticles 
[44-76] 
Inorganic compounds (metals, metals 
oxides, carbons and metals chalcogenides 
and carbides 
Nanoparticles 
nanotubes, nanobelts, 
nanorods, nanowires, 
nanocubes, 
mesoporous and 
amorphous 
nanostructured 
[17, 77-89] 
Among all the materials used, this review details the latest development of 
liposomes and protein nano and microparticles DS and their potential 
applications. 
Chapter I - Sonoproduction of particles for delivery purposes 
 
11 
 LIPOSOMES I-3.
Liposomes are highly versatile structures for research therapeutic and 
analytical applications [90]. 
Since Bangham et al. [91] described for the first time the preparation of 
liposomes. They have been often used as membrane model systems to reveal 
the basic nature of cell membranes. In 1971, Gregory Gregoriadis [92] proposed 
for the first time, the use of liposomes as drug carrier system, describing the 
conditions for the entrapment of Aspergillus niger amyloglucosidase (EC 3.2.1.3) 
and 131I-labelled albumin into liposomes composed of phosphatidylcholine, 
cholesterol and dicetyl phosphate. 
The unique physico-chemical properties of liposomes coupled with a 
structural versatility, explain the great potential of these resources organized as 
membrane models and vectors of drugs, which translate into huge numbers of 
studies achieved with these systems [93]. 
According to the parameters previously described it is important to state the 
essential physico-chemical characteristics along with their classification. 
Furthermore, an overview of liposomes preparation using the sonochemical 
methodology will be highlighted as well as their applications as DS. 
I-3.1. Physico-chemical considerations 
Phospholipids are the major structural components of biological membranes. 
They are amphiphatic molecules in which a glycerol bridge links a pair of 
hydrophobic chains and an hydrophilic polar head group, phosphocholine [32]. 
The hydrophobic part consists of two hydrocarbon chains of saturated or 
unsaturated fatty acids, which esterify the same number of hydroxyl groups of 
glycerol, and each chain can present ten to twenty-eight carbon atoms [94]. 
Amphipathic lipids have the ability to spontaneously form bilayer aggregates 
when dispersed in an aqueous solution, involving within a certain volume of 
solvent. These structures may consist of one or several concentric membranes, 
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varying in size from 20 nm to a few micrometres in diameter, with a membrane 
thickness approximately equal to 4 nm [32]. 
Phospholipids are abundant in nature and certainly the most used in the 
preparation of liposomes are those containing choline [34]. These are called 
lecithin or phosphatidylcholine (of the "lekithos, " a Greek word meaning egg 
yolk) and are dipolar molecules at physiological pH, with the quaternary 
ammonium group presenting a positive charge and a negative charge in the 
phosphate group (Figure I-4). Each class of a type of phospholipid, for example 
phosphatidylcholine, comprises a wide variety of molecules, as regarding the 
type of fatty acids linked to the glycerol skeleton. Fatty acid part of phospholipids 
molecule is important, and differences in fatty acid part can change the 
characteristics of the phospholipids. Fatty acids can differ in the number of 
carbon atoms chain and degree of unsaturation [95]. 
 
Figure I-4: General chemical structure of phosphatidylcholine (Adapted from Keller A. 
[96]). 
Lecithin from natural sources, as extracted from egg yolk or soybean, is a 
mixture of several molecules with carbonaceous chains of different lengths and 
different degrees of saturation. The most abundant fatty acid in lecithin from egg 
yolk is palmitic acid (35.3%), followed by oleic acid [32]. However, lecithin can 
also be obtained by synthesis, presenting a well-defined composition, particularly 
with respect to acyl chains, which can be obtained from saturated or unsaturated 
hydrocarbon chains, with greater or lesser number of carbon atoms, equal or 
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different. This type of phospholipids, such as dipalmitoylphosphatidylcholine 
(DPPC) (Figure I-5) or dimyristoylphosphatidylcholine (DMPC), can be easily 
characterized for various thermodynamic parameters, compared to the 
heterogeneous populations that are in the natural phospholipids [34]. 
 
Figure I-5: Chemical structure of DPPC. 
Lecithin, as just referred, is the major component of natural membranes, 
being widely used in the preparation of liposomes for variety applications. 
Besides phospholipids, the liposomes can also include other molecules, also 
present in natural membranes, such as cholesterol [97]. Cholesterol improves the 
fluidity of the membrane bilayer, reduces the permeability of water soluble 
molecules through the membrane, and improves the stability of bilayer 
membrane in the presence of biological fluids, such as blood/plasma [98]. 
One of the main physical characteristics of lipid bilayers is the existence of a 
certain temperature where the organization of phospholipids suffers a change. 
Thus, for different values of temperature, lipid bilayers can present itself in two 
distinct thermodynamically phases, occurring transition from one phase to 
another by varying the temperature [32]. Therefore, the lipid bilayers can be 
presented in a phase of great order, designated by solid-gel state, and for higher 
temperatures, a more fluid phase called liquid-crystal [32, 34], as shown 
schematically in Figure I-6. 
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Figure I-6: Schematic representation of the organizational structure presented by the 
hydrocarbon chains of phospholipids in the gel-solid state and liquid-
crystal. ΔT corresponds to the variation of temperature. 
The temperature of transition from one stage to another is called temperature 
of phase transition (Tc) and is specific to a particular lipid. Thus, when the 
temperature of the system is lower than Tc of the phospholipid components of a 
given bilayer, this presents an ordered structure where the hydrocarbon chains 
are in an extended conformation and tight packaged, and the freedom of 
movement is severely restricted. Above Tc, increases the mobility of the acyclic 
chains in the membrane, the area occupied by each phospholipid molecule is 
higher and the bilayer thickness decreases [32, 34]. 
The influence of hydrocarbon chain length and unsaturation (as well as head 
group) on the value of Tc for a membrane composed of different phospholipids is 
considerable. In general, increasing the chain length or the saturation of the 
chains, increases the transition temperature. For a homogeneous composition of 
membranes is possible to state a value of the phase transition temperature. 
However, for mixtures of phospholipids, Tc comprises a range of temperatures. 
The width of this interval depends strongly on the lipid composition and can 
cover more than 10 ºC or even be absent in certain mixtures of lipids, for 
example, in the presence of high concentrations of cholesterol (50%). The Tc 
described for DMPC is 23.5 ºC and for DPPC is 41.4 ºC, while the egg yolk 
phosphatidylcholine (EPC), an heterogeneous mixture, has a transition 
temperature of -15 to -7 ºC [32, 34]. 
An understanding of phase transitions and fluidity of phospholipids 
membranes is important both in the manufacture and exploitation of liposomes, 
since the phase behaviour of a liposome membrane determines such properties 
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as permeability, fusion, aggregation, protein biding, all of which can markedly 
affect the stability of liposomes and their behaviour in biological systems [32, 99]. 
Another important feature inherent to the membrane structure is its 
permeability, which is highly dependent on the dynamics and thermodynamics of 
membrane phase [34]. The degree of diffusion of molecules and ions through the 
bilayer varies considerably. The bilayers are sufficiently permeable to 
hydrophobic molecules but may constitute a barrier to hydrophilic molecules. 
Thus, compounds that are more hydrophilic can pass through the membrane, but 
more slowly, or else through typical channels in the membrane. The water and 
ions such as calcium ions, potassium, sodium and chlorine, for example, pass 
through the membrane channels (proteins), which control the entry and exit of 
these compounds in the cell [32]. 
I-3.2. Classification of liposomes 
Apart from their chemical constituents, liposomes can be characterized 
based on their number of lipid bilayers (lamellae) and size. Thus, without any 
further processing, the dispersion of phospholipids in water leads to a 
polydisperse population known as multilamellar vesicles (MLVs), whose sizes are 
usually ranging from 0.4 and 3.5 µm of diameter [32]. Each vesicle consists of 
multiple lipid bilayers (around five or more) concentrically arranged, between 
which there is a fraction of internal aqueous medium. The MLVs were used in 
early studies being the vesicles with the most immediate preparation. The 
liposomes formed by a single bilayer are called large unilamellar vesicles (LUVs) 
if its size exceeds 50 nm, according to some authors [94], or 100 nm according to 
others [98]. The small unilamellar vesicles (SUVs) are characterized by 
approximate diameters from 25 to 50 nm and unilamellar vesicles of intermediate 
size [intermediate sized unilamellar vesicles (IUVs)] for intermediate sizes [32]. In 
addition to these unilamellar vesicles, it should be also considered the giant 
unilamellar vesicles (GUVs), larger than 1 µm and can reach the tens of µm size, 
comparable to size of a eukaryotic cell (10 to 100 µm in diameter [32]). Figure I-7 
represents the types of liposomes described. 
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Figure I-7: Schematic representation of the different types of liposomes classified 
according to the size and number of lipid bilayers. Each line represents a 
lipid bilayer. 
According to the aim of study it should be selected the more suitable type of 
liposomes, usually MLVs, LUVs or SUVs. For example, in the study of structural, 
dynamic and thermodynamic properties of membranes in which the sensitivity 
can often be a problem, normally it is preferred the MLVs, due to its higher lipid 
concentration. On the other hand, unilamellar structures are chosen, particularly 
the LUVs, in studies of membrane permeability and the roles of proteins. SUVs, 
due to the high curvature, present anomalies in the packaging of lipids that make 
them susceptible to degradation in the presence of biological molecules [100]. 
Additionally, LUVs have a volume fraction for encapsulation much larger than 
SUVs for the same lipid concentration [5]. 
When they are applied as vehicles, multilamellar structures are usually 
preferred in the case of hydrophobic molecules to be encapsulated, while LUVs 
are more appropriate for the hydrophilic molecules, since they have a large 
volume/surface. Conversely, the MLVs provide a more sustained drug release 
than LUVs, as their membranes are being gradually degraded at the site of 
action. However, if it is desirable rapid delivery of the drugs, the LUVs are the 
most suitable ones [101]. For the surface studies there is a need of large 
surface/volume ratio and the obviously preferred choice are SUVs, while GUVs 
are too fragile for most applications. Although, these vesicles are very useful for 
studies of basic features, such as elasticity, permeability and tensile strength of 
bilayers, in which the optical microscope is the main method used [5]. 
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I-3.3. Preparation of liposomes 
The widespread use of liposomes for various purposes has created the need 
to develop preparation methods, which should be efficient, reproducible, and with 
the greatest simplicity. The methods of preparation of liposomes, currently 
available, are diverse and may have numerous variants. The classic preparation 
of liposomes, initiated by Alec Bangham in 1965, and used nowadays, is entitled 
by thin film hydration method [102]. This preparation process may undergo some 
changes, particularly regarding the organic solvent used, the possible addition of 
glass beads, from the drying of lipid and parameters agitation, such as time, 
intensity, mode of agitation and temperature [34]. However, this method always 
leads to the formation of MLVs very heterogeneous with regard to size, shape 
and number of lipid bilayers, and a small percentage of LUVs and SUVs [103]. 
Therefore, it is necessary to submit MLVs to further processes, when vesicles 
with specific sizes are needed. These processes include mechanical, chemical or 
electrostatic methods that allow obtaining unilamellar liposomes. There are also 
methods that use already preformed vesicles, SUVs to form mainly LUVs, small 
MLVs and GUVs. These methods are based primarily on melting, freezing and 
thawing or dehydration/rehydration of liposomes. However, the most frequently 
used methods are mechanical, and the most widespread of these are the 
sonication and extrusion, although, the homogenization and French press can 
also be applied [29, 32, 34]. 
Sonication is one of the most popular methods to prepare liposomes from the 
aqueous dispersion of phospholipids, which has been used from the beginning of 
the study of liposomes [29]. Since that several studies have been performed with 
ultrasound in order to obtain unilamellar vesicles with defined sizes. 
Finer and co-workers [30] found that the collisions produced by ultrasound 
led to complete disruption of the multilamellar particles, with the formation of 
short-lived bilayer fragments or other forms of small lecithin aggregates. These 
fragments then re-aggregate to form single-shelled vesicles of roughly uniform size. 
Woodbury and co-workers performed a study where the main goal was to 
obtain a detailed characterization of the various lipid suspensions produced by 
using different sonication times [36]. They had shown that mildly sonicated 
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liposomes generally have a bimodal distribution and are not well described by 
single mean. 
The studies of treatment time of ultrasound have been also performed by 
Maulucci et al. [35]. The results indicate that the lipid film, upon sonication, forms 
LUVs, which then progressively reduce their size when increasing the sonication 
time. At shorter sonication time, the total energy transferred by sonication was 
not sufficient to reduce MLVs and if the treatment is too long, the vesicles are 
damaged by the generated free radicals. Therefore, an optimal sonication time 
must be determined for the specific use of the vesicles. 
The size changes of liposomes as well as the polydispersity and lamellarity of 
the systems as a function of the ultrasound power applied, were also studied [37]. 
They concluded that the increase of ultrasound power decreases the number of 
lamellae, the vesicle size and the polydispersity, obtaining a homogeneous 
distribution of lipid vesicles. 
Later, the effect of sonication and freezing-thawing on the aggregate size and 
dynamic surface tension of aqueous DPPC dispersions was studied [38]. When 
DPPC dispersions were prepared using extensive sonication, they form vesicles 
that were quite clear, transparent, and stable for at least 30 days. The average 
dispersed vesicles diameter was 80 nm in water and 90 nm in standard 
phosphate saline buffer. After a freeze-thaw cycle, this dispersion became turbid, 
and precipitates of coagulated vesicles were observed with large particles of 
average size of 1.5 × 103 nm. The vesicle coagulation is due to the local salt 
concentration increase during the freezing of water. This dispersion had shown 
much higher equilibrium and dynamic surface tension than those before freezing. 
When this freeze-thawed dispersion was subjected to a resonication at 55 ºC, 
smaller vesicles with sizes of 70 nm were produced, and a lower surface tension 
behaviour was restored as before freezing [38]. 
Recently, Richardson and co-workers [39] explore also the role of cavitation 
in manipulating liposome size. They hypothesize that ultrasonic cavitation 
phenomena play a key role in altering the size distribution of liposomes 
processed in an ultrasonic bath. They manipulate the size of liposomes by 
correlating changes in liposome size with cavitation emissions at various acoustic 
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intensities and static pressures. Richardson and co-workers proved that the 
microstreaming around oscillating bubbles, and not necessarily collapse 
cavitation events, create shear sufficient to reduce the size of the liposomes 
during ultrasonic processing. 
Besides various powers, it was also study the influence of different 
ranges of frequencies (43-480 kHz) to obtain liposomes prepared with  
L-α-dilauroylphosphatidylcholine. It was observed a faster reduction of the mean 
size of liposome when a lower frequency was used [40]. The effect of frequency 
on the size reduction of liposome can be related to the strength of cavitation 
caused by the difference in the bubble dynamics. The amplitude of the oscillation 
of a cavitation bubble is larger at lower frequency because the bubble 
experiences longer time of negative pressure to glow larger [104]. The impulsive 
shock wave and the microjet stream created by a bubble are thus stronger at the 
lower frequency and consequently a size reduction of liposome was faster. 
More recent studies performed by Silva et al. [41, 42] reported the 
importance of the different parameters of sonication, such as power delivery, 
time, distance from ultrasound tip to base of reactor, when a transducer of 20 kHz 
is used to obtain LUVs. The data obtained reveals the importance of LUVs 
preparation in the nodal (lower production of •OH) and anti-nodal (higher 
production of •OH) horn position of ultrasound sources. 
Another approach based on the parameters previously mentioned [41, 42] 
was used to obtain the reduction of liposome sizes prepared with internal wool 
lipids (IWLs) [43]. 
I-3.4. Stability of liposomes 
Over time, the liposomes can undergo several types of changes, including 
physical and chemical modifications [91]. However, if prepared and stored under 
very specific conditions, the occurrence of these changes can be minimized. A 
stability study program must include the product characterization. 
Average size distribution of liposomes determined at the time of their 
preparation can change upon their storage. Liposomes tend to fuse and grow into 
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bigger vesicles, which is a thermodynamically more favourable state. Since this 
phenomenon may occur mainly at the Tc, it is advisable to store the suspensions 
of liposomes at a temperature different from that. Additionally, it can be 
advantageous to include a sufficient proportion of cholesterol into the membrane 
to reduce or eliminate the phase transition, particularly if it occurs in a 
temperature range near which the liposomes are stored or handled. The 
macroscopic aspect, average size and size distribution are important parameter 
to evaluate and can be obtained by examination of the suspension or by using the 
photon correlation spectroscopy (PCS) and/or electron microscopy [32, 34, 42, 98]. 
Chemically, phospholipids are susceptible to oxidation and hydrolysis 
reactions. Although, the most susceptible to degradation are lipids containing 
double bonds, since the unsaturation permits delocalization of the remaining 
unpaired electron along the lipid chain, and lower the energy of this state (and 
hence increase the probability of its being formed). The polyunsaturated fats are 
thus particularly susceptible to oxidative degradation [32, 34]. The oxidative 
degradation of the lipids in general can be minimized by protecting the lipid 
preparations from light, by adding antioxidants or by producing the product under 
nitrogen or argon environment [34, 98, 105, 106]. The hydrolysis of phospholipids 
leads to the formation of lysophospholipids and free fatty acids [107-109]. The 
presence of lysophospholipids enhances the permeability of liposomes and thus 
it is essential to keep its level to a minimum in a given preparation [109]. 
Hydrolysis is strongly affected by temperature and pH. In fact, this degenerative 
chemical process can occur to a lesser extent at low temperatures and pH values 
close to neutrality [32]. On the other hand, the use of lipids that contain ether 
linkages instead of ester, such as those found in the membranes of halophilic 
bacteria, completely avoids the hydrolysis reactions [32, 110, 111]. 
Oxidation and hydrolysis of phospholipid can be also promoted by free-radicals 
formed in the cavitation bubbles during the preparation of the sonicated 
phospholipid suspension [33]. Although, according to Kruus et al. [112], the 
formation of free radicals is not a major problem when low frequencies (≈ 20 kHz) 
and short sonication times (≈ 20 min) are used. Rabinovich-Guilatt et al. [113] 
proved that the use of a temperature of 50 ºC over 24 h induces only 1.6% of 
phosphocholine hydrolysis. 
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Other factors to be taken into consideration prior to starting a stability study 
are the formulation factors and environmental conditions, which may influence 
the stability of liposomes. Influence of formulation factors such as pH, buffer 
species, ionic strength, and solvent system play a major role in stabilizing a 
liposome formulation [98]. 
I-3.5. Liposomes as delivery systems 
The ability of liposomes to dissolve, protect and drive water-soluble or fat 
soluble drugs, as well as its biocompatibility with cell membranes and the 
possibility of adding certain ligands to their surface achieving a particular cell 
type, were the main reasons for their implementation systems as carriers of drugs 
in cosmetic, pharmacology and medicine [34, 93, 114, 115]. One of the main 
advantages of using liposomes as carriers is the easy drug incorporation, 
independently of their charge or molecular weight, and the accommodation of 
substances with very different polarity characteristics on the same system [115, 
116] (Figure I-8). 
 
Figure I-8: Possible locations of water-soluble drugs or other compounds without (1) 
or with electrostatic or ionic bonds (2), hydrophilic (3) or amphipathic (4) 
drugs in the phospholipid membrane (Adapted from Lasic D. D. [34]). 
As a pharmaceutical formulation, the main advantages conferred by liposome 
encapsulation of drugs are increased solubility of lipid soluble drugs and the 
protection granted by these systems to hydrolysis of the drugs, caused for 
example by the action of degenerative enzymes, adverse pH and action of light [34]. 
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The application of liposomes in vivo is limited by its retention at the level of 
the reticuloendothelial system (RES). In fact, liposomes in the bloodstream are 
quickly captured by the macrophages, as well as the liver, spleen, lymph nodes, 
lungs and bone marrow, which have the function of processing the foreign agents 
that enter in the body [117]. Thus, the half-life in plasma of liposomes can be 
reduced to few minutes. The problems led to the development of liposomes, with 
the inclusion of certain molecules in their outer layer, with new transport options 
in order to prevent their elimination by the RES. Indeed, the physical 
characteristics and composition of liposomes affects their capture by the RES, 
such as the size and fluidity. Therefore, larger liposomes are captured more 
quickly, as well as the more rigid liposomes due, to its constitution [118]. One 
way to going through this problem is coating liposomal vesicles with a hydrophilic 
polymer, such as polyethylene glycol (PEG), which reduces uptake by the RES 
[119-121]. As a result, coated liposomes remain in circulation longer than 
conventional liposomes. Additionally, incorporating targeting ligands on the 
surface of the liposomes, it is possible to direct them to certain organs. For 
example, an association with folic acid or antibodies, which are specific to 
particular cell [117, 122-126]. The modified liposomes are generically called 
stealth liposomes and may increase 100 times the half-life [121, 127]. 
 POLYMERIC PARTICLES I-4.
It has recently become a trend to develop new and suitable biomaterials, due to 
their bioavailability, biocompatibility and biodegradability coupled with low toxicity 
being the usefulness of polymers in drug delivery systems (DDS) well established. 
Continued improvement and accelerating research and development in polymeric 
materials has played a vital role in the progress of most controlled-release 
technologies. In the past 25 years, there has been a considerable increase in 
interest in this technology, as is shown by the increasing number of publications 
and patents in the area of controlled drug-release systems using synthetic, as 
well as naturally occurring polymeric materials [128]. 
The furthermost nano and microparticle formulations are effectively based on 
nano and micrometric-scaled emulsions. Therefore, the study of particle 
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formulation has to include the knowledge of emulsion formation phenomena. 
Nano and microemulsion generation is very commonly performed with such 
high-energy emulsification methods, particularly exploited in polymeric materials 
[129, 130]. The formation of such nano and micrometric scaled particles is 
governed by directly controllable formulation parameters, such as the quantity of 
energy and nature of the components. Two main groups of devices are used in 
the literature: the rotor/stator devices, which appear in the first articles of nano 
and microparticles, and high-efficiency devices, including high-pressure 
homogenizers and ultrasound generators [131]. 
Polymer-based nano and microparticles templates have been widely 
developed. Especially in the area of engineered nano and microparticles of 
polymer origin there is a vast area of possibilities for the chemical composition. 
They can be divided into two broad classes: protein-based and non-protein-based 
nano and microparticles platforms. Non-protein-based templates include PEG, 
poly(amidoamine) (PAMAM), dextran, chitosan, etc. [132]. 
I-4.1. Protein-based nano and microparticles 
Among of polymers systems, those based on proteins are very promising 
ones. Proteins are a class of natural molecules that have unique functionalities 
and potential applications in both biological as well as material fields [133]. Nano 
and microstructures derived from proteins, especially protein particles, are 
biodegradable, non-antigenic, metabolizable and can also be easily amenable for 
surface modification and covalent attachment of drugs and ligands [134, 135]. 
To develop protein-based templates, there are several criteria to be followed: 
first, the novel matrix should be easy to obtain with relatively low cost; second, 
the new template has to maintain the cells‟ viability and not cause any 
immunogenic reactions; third, the protein-based platform should be stable and 
keep its chemical and mechanical properties once it has been delivered in vitro or 
in vivo; fourth, the drug molecules should also be stable in this new material; and 
fifth, the biodegradable rate of this new novel platform should be slower than that 
of the drug molecule release rate [136]. 
Chapter I - Sonoproduction of particles for delivery purposes 
 
24 
A variety of proteins have been used and characterized for drug delivery, 
such as albumin [137-139], silk fibroin (SF) [140, 141], casein [142, 143], 
collagen [144, 145], and gelatin [146-148]. 
The serum albumin protein has been one of the most extensively studied and 
applied in the preparation of nano and microparticles, because of its availability, 
relative low cost, stability and unusual ligand-binding properties. For this reason, 
its main characteristics will be pointed in this review. 
Albumin is a globular protein, which is emerging as a versatile protein carrier 
for drug targeting and for improving the pharmacokinetic profile of bioactive 
compounds. This is the most abundant plasma protein (35-50 g.L-1 human 
serum) with a molecular weight of 66.5 kDa [149]. 
Like most of the plasma proteins, albumin is synthesized in the liver and is 
responsible for the transport of fatty acids and others lipids that would otherwise 
be insoluble in the circulating plasma [150]. 
The three-dimensional (3-D) structure of human serum albumin (HSA) has 
been elucidated by X-ray structure analysis [151, 152]. The approximate 3-D 
shape of HSA can be described as an ellipsoid consisting of three flexible 
spheres in a row (domains I, II, III) and is illustrated schematically in Figure I-9. 
 
Figure I-9 : X-ray structure of HSA (Adapted from Carter D. C. [152]). 
HSA is one of the smallest proteins present in blood plasma. Both size and 
abundance explain the fact that so many metabolic compounds and therapeutic 
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drugs are transported by this protein. The binding sites for metabolic substrates 
and diagnostic, as well as, therapeutic drugs have been extensively studied and 
reviewed [153, 154]. These properties, as well as its preferential uptake in tumor 
and inflamed tissue, its ready availability, its biodegradability and its lack of 
toxicity and immunogenicity make it an excellent candidate for drug delivery 
[103]. 
The bovine serum albumin (BSA) is also a very used protein in the 
preparation of microparticles, due to the lower cost when compared with the 
HSA. The primary structures of HSA and BSA are homologous by 80% [155]. 
Albumins are characterized by a low content of Tryptophan, Glycine and 
Methionine and a high content of Cysteine (seventeen disulphide bonds and one 
sulfhydryl group) and the charged amino acids (a.a.), Aspartic and Glutamic 
acids, Lysine and Arginine. The difference between the two proteins is that, in 
HSA, some hydrophobic a.a. are replaced by other hydrophobic residues, e.g. 
BSA holds two Tryptophan‟s a.a. in its structure and HSA has only one [150, 155]. 
I-4.2. Preparation of protein-based nano and microparticles 
In the later of 1960s, Rhodes and co-workers were the first investigators to 
produce microspheres from natural macromolecules for medical applications 
[156]. By slightly modifying the method proposed by Zolle [157], they succeed in 
producing HSA particles with a size bellow one micrometre [157]. The particles 
were formed by heat denaturation of a water-in-oil emulsion of albumin. However, 
the heat denaturation can be harmful for the entrapped drugs or bioactive 
molecules. To solve this problem, the heat denaturation was replaced by the 
chemical cross-linking agents, such as glutaraldehyde. Nevertheless, this method 
yields microspheres with a short storage life, low stability and high toxicity. These 
issues motivate new methods of microparticle manufacture in order to: 
improve protein stability, allow the further sterilization and eliminate the 
addition of cross-linking agents. 
Suslick and co-workers pioneered sonochemical synthesis of protein 
microspheres, where simple sonication of a protein solution produces 
microcapsules filled with air or a non-aqueous liquid [44]. They were made of 
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BSA and were filled with n-dodecane, n-decane, n-hexane, cyclohexane or 
toluene. The synthesis was conducted under high intensity ultrasonic probe upon 
sonicating the precursor solution under air or O2. The average diameter of the 
protein microspheres was 2.5 µm with a narrow size distribution. Ultrasonic 
irradiation of HSA generates similar microspheres to those of the BSA and the 
same was obtained for the protein microspheres of hemoglobin (Hb) [48]. 
In-depth mechanistic studies revealed that mechanism of proteinaceous 
microspheres preparation is a direct result of the chemical effects of ultrasound 
irradiation on an aqueous medium. Indeed, the microspheres formation is a 
combination of two acoustic phenomena: emulsification and cavitation. Ultrasonic 
emulsification is a well-known process and does occur in this biphasic system. 
Emulsification is necessary for microspheres formation. Nevertheless, in vortex 
mixing, emulsification occurs but microspheres are not formed. Consequently, 
emulsification by itself is not sufficient for microspheres formation. 
Ultrasonic emulsification creates the microscopic dispersion of the protein 
solution necessary to form the shape of the proteinaceous microsphere shell. 
However, ultrasonic irradiation of liquids produces acoustic cavitation: the 
formation, growth and implosive collapse of bubbles. The collapse of such 
bubbles creates transient hot-spots with enormous peak temperatures and 
production of free radicals. Aqueous sonochemistry caused by the implosive 
collapse of bubbles produces •OH and H• radicals, and in the presence of O2, 
superoxide (O2
•-) and HO2
• radicals. •OH, O2
•-, and HO2
• radicals are all potential 
protein cross-linking agents. Using various trapping agents, they concluded that 
the important oxidant involved in microsphere formation is superoxide [46, 47]. 
They proposed that the Cysteine, which is present in BSA, HSA, and Hb, is 
oxidized by the O2
•-. The microspheres are then held together by protein 
cross-linking through disulphide bounds from Cysteine oxidation (Figure I-10). 
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Figure I-10: Disulphide cross-linking holds the protein microspheres together (Adapted 
by Suslick K.S. [17]). 
In a later publication, Suslick and Grinstaff reported on the preparation of 
aqueous suspensions of air-filled proteinaceous microbubbles [45]. The synthesis 
involves the ultrasonic irradiation of aqueous protein solutions in the presence of 
O2. Yields and size distribution of HSA and BSA microbubbles were determined 
as a function of various experimental parameters. The ultrasound irradiation was 
conducted during three minutes [45]. This irradiation time is typical for the optimal 
formation of the protein microspheres. It is worth mentioning that the difference in 
the formation of the liquid- and air-filled bubbles is in the position of the sonicator. 
In a typical synthesis of liquid-filled protein microspheres, the organic liquid is 
layered over a 5% w/v protein solution and the horn is positioned at the 
water/organic interface. For air-filled microbubbles, the horn is placed at the 
water/air interface. 
Another approach has been developed about the mechanism of 
microspheres formation with ultrasound systems [51]. To probe whether the 
sonochemical microsphere formation process is more general and can be 
applied to proteins that do not contain Cysteine residues, an attempt was 
made employing this method to streptavidin. Streptavidin is a protein, which 
has no sulphur residues [51]. They had extended the sonochemical method to 
this non-sulphur containing protein and demonstrated the formation of protein 
microspheres. Nevertheless, no microspheres were obtained when the pH was 
kept at 7. However, when the pH was lowered to 6.0, by adding a concentrated 
acidic solution, microspheres were formed. According to the proposed 
Chapter I - Sonoproduction of particles for delivery purposes 
 
28 
explanation, hydrophobic or thermal denaturation of the protein after the initial 
ultrasonic emulsification assists in microsphere formation. A contribution is 
provided by the lowering of the pH, which helps to neutralize the basic COO- 
edges, thus creating a more favourable hydrophobic environment. To verify 
whether this hypothesis is correct, a poly(Glutamic acid) protein was sonicated 
[51]. This protein carries only carboxyl groups on the side chain. Microspheres of 
the poly(Glutamic acid) were formed only at a pH lower than 4.5. Thus, the 
authors concluded that hydrophobic interactions, which become more dominant 
in an acidic medium, are responsible for the production of the microspheres in a 
poly(Glutamic acid), as well as in streptavidin. 
In addition, sodium polyglutamate (SPG) microspheres have also been 
reported that are stabilized by hydrogen bonding networks instead of 
covalent cross-linking [58]. More specifically, the dominant interaction 
between the polymer chains are a network of hydrogen bonds or ion pairs:  
[RCO2
-···M+···O2CR] in which M
+ =H+ or Na+ [58]. 
Gedanken and co-workers [67] have synthesized microspheres made of a 
few different proteins. The three proteins used were BSA, green fluorescent 
protein (GFP) and cyan fluorescent protein - glucose binding protein - yellow 
fluorescent fused protein (CFP-GBP-YFP). The two synthesized microspheres 
made of mixed proteins are BSA-GFP and BSA-(CFP-GBP-YFP). The authors 
characterized the three possible arrangements from the assembly of two different 
kinds of proteins in microsphere structures. First, the two combined proteins form 
the microspheres walls. Second, the first protein forms the microspheres walls and 
the second one is encapsulated inside the liquid-filled proteinaceous microsphere 
bubble. Third, each kind of protein forms one-protein microspheres [67]. 
Recently, Silva et al. [72] highlighted the insights on the mechanism of 
protein microspheres formation using two different proteins, namely BSA and SF 
from Bombyx mori. As it was previously referred, BSA is a globular protein. In 
contrast, SF is a fibrous protein and is mainly composed of hydrophobic a.a. 
without Cysteine residues in its structure. The SF from Bombyx mori is an 
insoluble protein and its primary structure has been determined to be composed 
dominantly of a six a.a. residue motif, i.e., -Gly-Ala-Gly-Ala-Gly-Ser- (Figure I-11) 
[158-160]. 
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Figure I-11: Three-chain layer of a polypeptide GAGAGS model (Adapted from Zhou et 
al. [161]). 
The authors report the influence of different ratios of aqueous/organic phase 
and protein concentration on microspheres production using BSA and SF. An 
increase on protein concentration promotes ≈ 100% of yield on particles 
formation, independently of aqueous/organic ratio used. It was proved that the 
use of lower organic fraction leads to smaller sizes particles. It was also found 
that these parameters demonstrate to be an important tool to control the sizes of 
particles, ranging from 300 to 1500 nm. The conformation assessment obtained 
with Fourier transform infrared (FT-IR) analysis demonstrated a change on the 
secondary structure of SF upon sonication treatment, presenting an increase on 
the amount of β-sheet. Conversely, the sonochemical treatment did not affect the 
secondary structure of the globular protein, BSA. 
Based on these different sonochemical approaches to synthesize protein 
microspheres, a multitude of parameters should be controlled as well as the 
physico-chemical protein characteristics, to precise the main mechanism of 
protein microspheres formation for each protein in particular. 
Cavaco-Paulo and co-workers [73] further extended the sonochemical 
method to new engineering peptides, with a range of sizes and sequences, to 
highlight the mechanism of proteinaceous microspheres formation. It was 
reported the importance of some a.a. residues and their arrangement in peptide 
construction in respect to obtain microspheres with adjustable properties to cover 
a wide range of applications. The authors proved that the larger peptides with 
separated and clear hydrophobic and hydrophilic areas lead to small and more 
stable spheres. 
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I-4.3. Biological activity of protein-based nano and microparticles 
A related effort by Suslick and Wong was the biological activity of 
microspheres formed with Hb [48]. The microspheres of Hb were filled with air 
and are described as having many of the ideal characteristics needed for use as 
blood substitute. The results of the oxygen binding have shown that Hb 
microspheres can bind and release oxygen at the same oxygen pressures as 
native Hb. The authors have calculated the oxygen-carrying capacity of the Hb 
microbubbles and found that for O2 filled microbubbles it is greater by 50% than 
whole blood (0.32 mL O2 per mL microbubble versus 0.2 mL O2 per mL blood) [48]. 
Later, Avivi and Gedanken performed two other investigations probing the 
biological activity of proteinaceous microspheres [55, 60]. In the first, it was 
found that unlike a denaturation process, where the biological activity of the 
protein is destroyed, the sonochemical process leading to the microspherization 
of a protein reduces its biological activity but does not destroy it. Avidin 
microspheres are still active after the sonochemical process. Thus, it was 
verified that avidin microspheres have ability to bind biotin, but to a lesser 
degree than the native protein [55]. In a second study related also to the 
biological activity of proteinaceous microspheres, Avivi [60] formed microspheres 
of α-amylase (1,4-α-D-glucanohydrolase, endoamylase), a protein known to 
hydrolyse starch, glycogen, and related polysaccharides by randomly cleaving 
the internal α-1,4-glucosidic linkages. Microspheres of α-amylase were 
compared for their catalytic activity with those of the native protein. They 
concluded one more time that the sonochemical method does not destroy the 
enzymatic activity of the microspheres. In this research, it was demonstrated 
that the sonication leading to the modification into microspheres of two 
enzymes, α-amylase and α-chymotrypsin, is not a denaturation process. The 
protein microspheres are catalytically active, but their reactivity is reduced as 
compared to the native protein. 
More recently, it was developed a new methodology to recover the biological 
function of protein [74]. The refolding of ribonuclease A (RNase A) microspheres, 
assisted by protein disulphide isomerase, is highlighted in this study. The 
ultrasound application was shown to induce a loss of 35% of RNase A enzymatic 
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activity when compared to the native RNase A, and protein disulphide isomerase 
was able to restore it [74]. Moreover, the application of protein disulphide 
isomerase on RNase A microspheres emulsion, in the presence of appropriate 
oxidative environment, suggested the refolding of microspheres into the aqueous 
medium by a protein disulphide isomerase induced-structural change. 
I-4.4. Protein nano and microparticles stability 
When protein nano and microparticles are used as the DS, their stability 
becomes a major concern, mainly against aging and aggregation. This issue has 
been studied for quite long time and a variety of factors are known to influence it. 
These factors include, but are not limited to, particle size distribution, surfactant 
type and concentration, aqueous solubility of the dispersed phase, temperature, 
surface tension and ionic strength [162]. To investigate the stability of prepared 
particles, a program of study should be performed to measure in appropriate 
interval time their physical stability. 
The most important parameter affecting the stability of microspheres is their 
size and its distribution, which can be determined by PCS. If the microspheres 
are even slightly soluble in the aqueous phase, mass transfer will occur from the 
smaller microspheres to the larger ones. This phenomenon, Ostwald ripening, 
was first theorized by Ostwald in 1901 [163]. Ripening usually occurs in solution 
due to the lack of monodispersity of microspheres. If all microspheres have the 
same size, ripening does not occur. The protein microspheres prepared by 
sonication usually have a broad size distribution, due to the disruption of acoustic 
sound. 
The addition of a surfactant to the emulsion can help to solve this problem. 
The surfactant, also called tensioactive agent, is frequently employed for the 
dispersion of one phase in another immiscible phase and for the stabilization of 
obtained emulsion. It reduces the surface tension of continuous phase, avoids 
the coalescence and agglomeration of drops and stabilizes the emulsion. 
A suitable surfactant should be able to give microspheres of a regular size 
with small size distribution, guaranteeing a more predictable and stable drug 
release. 
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There are four different types of surfactant classified by the nature of the 
hydrophilic part of molecule: anionic, cationic, amphoteric and non-ionic. The 
anionic surfactants have a negative charge in the aqueous solution. They have a 
relatively high hydrophilic/lipophilic balance level, because they are disposed to 
be hydrophilic. Contrariwise, the cationic surfactants present a positive charge in 
aqueous solution. The amphoteric surfactants behave as anionic in alkali pH and 
as cationic in acid pH. Non-ionic surfactants have no charge [164]. 
It is unrealistic to find a single surfactant that properly works for all different 
processes. Different formulations impose different requirements on stabilizers 
[165-168]. Furthermore, differences in the surfaces characteristics of drug would 
require different properties of stabilizers [169]. 
The amount of stabilizer used will also have an effect on the properties of the 
micro and nanoparticles. Most importantly, if the concentration of the stabilizer is 
too low, aggregation of the polymer droplets will occur and little if any particles 
will be recovered. Alternatively, if too much of the stabilizer is used, the drug 
incorporation could be reduced due to interaction between the drug and 
stabilizer. However, when the stabilizer concentration is between the “limits”, 
adjusting the concentration can be a means of controlling particle size [170]. 
Recently, it was demonstrated the importance of adding stabilizers to obtain 
a monodisperse population of proteinaceous microspheres by sonochemical 
synthesis [76]. Several stabilizers were studied and the polyvinyl alcohol (PVA) 
shown to be the best choice to obtain BSA and HSA microspheres with small 
size, homogeneous dispersion and high stability. The authors also proved that 
the presence of PVA increased the entrapment efficiency of an anti-inflammatory 
drug, piroxicam. 
I-4.5. Protein-based nano and microparticles as delivery systems 
Another important issue is the possibility of using such devices as DDS for 
different diseases. Since the first reports on the preparation of uniformly sized 
albumin microspheres in the early 1970s, these biodegradable, biocompatible 
particles have found various applications. Initially conceived as a diagnostic tool 
[171], albumin particles have been utilized as drug-carrier systems [172]. 
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In general, the polymeric DS release bioactive agents by the following 
mechanisms [173, 174]: diffusion, chemical reaction or solvent activation. The 
release of a bioactive agent from a particle is primarily controlled by diffusion of 
the bioactive agent through the polymer [175]. For biodegradable polymers, 
degradation is a chemical process, whereas erosion is a physical phenomenon 
dependent on dissolution and diffusion process. As soon as the bioactive 
agent-containing polymer (A) comes into contact with the external liquid 
environment, it enters the polymer matrix (B), resulting in a swelling process, 
which allows the diffusion of the bioactive agent into the external environment 
[175] (C), as illustrated in Figure I-12. 
 
Figure I-12: Schemes of the release of entrapped drug or bioactive agents from 
biodegradable polymeric particles. When the polymer device incorporating 
the bioactive agent (A) is inserted into the environment, the fluid from the 
surrounding medium enters the particle (B), causing swelling of the device. 
The fluid creates diffusion channels (C) and the incorporated active agent is 
released to the external environment. The degradation of material device 
occurs over time or by chemical reactions (e.g. enzymatic attack and 
chemical reactions on particular polymeric sites). 
Factors influencing the release rate include the molecular size of the 
bioactive agent and the entrapped percentage into the nano and microparticle, as 
well as polymer composition, and the dimensions and shape of the particles [173]. 
Regarding the release profile, strategies to control or render it more adequate 
for a particular application, by means of modifying parameters such as the 
surface (by coating, chemical modification and use of surfactants) or creating 
dual-release systems (layers of materials that can incorporate different 
molecules) can greatly improve the properties of several materials. With this, the 
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obtained microspheres can be changed to increase their stability as well as to 
target an organ or a tissue. 
The availability of numerous exploitable side groups in proteins such as 
amine, hydroxyl, thiol and carboxyl groups makes it possible to use conjugation 
routes on prefabricated particles. 
The encapsulation of the antibiotic tetracycline (TTCL) in BSA microspheres 
by sonochemical method, was successfully obtained by Avivi and Gedanken [53]. 
In the same research group the proteinaceous microspheres of BSA containing 
an anti-cancer drug (Taxol) were produced and characterized [62]. Later, the 
gemcitabine, which is also an anti-cancer drug, was encapsulated on BSA 
microspheres (BSA-Gemzar) [66]. The BSA-Gemzar composite was examined 
for its anti-cancer activity (in vitro) in renal cancer cells (RCC, 786-O cells) 
using [3H] thymidine incorporation assays. They found that the influence of the 
Gemzar-loaded microspheres on the cancer cells was significantly greater than 
that of an equimolar concentration of Gemzar. 
Recently, the benefits of encapsulated oil were verified by Silva et al. [75]. 
The authors reported a novel approach using proteinaceous microspheres of 
BSA, HSA and SF containing different organic solvents, namely n-dodecane, 
mineral oil and vegetable oil, to reduce the activity of human neutrophil elastase 
(HNE) found in high levels on chronic wounds. The ability of these devices to 
inhibit HNE was evaluated using porcine pancreatic elastase (PPE) solution as a 
model of wound exudates. These devices demonstrate an innovative way to 
control the imbalance of elastase/antielastase found in chronic wounds. 
The entrapment of an anti-inflammatory drug, piroxicam, was also achieved, 
using BSA and HSA [76]. The work performed included the determination of the 
release kinetics of piroxicam from proteinaceous microspheres in the presence of 
protease, indicating an Anomalous drug transport mechanism (diffusion and 
polymer degradation). In the presence of higher protease concentration, BSA 
microspheres exhibit Case II transport, leading to zero order release (polymer 
degradation). 
Suslick and co-workers [58] reported on a noncovalent, electrostatic layer-by-layer 
(LBL) modification that successfully targets protein microspheres to the integrin 
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receptors that are over expressed in several tumor types. Suslick has found that 
these negatively charged vesicles are excellent templates for LBL electrostatic 
adhesion. 
Multilayer deposition of polyelectrolytes onto air-filled microbubbles is an 
attractive strategy to design targeted particles. Cavalieri et al. [64] report the 
synthesis of stable and functional microbubbles, coated with chemically reduced 
lysozyme, using high intensity ultrasound in aqueous solution. In order to 
demonstrate the possibility of surface functionalization of lysozyme microbubbles, 
which is of importance in targeted drug delivery, they adsorbed a polyelectrolyte 
on the surface of the microbubbles. Lysozyme air-filled microbubbles are 
positively charged colloidal particles and provide a good template for assembly of 
polyelectrolyte multilayer using the LBL approach. Two layers of poly(styrene 
sulfonate)/poly(allylamine hydrochloride) were assembled on the lysozyme shell. 
 APPLICATION OF DELIVERY DEVICES FOR WOUND DRESSING I-5.
Fundamental principles of nanoscience are now increasingly being employed 
for the manufacturing of innovative textile products with biomedical properties. 
Medical textiles and biomaterials for healthcare is a culmination of the worldwide 
research into medical textiles and biomaterials. 
The future development of biomedical and protective textiles with selective 
properties that benefit the patient is based on applying scientific and clinical 
advances in wound healing, anti-microbial and enzyme-based fabrics [176]. 
From the ancient times, for effective healing of a wound, a suitable material 
had to be used to cover the wound in order to prevent any infection [177]. The 
use of biomedical textiles has being expanding as a result of innovations in 
medical procedures and textile technology. In each application area of biomedical 
textiles, advances continue, but they all depend on the properties of the fibre (or 
fibre blend) and the constructions fabricated from them. Although, medical device 
engineers have been utilizing textile structures for decades, their complexity is 
increasing as biomaterial and fabric-forming options become more abundant. 
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Biomedical textile fibres comprise synthetic fibres and those derived from natural 
sources designed a textile-based wound dressings [178]. 
Over the last few decades the wound dressings have undergone an 
evolutionary process from natural materials that simply covered and concealed 
the wound, to materials that focused on moisture management and, more 
recently, to materials that either deliver active ingredients or interact directly with 
cells or specific chemicals in the local wound environment [179]. 
The prolonged contact time of a drug with a body tissue, through the use of 
wound dressings, can significantly improve the performance of many drugs. 
These improvements range from better treatment of local pathologies to 
improved drug bioavailability and controlled release to enhanced patient 
compliance [180]. Furthermore, dressings that will deliver an active substance to 
a specific target site in a controlled fashion for a sustained period could help 
solve or minimize the non-compliance patients. In this highlight, the use of DS 
attached onto textiles-based wound dressings is being exploited for the treatment 
of several diseases. 
There are a variety of methods for the attachment of the DS onto several 
dressings. The sonochemical method appears as one of the most effective 
method, once that it is possible to produce and attach the microspheres to fibres 
by one-step reaction. 
BSA and casein microspheres have been attached to cotton and polyester 
fabrics using sonochemical radiation [181]. Proteinaceous microspheres bound to 
polyester remain linked to the fabric even after repeated washings in a washing 
machine, suggesting that these coated fibres can be used either for one-time 
application or for repeated use. 
Gouveia [182] also demonstrate the potentialities of sonochemical 
methodology to develop a coating process based on BSA/L-Cysteine (L-Cys) 
microspheres on different textile materials, namely 100% of cotton, wool, 
polyester, polyamide, cellulose acetate and viscose. The microspheres 
developed by this process evidence anti-microbial property by themselves, due to 
the addition of L-Cys. 
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Recently, it was reported the use of an anti-inflammatory drug, piroxicam, 
sonochemical entrapped on BSA microspheres and attached onto cotton and 
nonwoven gauzes [183]. This work demonstrates the ability of the functionalized 
biomaterial to deliver the pharmaceutical agent. 
 MAJOR REMARKS AND FUTURE OUTLOOK I-6.
The rapidly developing field of nano and micro structured synthesis 
constantly attracts new methods and solutions for further improving the process 
performance. 
The usefulness of sonochemical synthesis as a synthetic tool resides in its 
versatility. In this review it was highlighted the use of ultrasound sources to 
produce different nano and microparticles starting from phospholipids and 
polymeric based-proteins. The progress achieved on the synthesis of lipidic and 
polymeric nano and microstructures has been accompanied by the parallel 
exploitation of these materials in various fields, among them the controlled 
release. The sonochemical method has been further extended to the applications 
of these delivery devices designed to be textile-based wound dressings. 
There are still some challenges left to be overcome for further development 
delivery-based platforms. The variety of natural proteins encourages us to 
explore more naturally existing proteins for versatile drug delivery, which can be 
prepared by sonochemical method. 
Future developments for delivery devices can focus on the enhanced 
site-specific drug delivery by using receptor-targeting ligands, improve sustained 
drug release rates with enhanced permeability, retention time and minimize the 
undesirable side effects. 
Furthermore, there is a demand to obtain preparation methods of the nano 
and microparticles that are able to be reproducible in an industrial scale. 
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Chapter II 
Chapter II -  Materials and methods 
The main aim of this Chapter is to describe in more detail the experimental 
work that was employed throughout the thesis. Each of the following seven 
chapters has a section of “Materials and methods”, but due to constraints of 
article length it is not possible to show all the details necessary for the correct 
understanding of the experiments performed. In this Chapter it will be highlighted 
each technique used and the experiment details are described in the followed 
Chapters (III to IX). 
 MATERIALS II-1.
The majority of the chemical reagents, unless otherwise noted, was 
purchased from Sigma-Aldrich and used as provided. 
The lipophilic probe 1,1'-dioctadecyl-3,3,3',3'-tetramethylindodicarbocyanine 
perchlorate (DID) and the Nile red were purchased from Invitrogen. 
All the chemicals were stored and manipulated following the manufacturer‟s 
instructions and safety practices. 
Silk cocoons from Bombyx mori were donated from “Sezione Specializzata 
per la Bachicoltura” (Padova). 
The gauzes fibres were commercial available in a local pharmacy (100% 
cotton gauze and nonwoven gauze composed by 67% of viscose and 33% 
polyester). 
The centricon tubes (molecular-weight cut-off of 3 kDa and 100 kDa) were 
purchased from Amicon. 
Chapter II - Materials and Methods 
 
42 
 ULTRASOUND EQUIPMENT II-2.
The experimental set-up used was composed of a probe type ultrasound 
source (20 kHz Sonics and Materials Vibracell CV 33) fitted with a 3 mm diameter 
titanium micro-tip. Power delivery was controlled as percentage amplitude (20%, 
30% and 40%). The reaction vessel was an open glass cell (diameter 19 mm and 
height 75 mm), which contained 16 mL of sample solution (Figure II-1). 
The sonochemical reactor temperature was controlled via a thermo-stated 
water bath with a freezer exchanger placed within a thermo jacket cell. 
Temperature was monitored throughout using K type thermocouples (TCs). 
 
Figure II-1: Experimental set-up: a) ultrasound probe (3 mm diameter); b) glass vessel 
(diameter 19 mm and height 75 mm); c) jacketed vessel (diameter 130 mm 
and height 180 mm); d) temperature control bath. 
 PREPARATION OF PROTEIN SOLUTIONS II-3.
The bovine serum albumin (BSA) was weighted and solubilised, while human 
serum albumin (HSA) was diluted in phosphate buffered saline solution (PBS, 
0.01 M, pH=7.4) or deionized water. 
Silk fibroin (SF) was purified from its sericin content, as previously described 
[184]. The cocoons were cut, cleaned from debris and larvae and autoclaved for 
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30 min at 120 ºC. SF was then thoroughly washed with deionized water and dried 
overnight at room temperature. 
The solutions of SF were prepared by dissolving 1 g of degummed silk fibres 
into 10 mL of saturated aqueous lithium bromide (LiBr) at 60 °C for 3 h. The 
solution was then diluted by adding 90 mL of deionised water, filtered and 
dialyzed against deionized water until complete removal of salt, using cellulose 
tubing (molecular - weight cut-off of 12000 - 14000 Da) [184, 185]. 
 PRODUCTION OF NANO AND MICROPARTICLES II-4.
II-4.1. Preparation of unilamellar vesicles 
Liposomes were prepared by the thin film hydration method [91]. According 
to this method, a known amount of dipalmitoylphosphatidylcholine (DPPC) was 
dissolved in chloroform. 
The organic solvent was evaporated under a nitrogen stream and the 
residual traces of solvent were removed by a further evaporation for, at least, 
three hours under the same stream. The resulting dried lipid film was dispersed 
by the addition of phosphate buffer (0.1 M, pH 7.4) in a sufficient volume to obtain 
a final phospholipid concentration of 1500 µM. These mixtures were then 
vortexed above their phase transition temperature (41.4 ºC) to produce 
multilamellar vesicles (MLVs). MLVs suspension were sonicated at 50 ± 1 ºC to 
produce large unilamellar vesicles (LUVs) and was carried out with a total 
treatment of 21 min monitored in 3 min increments (Figure II-2). A pulsed duty 
cycle of 8 s on, 2 s off was used for all the experiments with indicated power 
delivery of 20%, 30% and 40%. 
Preparation of liposomes with peptides (5 µM) followed a similar procedure 
with the lipid solution in chloroform and the peptides dissolved in pure ethanol 
and dried together under nitrogen. 
 
 
Chapter II - Materials and Methods 
 
44 
 
Figure II-2: Schematic representation of MLVs and LUVs preparation: 1) formation of 
lipid film on the walls of the flask by evaporation to dryness of the organic 
solvent, 2) addition of an aqueous solution to the lipid film, 3) agitation to 
obtain MLVs; 4) Sonication of MLVs leading to the formation of LUVs. 
II-4.2. Preparation of proteinaceous microspheres 
The microspheres were prepared by an adaptation of Suslick method.  
Briefly, the bottom of the high intensity ultrasonic horn was positioned at the 
aqueous-organic interface employing an amplitude of 40% with a temperature of 
10 ± 1 ºC and with a total treatment of 3 min. The organic phase was chosen 
from different food-grade and/or medical approved oils. The separation of phases 
was accomplished in a few minutes. However, to obtain a complete separation of 
the microspheres from the mother solution, the flasks were placed in a 
refrigerator (4 ºC) for 24 h. After, microspheres were collected by centrifugation 
(2000 g, 30 min) using the centricon tubes (molecular-weight cut-off of 100 kDa 
or 3 kDa, for proteins and peptides, respectively) in order to separate the 
microspheres from the protein/peptide mother solution (supernatant) (Figure II-3). 
 
Figure II-3: Schematic representation of protein/peptide microsphere preparation by 
sonochemical method. 
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II-4.2.1. Preparation of proteinaceous microspheres containing piroxicam 
Microspheres with the anti-inflammatory drug selected in this work were 
employed to determine the percentage of entrapment efficiency of drug, together 
with the studies of the entrapped molecule in vitro release profiles. The 
microspheres used for these studies are the following: BSA and HSA. The 
anti-inflammatory drug was the piroxicam (Figure II-4). 
Microspheres with anti-inflammatory drug were synthesized using the 
sonochemical method. The piroxicam (3000 µM) was added to protein solution 
(5.0 g.L-1) and layered with vegetable oil and submitted to ultrasound treatment in 
the same conditions described above (II-4.2.). The very low solubility of piroxicam 
required the use of dimethyl sulfoxide (DMSO): water solutions (1:99 v/v). 
When stabilizers were used, they were dissolved in the aqueous phase. In 
this thesis, three different stabilizers were added to the formulation, namely 
polyvinyl alcohol (PVA), pluronic acid F68 (pluronic F68) and tween 80. 
 
Figure II-4: Chemical structure of piroxicam. 
 CHARACTERIZATION OF DEVELOPED MICRO AND NANOPARTICLES II-5.
II-5.1. Photon correlation spectroscopy (PCS) 
The diameter of the particles, as well as its homogeneity, was determined by 
photonic correlation spectroscopy (PCS), also known as dynamic light scattering 
(DLS). This method measures the Brownian motion and relates this to the sizes 
of the particles. 
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The Brownian motion is defined as the random movement of particles in a 
liquid due to the bombardment by the molecules surround them [186]. The 
particles in a liquid move randomly and their speed of movement is used to 
determine the size of particle. The randomly moving particles are irradiated with a 
laser beam and the intensity of the light scattered from a small volume of the 
sample in a (usually) fixed or variable angle is recorded in dependence on time. 
Small particles lead to fast intensity fluctuations as a result of their high diffusion 
coefficient, whereas for larger particles, which move more slowly, the fluctuations 
are slower [186, 187]. Because PCS relies on the determination of the particle 
diffusion coefficient (D), it is not a direct method for the determination of particle 
sizes. Information on the particle size can be obtained by the Stokes - Einstein 
equation analysing the experimental signals emitted at different sampling times 
[187]. From the value of D and together with the values of temperature (T) and 
the medium viscosity (η) it is possible to determine the diameter (d) of particles 
through the equation of Stokes-Einstein (Equation II-1) [187]. K is the Boltzmann 
constant and T the temperature in Kelvin (K). 
d
KT
D


3  
Equation II-1: Determination of particle diameter using Stokes-Einstein equation. 
In addition to the determination of particle size it is possible to calculate the 
value of polydispersity index (PDI), which is indicative of the degree of 
heterogeneity regarding to the sample size. Thus, the greater the range of 
diameters which lies between the average diameter, i.e. the higher the standard 
deviation, the greater is the PDl, whose value ranges between 0.0 and 1.0 [186]. 
The size and PDI of microparticles was measured using a Malvern zetasizer 
NS (Malvern Instruments). 
The size of liposomes vesicles was determined at 50 ± 0.1 ºC. However, the 
size of proteinaceous microspheres, as well as the peptide microspheres, was 
determined at 25 ± 0.1 ºC. 
In order to verify the reproducibility of the preparation microparticles 
assembled under the typical process described above, the procedure was carried 
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out at least three times for each of the individual nano and microparticles and the 
results were expressed as mean value ± standard deviation. 
II-5.2. Determination of zeta-potential 
Almost all particles in contact with a liquid acquire an electric charge on their 
surface. The electric potential at the shear plane is called the zeta-potential [187]. 
The determination of zeta-potential was carried out using the same 
equipment described in the study of the diameter (Malvern zetasizer NS) and 
provides information on the membrane potential of particles. 
Because the surface potential of the particles cannot be measured directly, 
the zeta-potential (electrical potential at the surface of hydrodynamic shear 
around the colloidal particles) is usually determined as a characteristic parameter 
for the nano and microparticle charge (Figure II-5) [187]. 
 
Figure II-5: Schematic representation of the double layer of charges at the surface of an 
anionic particle (biological membrane or membrane models) (Adapted from 
Malvern I. [188]). 
For measurement, a dilute suspension of the particles is subjected to a weak 
electric field, and the mobility of the particles is commonly determined by laser 
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Doppler anemometry [188]. This technique is based on the evaluation of a 
frequency (Doppler) shift that is observed for the light scattered from the particles 
motion in the electric field [187]. 
The zeta-potential is based on measuring the electrophoretic mobility of particles, 
and determined, by the Henry equation, (Equation II-2) where, µe is the 
electrophoretic mobility, the zeta () -potential, ε is the dielectric constant, f (Ka) is 
the role of Henry and η is the viscosity of the medium [188]. 
 



3
apotentialf2
e  
Equation II-2: Determination of zeta-potential using the Henry equation. 
For measuring the electrophoretic mobility, it was used a cell that has two 
electrodes that create, a potential difference, in which the particles move in 
suspension (Figure II-6). The displacement speed of particles in this field 
depends on their electrical charge [188]. 
 
Figure II-6: Schematic representation of a cell used for determining zeta-potential of a 
sample with a negative charged particle (Adapted from Malvern I. [188]). 
To determine the surface charge of nano and microparticles prepared, it was 
used the technique of electrophoretic laser Doppler anemometry [188]. 
Liposomes were suspended in PBS and measured at 50 ± 0.1 ºC. However, 
for the protein microspheres the measurements were performed at 25 ± 0.1 ºC 
and diluted with deionized water or PBS, according to the solvent used in their 
preparation. The instrument was routinely calibrated with a ± 66 mV latex 
standard. 
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The measurements were performed in triplicate and the results were 
expressed as mean value ± standard deviation. 
II-5.3. Stability studies 
A general and crucial aspect of colloid chemistry should be considered, and 
that is the means by which the particles are stabilized in the dispersing medium, 
since small particles can be unstable with respect to agglomeration to the bulk 
solution [189]. The stability of the microspheres was measured in terms of size 
distribution, zeta-potential and macroscopic aspect. The measurements of size 
and zeta-potential were done every week by the procedure previously described. 
Measurements were recorded in triplicate and the results were expressed as 
mean value ± standard deviation. 
II-5.4. Scanning electron microscopy (SEM) 
Scanning electron microscopy (SEM) has been routinely applied for the 
morphological analysis of nano and microparticles. For investigation, the particles 
are usually dried and their surface has to be coated with a conductive layer, 
commonly by sputtering with gold. 
In SEM the specimen is scanned point by point with the electron beam, and 
secondary electrons that are emitted by the sample surface on irradiation with the 
electron beam are detected. In this way, a three-dimensional (3-D) impression of 
the structures in the sample, or of their surface, respectively, is obtained [187]. 
To verify the liposomes morphology, the sample preparation included the 
drying and covering with a gold layer. The visualization was made using the 
LEICA S360 microscope. 
The microspheres and the attachment of microspheres onto the gauzes were 
evaluated also by SEM. The samples were previously gold coated in vacuum. 
However, different equipment was used for their observation. The SEM 
photographs were obtained with a scanning electronic microscope model NOVA 
Nano SEM 200 FEI with a backscattered and secondary electrons detected. 
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II-5.5. Scanning transmission electron microscopy (STEM) 
In conventional SEM study, the drastic drying conditions imposed by high 
vacuum in the microscope chamber have always prevented the directed studies 
of wet samples and dynamic imaging in a changing sample environment. Thus, 
scanning transmission electron microscopy (STEM) allows observing directly a 
liquid layer containing nano/micro objects [190]. 
For STEM analysis, the diluted microparticles suspension was dropped in 
Copper grids with carbon film 400 meshes, 3 mm diameter. The shape and 
morphology of particles were observed using a NOVA Nano SEM 200 FEI. 
II-5.6. Lowry method 
The Lowry method [191] has been, for decades, the procedure of choice for 
quantification of soluble proteins, due to its sensitivity, simplicity, and precision. 
This method was performed to quantify the protein in supernatant, using BSA as 
standard protein. The total protein concentration is exhibited by a colour change 
of the sample solution in proportion to protein concentration, which can then be 
measured using colorimetric techniques. The absorbance was measured at 
750 nm, using a Heλios γ spectrophotometer (Unicam). 
The efficiency of the microspheres formation was calculated using the 
Equation II-3, where [P]total and [P]supernatant is the initial and the final protein or 
peptide concentration in the aqueous solution, respectively. 
 
   
 
100
P
PP
%formationesMicrospher
total
ttanernasuptotal


  
Equation II-3: Determination of efficiency of the microspheres formation. 
This process indicates the percentage of protein/peptide that formed 
microspheres respecting to the total amount used in that preparation. 
Measurements were recorded in triplicate and the results were expressed as 
mean value ± standard deviation. 
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II-5.7. Quantification of piroxicam entrapped into proteinaceous 
microspheres 
Entrapment efficiency of piroxicam in proteinaceous microspheres was 
measured by ultraviolet (UV) spectrophotometry, at 353 nm using a Heλios γ 
ThermoSpectronic spectrophotometer (Unicam). The separation of free piroxicam 
was achieved by centrifugation of samples at 2000 g for 30 min, using the 
centricon tubes (molecular-weight cut-off of 3 kDa). The entrapment efficiency of 
piroxicam was determined using the Equation II-4, where [Piroxicam]initial is the 
initial concentration used and [Piroxicam]final is the final concentration in 
supernatant. 
 
   
 
100
Piroxicam
PiroxicamPiroxicam
%Entrapment
final
finalinitial 

  
Equation II-4: Determination of the entrapment efficiency of piroxicam. 
Measurements were recorded in triplicate and the results were expressed as 
mean value ± standard deviation. 
II-5.8. Confocal microscopy 
A confocal microscope provides a significant imaging improvement over 
conventional fluorescence microscopes overcoming some limitations. It creates 
sharper, more detailed images, and allows collection of data in 3-D [192]. 
For confocal analysis proteins were labelled with fluorescein isothiocyanate 
(FITC; 495 nm/521 nm) and 1,1'-dioctadecyl-3,3,3',3'-tetramethylindodicarbocyanine 
perchlorate (DID), which is an hydrophobic probe with markedly red-shifted 
fluorescence excitation and emission spectra. However, another dye, Nile red, 
was used as a probe. The main differences is that Nile red is a dye that exhibits 
solvatochromism and its absorption band varies in spectral position, shape and 
intensity with the nature of the solvent [193, 194]. 
The samples were analysed with a confocal laser scanning microscope Leica 
TCS SPE. For the 3-D reconstructions it was use the Imaris software (version 
7.0, Bitplane, Zurich). 
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II-5.9. Fourier transform infrared (FT-IR) spectroscopy 
The Fourier was used to quantitatively assess protein secondary structure by 
Fourier transform infrared (FT-IR) spectroscopy. This approach can provide detail 
information regarding protein conformation without alteration or degradation of 
the controlled release system [155]. 
Infrared spectra were recorded at room temperature using a Perkin Elmer 
Spectrum 100 Infrared spectrophotometer from 4000 cm-1 to 500 cm-1. To 
eliminate spectral contributions, due to atmospheric water vapor, the instrument 
was continuously purged with dry air. The protein microspheres emulsion was 
quickly transferred to a potassium bromide (KBr) Liquid Omni Windows support 
cell in an Omni Cell Assembly accessory, specially designed for liquid solutions. 
All samples were measured at least three times. 
Gaussian deconvolution of Amide I band region was performed using 
OriginPro 8.5 software. The number of components and their peak position were 
determined from the second derivative spectrum of the same region. The 
secondary structure content was calculated from the areas of the assigned peak 
as percentage fraction of the total area of the Amide I range. For all data, a linear 
baseline was fitted and a self-deconvolution was performed using Gaussian 
function. 
II-5.10. Molecular dynamic studies 
Molecular dynamics simulations were performed with the GROMACS 
package, using the GROMOS96 force field with an integration time step of 2 fs. 
Bond lengths of the solute were constrained with LINCS and the ones of water 
with SETTLE. Non-bonded interactions were calculated using a twin-range 
method with short and long range cut-offs of 8 and 14 Å, respectively. The SPC 
water model was used. The solute and solvent were coupled to two separate 
heat baths with temperature coupling constants of 0.1 ps and reference 
temperatures of 300 K. The pressure control was implemented with a reference 
pressure of 1 atm and a relaxation time of 0.5 ps. 
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Chapter III 
Chapter III -  Effect of ultrasound parameters for unilamellar liposome 
preparation† 
ABSTRACT 
In this study, it was investigated the effects of ultrasound, namely power 
input, distance from ultrasound tip to base of reactor and treatment time, in the 
formation of liposomes. Results indicate a dependence on cavitation events that 
are a function of power input, and consequently dependent on the position of the 
probe within the reaction vessel and the wave behaviour. Short treatment times 
are required to achieve nanosized vesicles in anti-nodal (/4; 19 mm) reactor 
geometries. In this wave point the cavitation phenomenon is more pronounced 
when compared with the nodal point (/2; 38 mm). Therefore, the consideration 
of the above parameters is vital if dependable and repeatable results are to be 
achieved. 
 
 
 
                                            
†
 This chapter is based on the following publication: 
Silva R; Ferreira H, Little C, Cavaco-Paulo A, Effect of ultrasound parameters for 
unilamellar liposome preparation, Ultrasonics Sonochemsitry, 2010 (17), pp 628-632. 
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 INTRODUCTION III-1.
Liposome applications can been found in many different areas as 
biochemistry, molecular biology, food technology, pharmaceutical and medical. 
Each application requires vesicles with different characteristics, which will be 
dependent for example, on the material to be encapsulated, as well as on the 
different release properties [5, 98, 195]. Different methodologies are described in 
the literature to produce multilamellar vesicles (MLVs), large unilamellar vesicles 
(LUVs) and small unilamellar vesicles (SUVs) [5, 32, 98, 103]. 
The use of ultrasound methods to produce LUVs and SUVs are widely 
reported in the literature [32, 37, 196]. However, the productions of these 
phospholipid vesicles are poorly reproducible, since that ultrasound experimental 
set-up is not well described. 
Ultrasound phenomena in liquid media enhance mass transports of their 
constituents in a non-homogeneous fashion allowing the fast formation of vesicles 
[197, 198]. Several authors had pointed the fact that the most claimed ultrasound 
characteristics are in direct dependence of power input and duration of sonication 
effects [14, 25, 28]. However, the control of these two parameters leaves the 
possibility of variation sound field intensity arising from the relationship between 
the frequency of ultrasound, position of probe tip from the base of the vessel and 
the phase of the sound wave upon reflection at the base. 
It is well known that ultrasound mechanical waves generate cavitation in 
liquids with the formation of local hot spots and free radicals [20, 22]. Previous 
work, done by Little et al., has shown that variations of the ultrasound path-length 
had a marked effect on rates of temperature rise and radical production within the 
bulk solution [199]. Therefore, the power input, the duration of treatment and the 
position of the ultrasound source within the solution, will have an outcome on the 
ultrasound conditions imposed on the solution. This will affect the levels of 
hydroxyl radicals (•OH) generated in solution. In fact, the chemical effects of the 
cavitation bubble collapse, namely •OH radical formation, are rarely considered in 
detriment of the extent of the tensile stresses imposed by ultrasound, which are 
usually reported [199]. 
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The present work intends to show the need of control experimental set of 
operating parameters to engineer the characteristics of phospholipids vesicles. 
For that it was performed an extensive reactor characterization process. The 
methodology that was used explored the effects of the three parameters referred, 
namely power input, sonication time and depth (measure from the base of the 
vessel), in the production of •OH radicals and consequently in the formation of 
vesicles. These conditions were related with lipid vesicle size, the polydispersity 
index (PDl) and surface charge (before and after sonication), usually determined 
in terms of zeta-potential. 
 MATERIALS AND METHODS III-2.
III-2.1. Calorimetry and dosimetry procedures 
The reactor was characterized via calorimetry and dosimetry by an 
adaptation of the previously published method [199]. Calorimetry measurements 
were performed within a custom made enclosure with temperature recorded via 
four wire ended k-type thermocouples (TCs), three positioned at the outer sides 
and one at the base of a glass vessel of the same type as that used for dosimetry 
and liposome formation. The TCs were interfaced with a Pico Technology TC-08 
Thermocouple data logger connected to a computer with Pico Log software 
version R.33. The sonochemical reactor temperature was controlled via a 
thermo-stated water bath with a heat exchanger placed within a thermo jacket 
cell. The vessel was filled with 16 mL of deionized water and the probe activated 
for ninety seconds (90 s) constant ultrasound at the indicated power input 
settings. The initial temperature (Ti) was taken from the average within the 
solution for 10 s prior to activation, and the final temperature (Tf) the average in 
the final 40 s of sampling. Calorimetry was performed using deionized water and 
the calorific power of the reactor was determined from Equation III-1, where E is 
the calculated energy (J) to raise the water temperature, ΔTAve is equal to 
difference of the final and initial temperature (Tf -Ti; K), m is the mass of H2O (Kg) 
and Cp is the heat capacity of H2O (4186 J.Kg
-1.K-1). The change in temperature 
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(ΔT) from the initial to final levels was calculated for each TC position where ΔT, 
values were averaged from the four TCs positions to give ΔTAve. 
pAver CmTE   
Equation III-1: Determination of calorific power (J). 
Calorific power was subsequently converted to intensity (I) units of W.cm-2 
using Equation III-2, where Δt is the time of ultrasound activation and .r2 the 
surface area of the micro-tip. 
2rt
E
I


 
Equation III-2: Conversion of calorific power into intensity (W.cm
-2
). 
A total sonication time of 90 s using the previously specified duty cycle was 
used at an indicated power input percentages of 20%, 30% and 40%. The 
dosimetry procedure was performed by the ultrasonic irradiation of buffered 
aqueous terephthalic acid (TA) solution [199]. This leads to the breakdown or 
sonolysis of the water, which results in the formation of •OH and hydrogen (H•) 
radicals. The reaction is specific to •OH radical and results in conversion of TA to 
2-hydroxyl-terephthalic acid (HTA), which exhibits fluorescence under UV 
excitation and accounts for 35% of •OH radical formation [14]. The detection of 
HTA was performed on a Shimadzu RF-1501 spectrofluorophotometer, using an 
excitation wavelength of 314 nm and an emission wavelength of 425 nm. 
Samples were taken (2 mL) in triplicate and returned after analysis. The HTA 
decay rate during the 15 min of incubation time was negligible. Fluorescence 
data was averaged and converted to nmol.mL-1.s-1 using the calibration curve of 
fluorescence vs HTA concentration (nmol.mL-1). The calorimetry and dosimetry 
procedures were based on the variations of the distance between the ultrasound 
tip and the base of the reaction chamber, shown as x in Figure III-1. 
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Figure III-1: Experimental set-up: a) ultrasound probe (3 mm diameter); b) glass vessel 
(diameter 19 mm and height 75 mm); c) jacketed vessel (diameter 130 mm 
and height 180 mm); d) lipid solution (16 mL, 1500 µM); e) temperature 
control bath (50 ºC) and x) distance between ultrasound tip and base of the 
glass vessel. 
These distances variations were chosen based on a guideline wavelength. The 
Marczak equation (Equation III-3) [200] gave us the value of the velocity of sound 
in pure water (c), and therefore, it is possible to determine the wavelength 
according to the Equation III-4, where T is the temperature in degrees Celsius 
and f is the frequency in kHz. 
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Equation III-3: Determination of velocity of sound in pure water using the Marczak 
equation. 
f
c

 
Equation III-4: Determination of wavelength. 
According to Equation III-3 and Equation III-4 for 50 ºC the wavelength was 
77.1 mm. 
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III-2.2. Preparation and characterization of liposomes 
Liposomes were prepared according with the method described in Chapter 
dedicated to materials and methods. The procedure for the further 
characterization of liposomes (size distribution and the zeta-potential) is also 
mentioned in the same Chapter. 
 RESULTS AND DISCUSSION III-3.
The reactor was characterized via calorimetry and dosimetry procedures, as 
previously described, prior to testing the liposome behaviour to the sonication. 
These two procedures were performed at 19 mm (anti-nodal point; /4) and 
38 mm (nodal point; /2) of depth, which were calculated based on an estimated 
wavelength of 77.1 mm. The nodal point is known as a point where the wave has 
the minimal amplitude. The opposite of a nodal point is an anti-nodal point, where 
the amplitude of the wave is maximum. 
The calorimetry results are presented in Figure III-2. In this figure, it is 
possible to observe that the energy deposition for these two depths (19 and 
38 mm) increase with the power input. The highest value of input energy (about 
of 50 W.cm-2) was obtained at 19 mm of depth and 40% of power input. Although, 
when it was used the 20% of power input at two different depths (19 and 38 mm), 
it was obtained the same input energy inside of the reactor (about 15 W.cm-2). 
After the calorimetry method it was performed the TA dosimeter, which is 
extensively used as an •OH radical indicator [25, 28]. The extent of the 
conversion of TA to HTA obtained in the dosimetry procedure is shown in 
Figure III-3. 
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Figure III-2: Variation of measured input energy (W.cm
-2
) with power input (%), at 
different depths (19 and 38 mm). 
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Figure III-3: Variation of rate of 
•
OH radical formation (nmol.mL
-1
.sec
-1
) with power input 
(%), at different depths (19 and 38 mm). 
The behaviour at the 38 mm (/2) position showed an almost linear 
production of •OH radicals. Conversely, the 19 mm (/4) position displayed a 
significant increase in •OH radical production at 40% of power input. The possible 
reason for this is that whilst cavitation bubble implosion is regarded as necessary 
for •OH radical formation, and is also a contributor of heat, other factors are 
present, which contribute heat to energy to the solution when conditions do not 
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favour •OH radical production. These include cavitation bubble implosion of 
insufficient energy to form radicals, fluid friction within the bulk solution from the 
mixing effect, and friction between the bulk solution with the stationary boundary 
layer adjacent to the side of the vessel. These friction forces could continue to 
provide heat energy even when the differential in acoustic pressure is not enough 
to sustain effective cavitation [199]. After this characterization, it was possible to 
identify the minima and maxima •OH radical activity points as occurring at 38 mm 
(nodal point) and 19 mm (anti-nodal point) positions, respectively. 
The characterization described above is essential, once that the ultrasound 
can promote the hydrolysis and the oxidation of phospholipids, via the free 
radicals produced in the cavitation bubbles collapse. Additionally, high 
temperatures accelerate phosphocholine hydrolysis. Thus, during the sonication 
procedure, temperature should be controlled otherwise oxidation and hydrolysis 
reactions are favoured [33, 201]. However, according to Rabinovich Guilatt et al. 
[113] a temperature of 50 ºC over 24 h induces only 1.6% of phosphocholine 
hydrolysis. In this context, in order to minimize the hydrolysis, the temperature 
was controlled during all the experiment using a thermo-stated bath and the 
sonication was carried out in time intervals of 3 min. Therefore, in these working 
conditions the hydrolysis should be negligible. 
Afterwards, the ultrasonic treatment of the liposomes was carried out at 
amplitudes of 20%, 30% and 40%, using the depths of 38 and 19 mm, measured 
from the base of the vessel. The variation of the vesicles size with sonication 
time, at different fixed sonication powers and different depths, was analysed by 
photon correlation spectroscopy (PCS). Size distribution is a crucial parameter for 
the characterization of liposomes and can be weighted by number, surface area, 
volume or any other property of the particle being measured. These different 
measurements are dependable of the liposomes applications. Liposomal delivery 
of an encapsulated hydrophilic drug, for example, is best described by a volume-
weighted histogram to determine the liposome size at which most of the drug is 
carried. Delivery of a membrane-bound molecule may be better described by a 
surface-area weighted histogram [37]. In this work, the size of liposomes was 
measured in terms of volume, so these liposomes can be used as vehicle for 
controlled release [42]. 
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Figure III-4 shows the vesicle size, after increasing sonication times and 
using constant sonication amplitudes: 20%, 30% and 40%, for the system 
containing 1500 µM of dipalmitoylphosphatidylcholine (DPPC). This figure shows 
a decrease of the particle size with the increase of the sonication time, until a 
plateau size was obtained after 21 min of sonication. These results also 
demonstrate that the vesicle sizes decreased when sonication amplitude 
increased. In addition, using different sonication times and different depths, a 
difference in the sizes were observed. Considering a constant sonication time 
and amplitude, a higher value of liposome sizes were observed when the 
treatment was made at 38 mm. On the other hand, at the anti-nodal point 
(19 mm) the cavitation phenomenon is more pronounced promoting a higher •OH 
radical formation. These phenomena could affect the composition of samples and 
the formation of vesicles with lower sizes. However, in the nodal point (38 mm) 
the size obtained was not so different, after 21 min of treatment, with the 
advantage to decrease the possibility of phospholipid oxidation since at this depth 
the •OH radical production is much lower. 
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Figure III-4: Effect of sonication on DPPC liposomes (1500 µM) sizes (Z-average; nm) 
using 19 mm (a) and 38 mm (b) of depth, applying different amplitudes (20, 
30, 40%) after 3, 6, 9, 12, 15, 18 and 21 min, at 50 ºC and pH 7.4. 
Figure III-4 also shows that using higher amplitude it was possible to obtain a 
decrease in PDl. In fact, the size and PDl decreased as the higher power exerts 
greater shear forces within the solution. The greater extent of streaming from the 
ultrasound source promotes higher mixing of the solution and consequently more 
homogeneity. Therefore, at 19 mm and after 21 min of treatment a drop in the 
physical size and PDl was observed. However, at 38 mm the difference of size 
was not so significant and the possibility of occurring oxidative reactions is lower. 
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This is very important when it is used polyunsaturated phospholipids, because 
they are easily oxidised. 
In Figure III-5 and Figure III-6 it can be observed two different sizes of 
population. Current theories postulate that sonication, as other methods of 
liposome formation, randomly fragment MLVs into what are termed LUVs [5, 
202]. These disc-like fragments are thought to fold up into thermodynamically 
stable liposomes [203]. Alternatively, tiny unstable liposomes, formed during 
sonication, may fuse together to form slightly larger, stable liposomes [204, 205]. 
 a)  b) 
Figure III-5: Size distribution of liposomes (1500 µM) using 19 mm (a) and 38 mm (b) of 
depth, after 21 min of sonication, with 40% of amplitude, at 50 ºC and pH 7.4. 
 a)  b) 
Figure III-6: Size distribution of liposomes (1500 µM) using 19 mm (a) and 38 mm (b) of 
depth, after 21 min of sonication, with 20% of amplitude, at 50 ºC and pH 7.4. 
The determinations of zeta-potential were made before and after sonication. 
After the measurements it was verified that the potential surface of liposomes did 
not change significantly by the use of ultrasound (≈ 4 and ≈ 3 mV, before and 
after ultrasound, respectively). 
 CONCLUSION III-4.
The results of this work show the importance of reactor characterization to 
attain the control of liposome sizes using an ultrasonic probe system. It was 
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considered that the three principal factors of ultrasound which could influence the 
ranges of size of liposomes are: depth, power input and extent of treatment. 
Indeed, these factors that could influence the cavitation phenomenon have an 
impact on the rate and structure of the vesicles formed. At 19 mm of depth, 40% 
of amplitude and 21 min of treatment, carried out in time intervals of 3 min, it is 
possible to obtain a more homogeneous population of nanosized vesicles than 
38 mm. These two positions are of importance when using ultrasound for the 
breakup of multilamellar liposome layer stuff, in particular the position at which 
constructive interference (anti-nodal point; 19 mm) occurs as this maximises 
cavitation events and associated phenomena. 
These findings seem to indicate the usefulness of the ultrasound method to 
obtain unilamellar liposomes, particularly when the parameters are controlled. 
The knowledge of this can be further extended to the synthesis of other 
nanomaterials. 
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Chapter IV 
Chapter IV -  Incorporation of peptides in phospholipid aggregates using 
ultrasound‡ 
ABSTRACT 
In the previous Chapter (III) the optimum conditions for ultrasound 
preparation of liposomes were achieved. Considering these parameters, in this 
Chapter it was investigated their influence when peptides where incorporated in 
phospholipid aggregates (liposomes). These liposomes or vesicles are known as 
transport agents in skin drug delivery and also for cosmetic use. They might be a 
good model to deliver larger peptides into hair to restore fibre strength after 
hair coloration, modelling, permanent wave and/or straightening. The 
preparation of liposomes dipalmitoylphosphatidylcholine (DPPC) with peptides 
(LLLLKLLLLKLLLLKLLLLK; LLLLLLCLCLLLKAKAK) was made by the thin film 
hydration method. The large unilamellar vesicles (LUVs) were obtained by 
sonication, applying different experimental conditions, such as depth (mm) and 
power input (%). Photon correlation spectroscopy (PCS), zeta-potential and 
scanning electronic microscopy (SEM) results confirmed that the incorporation of 
these peptides, with different sequence of amino acids (a.a.), presented 
differences on the diameter, zeta-potential of membrane surface and shape of 
liposomes. The liposomes that included peptide LLLLKLLLLKLLLLKLLLLK 
present an increased in zeta-potential values after using ultrasound and an 
„„amorphous” morphology. Conversely, the liposomes that incorporated the 
peptide LLLLLLCLCLLLKAKAK presented a define shape (rod shape) and the 
potential surface of liposome did not change significantly by the use of 
ultrasound. 
 
                                            
‡
 This chapter is based on the following publication: 
Silva R, Little C, Ferreira H, Cavaco-Paulo A, Incorporation of peptides in phospholipids 
aggregates using ultrasound, Ultrasonics Sonochemistry, 2008 (15), pp 1026-1032. 
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 INTRODUCTION IV-1.
The potential use of liposomes as microencapsulators for drug delivery and 
for cosmetics applications has been well-studied [32, 93, 117, 206-209]. Several 
types of liposomes can be distinguished, depending on the preparation method, 
such as multi-, oligo- and unilamellar vesicles, containing several, few or only one 
bilayer shell, respectively [32, 97, 98, 103]. Nevertheless, all liposomes are 
basically lipid bilayer containers in which several substances could be entrapped 
or at least anchored into their structure [98]. Due to their unique physical and 
chemical properties, such as their stability in solution for long periods of time with 
no significant changes in size or structure [93], and their ability to incorporate 
lipophilic, amphiphilic and/or hydrophilic compounds [117], liposomes can be 
used in a wide range of applications. 
Multilamellar vesicles (MLVs) have high encapsulation efficiency, but also 
great variations on the vesicle size, size distribution and lamellarity. The use of 
mechanical treatments such as: repetitive freezing/thawing cycles, extrusion 
through polycarbonate membranes, dehydration/rehydration cycles, 
microfluidation or sonication can transform the MLVs suspension into large 
unilamellar vesicles (LUVs) and small unilamellar vesicles (SUVs). In addition to 
a stand-alone treatment, ultrasound can be applied to the other methods to 
increase efficiency in the formation of hydrated lipid vesicles of the smallest size. 
Ultrasound has recently been applied to obtain stable nanosuspensions which 
have emerged as a promising strategy for an efficiency delivery of hydrophobic 
drugs, because of their versatile features such as very small particle size. The 
ability to produce the nanoparticles of desired size with great precision (narrow 
size distribution and small variation) is the key factor of producing the 
nanosuspensions [37, 210]. 
The extreme conditions generated within the collapsing cavitational bubbles 
have been used for the size reduction of the material to the nanoscale. 
Nanoparticle synthesis techniques include sonochemical processing, cavitation 
processing and high-energy ball milling. In sonochemistry, an acoustic cavitation 
process can generate a localized hot zone with an extremely high temperature 
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gradient and pressure. Such sudden changes in the temperature and pressure 
assist the destruction of the sonochemical precursor and the formation of 
nanoparticles [17, 89]. 
Symmetric collapse of a cavitation bubble results in hot spots of nearly 
5000 K within the bulk solution [22] and high velocity shock waves travelling 
through the solution. Collapse in proximity to surfaces can result in deformation of 
the bubble, manifesting as asymmetric collapse. This behaviour causes micro-
streaming and high velocity shock waves within the bulk solution in the direction 
of the surface [197]. 
Myriad applications of ultrasound in medicine and industry have been 
developed; however, the details of ultrasound-induced damage to biomolecules, 
especially proteins, remain poorly characterized [211]. Such characterization is 
difficult, owing to the potentially complex mechanisms of sonication. These may 
include the formation of liquid-gas interfaces, local heating effects, sheer and 
tensile stresses and reactions occurring with generated free radicals [14, 212]. 
Loomis and Wood first reported the damaging effects of ultrasound radiation 
on biological systems in 1927 [213]. Many applications of ultrasound in common 
use today may alter protein structures [14]. However, sonication is used to 
prepare proteinaceous microspheres and these proteins can retain their 
functionality [45]. These vehicles are widely used as ultrasound contrast agents, 
and are being investigated as possible gene transfer vehicles [214]. Sonication is 
also employed in procedures to encapsulate therapeutic proteins, such as 
asparaginase, insulin for controlled release in vivo [215-217]. 
This work describes the sonication conditions to obtain systems of lipid 
vesicles with low polydispersity and lamellarity and also study how they can 
interfere with the physico-chemical properties of liposomes when different 
peptides were incorporated in the lipid bilayer. For that, it was investigated the 
size changes as well as the polydispersity index (PDI) using the photon 
correlation spectroscopy (PCS), and the zeta-potential, usually determined as a 
characteristic parameter for the particle charge. The morphology, as a function of 
the ultrasound power and the different depths (from the base of the vessel), were 
examined using scanning electron microscopy (SEM). 
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 MATERIALS AND METHODS IV-2.
IV-2.1. Peptide development 
The two synthesized peptides with approximately 20 amino acids (a.a.) were: 
C-term: LLLLLLCLCLLLKAKAK and C-term: LLLLKLLLLKLLLLKLLLLK, where L, 
C, K and A is the one-letter code for the a.a. Leucine, Cysteine, Lysine and 
Alanine. The peptides were covalently linked by the N-terminal to a fluorescent 
dye, (5(6)-carboxytetramethyl-rhodamine, succinimidyl ester), i.e., 5(6)-TAMRA, 
with spectral properties of Absmax = 544 nm and Emmax = 572 nm, to facilitate the 
analysis of peptide penetration. The peptides structures were synthesized by JPT 
Peptide Technologies GmbH (Berlin, Germany). The peptides were supplied as a 
lyophilized material. They were analysed by high performance liquid 
chromatography (HPLC) and mass spectrometry (MS), and their purity was over 
70% (HPLC, 220 nm, C18, linear gradient). 
IV-2.2. Preparation and characterization of liposomes containing synthetic 
peptide 
Liposomes were prepared according to the method previously described in 
the Chapter II. The procedure for the further characterization of liposomes 
containing the bioactive agent (two peptides previously described) including the 
determination of size and its distribution and the zeta-potential, are also 
mentioned in Chapter II. 
The peptide surface charge analysis was obtained by using the PyMOL v0.99 
[218]. 
 RESULTS AND DISCUSSION IV-3.
Prior to testing of the liposome behaviour to the sonication, the reactor was 
categorized as previously mentioned on the Chapter III. This identified the 
minima and maxima hydroxyl radical (•OH) activity points as occurring at 38 mm 
(nodal-point /2) and 19 mm (anti-nodal point /4) positions, respectively. 
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Subsequently, ultrasonic treatment of the liposomes with and without peptides 
was carried out at amplitudes of 20%, 30%, and 40% and using the depths, 
measured from the base of the vessel, of 38 mm and 19 mm. First, liposome 
dispersions without peptides were sonicated at the specified powers and depths. 
An analysis of size distributions of liposomes before applying ultrasound (MLVs) 
was performed and it was observed that these MLVs presented a large size  
(≈ 2400 nm) with a higher PDl (≈ 0.910). This result was attributed to the 
heterogeneity of MLVs population presented in the sample. 
Figure IV-1 shows the size (nm) and the PDl that were obtained after 12 min 
of sonication. According with the previous results (Chapter III) this time frame 
was sufficient to promote the size decrease of liposomes vesicles. 
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Figure IV-1: Effect of sonication on liposomes (1500 µM, pH=7.4) size (Z-average; nm) 
using different depths (a) 19 mm, (b) 38 mm, applying different amplitudes 
(20, 30, 40%) after 3, 6, 9 and 12 min of sonication, at 50 ºC. 
Initial data, from the zetasizer, gave a high Z-average with a high PDl during 
the first minutes. After the treatment with ultrasound, there was a decrease in the 
PDI with a rapid drop in the Z-average. Physical size and PDl decreased with 
higher power intensity (40%), since with this power it is possible to achieve more 
rapid mixing of solution. 
The highest value of PDl obtained for the lowest sonication amplitude (20%), 
is associated with a wide distribution of liposomes size. This fact seems to 
indicate that this amplitude is not enough to decrease homogeneously the size of 
particles. A drop in the physical size and PDl at 19 mm was observed. 
The production of •OH radicals is notably higher since at this depth the 
cavitation phenomenon is more pronounced (anti-nodal point) and the greater 
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extent of streaming from the ultrasound source promotes a decrease in the size 
of liposomes. 
The determinations of liposomes zeta-potential (mV) were made before and 
after sonication. After the measurements, it was verified that the potential surface 
of liposomes did not change significantly by the use of ultrasound (≈ 4 and 3 mV, 
before and after ultrasound, respectively). 
Hydrolysis of phospholipids is promoted presumably by free radicals in the 
cavitation bubbles during the preparation of the sonicated phospholipids 
suspension in water. However, it is difficult to guarantee a minimum lipid 
oxidation level by control of temperature [33, 201], due to ultrasonic irradiation of 
water develops •OH and hydrogen peroxide, which also contributes for lipid 
oxidation [29]. According to Kruus et al. [112], the formation of free radicals is not 
a major problem when low frequencies (≈ 20 kHz) and short sonication times  
(≈ 20 min) are used. High temperatures accelerate phosphocholine hydrolysis; 
however according to Rabinovich-Guilatt et al. [113] a temperature of 50 ºC over 
24 h induces only 1.6% of phosphocholine hydrolysis. Therefore, this hydrolysis 
should be negligible with these working conditions. This is extreme important, as 
the principle goal is the entrapment of peptides in liposomes and the protection of 
these peptides against the free radicals produced by sonication. 
In order to minimise the oxidation, sonication was carried out in time intervals 
of 3 min and the temperature was controlled during all the experiment using a 
thermo-stated bath. 
After pointing all these parameters for the characterization of liposomes, the 
incorporation of two different peptides on the LUVs was studied. The peptides 
were formulated together with a lipid, dipalmitoylphosphatidylcholine (DPPC), 
which was added to attain a peptide formulation compatible with a water 
environment. 
Due to the large size of the Leucine side chain, the synthesized peptides tend 
to acquire an alpha helix structure in water. The interaction with phospholipids 
could further stabilize the alpha helix structure [219, 220]. However, the exact 
structure of these peptides in water is yet to be confirmed. 
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The peptide sequences were visualized by a molecular modelling program to 
identify the major differences in their structure (Figure IV-2). The molecular 
modelling program allows the creating of the structure based on the a.a. 
sequence, which differs in the position of the charged group (Lysine represented 
as K) in the sequence of peptides. 
Figure IV-2 shows the structures of C-term and N-term peptides in vacuum. 
Besides illustrating the amphiphatic nature of the alpha-helix, it also indicates a 
much narrower spatial distribution of the positively charged side chains in the 
peptides. These peptides tend to be, therefore, both amphipathic and cationic. 
Amphipathicity increases their affinity for biological membranes, while the positive 
charge increases their specificity toward negatively charged membranes [219, 220]. 
 a)  b) 
Figure IV-2: Surface charge analysis for the C-term and N-term peptides (a: 
LLLLKLLLLKLLLLKLLLLK, b: LLLLLLCLCLLLKAKAK), attained by PyMOL 
v0.99. Red denotes the negatively charged C-terminus while blue denotes 
the positively charged side chains. The scale represents the charge 
potential. 
It was previously described that different depths and amplitudes have 
different effects on liposomes. For this reason the extent of this influence was 
investigated when the peptides were incorporated on liposomes. The peptides 
inserted on liposomes were sonicated at the minimum amplitude (20%) and the 
maximum amplitude (40%). 
Figure IV-3 shows the influence of power at 19 mm and 38 mm positions, on 
the LUVs size and PDl. Lower sizes were obtained with 19 mm of depth, most 
likely due to the higher production of •OH that are related with higher effects of 
the cavitation phenomenon. The use of the higher amplitude (40%) promoted 
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size decreases in both peptide formulations. The higher power is associated with 
greater mixing, promoting a more homogeneous solution and it is possible to 
obtain particles with lower size and with lower polydispersity. 
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Figure IV-3: Z-average (nm) and PDl values for peptides (5 µM; a: 
LLLLKLLLLKLLLLKLLLLK, b: LLLLLLCLCLLLKAKAK) entrapped on 
liposome (1500 µM, pH=7.4) using different depths (19 and 38 mm) and 
amplitudes (20 and 40%) after 3, 6, 9 and 12 min of sonication, at 50 ºC. 
Figure IV-4 shows the influence of sonication on membrane surface of 
liposomes with the peptides. The Lysine a.a. (indicated in bold) of the peptide 
LLLLKLLLLKLLLLKLLLLK are positively charged, and therefore they can be 
located on the polar surface of liposomes resulting in an increased positive 
charge and consequently an increase in the zeta-potential values. Although, 
compared with the other peptide motif the presence of one more Lysine residue 
can also lead to an increase on the zeta-potential value. 
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Figure IV-4: Zeta () -potential (mV) values for peptides (5 µM; a: 
LLLLKLLLLKLLLLKLLLLK; b: LLLLLLCLCLLLKAKAK) entrapped on 
liposome (1500 µM, pH=7.4) using different depths (19 and 38 mm) and 
amplitudes (20 and 40%) after 3 and 12 min of sonication, at 50 ºC. 
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Conversely, for the other peptide (LLLLLLCLCLLLKAKAK), the values of 
zeta-potential do not change significantly, here the Lysine a.a. residues are at the 
extremity of the fragment, allowing the positioning of the other a.a. residues 
(Cysteine, Alanine and Leucine) to the inside of the liposome as they are more 
hydrophobic. The zeta-potential values for the maximum of amplitude (40%) were 
very similar to the results with minimum of amplitude (20%). 
Samples of each peptide were analysed by SEM, after treatment with 
ultrasound at 19 and 38 mm of depth and 40% amplitude. The photographs were 
taken at different magnifications of x50, x800, and x5000. Figure IV-5 shows that 
peptide LLLLKLLLLKLLLLKLLLLK has an „„amorphous” aspect, possibly due to 
the positively charged Lysine amino acid (K) distributed in the sequence of 
peptide. 
 a)  b) 
 c) 
Figure IV-5: SEM microphotographs: a) DPPC; b) LLLLKLLLLKLLLLKLLLLK; c) 
LLLLLLCLCLLLKAKAK, after 12 min of sonication at 19 mm of depth and 
40% of amplitude (the samples were dried after ultrasound treatment), using 
different magnifications (x50; x800; x5000). 
The peptide with the amino acid Cysteine (LLLLLLCLCLLLKAKAK) and with 
the positive charge on the C-terminal presented a defined rod shape. This 
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suggests that the peptide can have their hydrophilic part (positive charge) 
oriented towards the polar part of the lipid bilayers while their hydrophobic 
segment (not charged) is in the upper part and between lipophilic tails. 
Figure IV-6 shows differences between these two peptides that were 
analysed, nevertheless these differences are not so pronounced when the 38 mm 
of depth was used. This fact can be related with the effect of cavitation that is 
more prominent at 19 mm due to an increased production of •OH (anti-nodal 
point). 
a)  b) 
 c) 
Figure IV-6: SEM microphotographs: a) DPPC; b) LLLLKLLLLKLLLLKLLLLK; c) 
LLLLLLCLCLLLKAKAK, after 12 min of sonication at 38 mm of depth and 
40% of amplitude (the samples were dried after ultrasound treatment), using 
different magnifications (x50; x800; x5000). 
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 CONCLUSIONS IV-4.
This study shows the three principal factors of ultrasound that could influence 
the ranges of sizes and zeta-potential: depth, amplitude and time of treatment. 
The results from zeta-potential measurements and SEM analysis 
demonstrated that the insertion of peptides led to a change on the properties of 
lipidic membrane. 
The size and PDl decreased with an increase of amplitude (40%) as the 
higher power exerts greater shear forces within the solution. The greater extent of 
streaming from the ultrasound source promotes greater mixing of the solution and 
consequently more homogeneity. At 19 mm a drop in the physical size and PDl 
was observed. At this depth the rate of radical production is higher, further 
promoting the decrease in liposomes size even when peptides are entrapped in 
phospholipids aggregates. This size reduction increases their surface area and 
consequently their ability for controlled release of peptides. 
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Chapter V 
Chapter V -  Insights on the mechanism of protein microspheres formation§ 
ABSTRACT 
Protein microspheres of bovine serum albumin (BSA) and silk fibroin (SF) 
were obtained by applying high intensity ultrasound in a biphasic 
aqueous/organic system. In the study performed in Chapters III and IV, we 
demonstrated the influence of different parameters of ultrasound system, such as 
input energy on the reduction of liposome sizes. 
In this Chapter, additionally with Suslick‟s protein microspheres production 
procedure, this parameter was taken into account for the production of protein 
structured materials. 
The ratios of aqueous/organic phase and protein concentration were 
investigated on particles production. An increase on protein concentration 
promotes ≈100% of yield on particles formation, independently of 
aqueous/organic ratio that was used. It was found that these parameters prove to 
be an important tool to predict and control the sizes of particles ranging from 300 
to 1500 nm. Furthermore, these proteinaceous spheres present a negative 
surface charge and have a high stability over four months. 
The conformation assessment obtained with Fourier transform infrared 
(FT-IR) analysis show a change on the secondary structure of SF upon 
sonication treatment, presenting an increase on the amount of β-sheet. 
Conversely, the sonochemical treatment did not affect the secondary structure of 
the globular protein, BSA. 
                                            
§
 This chapter is based on the following publication: 
Silva R, Ferreira H, Araujo R, Azoia N, Rollet A, Angel U, Gomes AC, Freddi G, Güebitz 
G, Gedanken A, Cavaco-Paulo A, Insights on the mechanism of protein microspheres 
formation, submitted. 
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Molecular dynamic studies indicate that the protein have a change of 
conformation at water/oil interface and shows the importance of hydrophobic 
areas on the spheres stability. Those results were confirmed by confocal 
microscopy. 
No significant cytotoxicity was found in a concentration range below 
300 mg.L-1. All those properties shown here, seems to indicate a great potential 
for several biomedical applications, such as a vehicle for controlled release of 
drugs. 
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 INTRODUCTION V-1.
The ability to fabricate, characterize and manipulate artificial and natural 
structures, whose features are controlled at the micro/nano level, has gained 
considerable attention in recent years [41, 42, 221-224]. 
Among these micro/nano devices, the ones based on proteins may be rather 
promising, since they are biodegradable and non-antigenic [23, 66, 136, 225]. In 
the late 1960s, a modified polymerization method for the preparation of 
proteinaceous microspheres was developed by Rhodes and co-workers [156]. 
The microspheres formation was accomplished by a modified emulsion 
polymerization method, using either heat denaturation at various temperatures or 
a cross-linking agent, such as glutaraldehyde. However, this method yields 
microspheres with a short storage life, low stability and high toxicity. 
A sonochemical method has been developed by Suslick and co-workers for 
the synthesis of nonaqueous liquid-filled microcapsules and air-filled 
microbubbles [44]. Suslick has shown that micrometre sized gas- or liquid filled 
proteinaceous microspheres can be produced from various kinds of proteins, 
such as bovine serum albumin (BSA), human serum albumin (HSA) and 
hemoglobin (Hb) [44-48]. Suslick reports on microspheres at high concentrations 
with a long shelf life and high stability. The mechanism of proteinaceous 
microspheres' preparation obtained by the sonochemical method has been 
discussed previously and is a direct result of the chemical effects of ultrasound 
irradiation on an aqueous medium [44]. Indeed, the microspheres formation is a 
combination of two acoustic phenomena: emulsification and cavitation. 
Ultrasonic emulsification creates the microscopic dispersion of the protein 
solution necessary to form the shape of the proteinaceous microsphere shell. On 
the other hand, ultrasonic irradiation of liquids produces acoustic cavitation: the 
formation, growth and implosive collapse of bubbles, which creates transient 
hot-spots with enormous peak temperatures and production of free radicals [22, 
25, 199]. The superoxide radical (O2
-•) can create inter-protein disulphide bonds, 
that cross-link the proteins [44-48]. However, Gedanken and co-workers have 
been shown that it is possible to form microspheres with proteins that did not 
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comprise the Cysteine amino acids (a.a.) in their structure, as streptavidin or poly 
(Glutamic acid) [51]. According to their explanation, hydrophobic interactions or 
thermal denaturation of the protein after the initial ultrasonic emulsification assists 
in microspheres formation [51]. Several works [44, 51, 55, 65, 67, 226] have 
already been performed to clarify the mechanism of proteinaceous microspheres 
formation by the ultrasound system, however, further complementary studies are 
needed to establish the mechanism of their formation. 
It is our particular interest to engineer microspheres, using BSA and silk 
fibroin (SF), by ultrasonic method, based on Suslick's procedure [44] and on our 
previous results, for a better understanding of the mechanism of microspheres 
formation. 
Albumins are globular proteins that are characterized by a low content of 
hydrophobic a.a. and a high content of Cysteine (seventeen disulphide bonds 
and one sulfhydryl group) and the charged a.a., Aspartic and Glutamic acids, 
Lysine and Arginine [150, 155, 227]. Conversely, SF is a fibrous protein and is 
mainly composed of hydrophobic a.a., without Cysteine residues in its structure. 
The a.a. composition of SF from Bombyx mori is characterized by a high content 
of Glycine, Alanine and Serine, whose total share in the protein 85 mol %, 
Tyrosine accounts for 5.3 mol %, and acidic and basic a.a. total is about 3.0 and 
1.1 mol %, respectively [184, 228]. This characteristic of a.a. pattern results from 
the contribution of two polypeptides, i.e., the heavy and light chains. The heavy 
chain represents about 90% of the total weight of SF and is predominated with its 
characteristic -(Glycine-Alanine)n- rich sequences over the more heterogeneous 
primary structure of the light chain [159, 160]. 
To find the arrangement of different proteins in microspheres structure we 
analysed and characterized the particles, submitting them to different techniques. 
The ability of proteins to form microspheres was studied quantifying the 
protein concentration, by the Lowry assay [191], on the supernatant, after 
ultrasound treatment. The influence of the sonochemical method on secondary 
structure of proteins was determined by Fourier transform infrared (FT-IR) 
spectroscopy. Particle size as well as the polydispersity index (PDl) of 
microspheres was evaluated by photon correlation spectroscopy (PCS). It is well 
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known, that the particle size can significantly affect the properties of the 
microspheres and is important for their interaction with the biological 
environment, e.g., as concerns their ability to pass fine capillaries or to leave the 
vascular compartment via fenestrations after intravenous administration [187]. In 
addition to the determination of size and its distribution, the zeta-potential was 
also evaluated by electrophoretic laser Doppler anemometry, to obtain an 
indication of microspheres surface potential. Since the surface potential of the 
particles cannot be measured directly, the zeta-potential (electrical potential at 
the surface of hydrodynamic shear around the colloidal particle) is usually 
determined as a characteristic parameter for the microparticle charge. This 
parameter can also allow us to predict physical stability of microspheres 
dispersion [229]. In fact, the zeta-potential is an important feature for the particle, 
because a more pronounced zeta-potential value, either positive or negative, 
favours the particle-suspension stability [230, 231]. 
The electron microscopic techniques in particular have been employed to 
characterize the overall structure and shape of the microspheres. In this study, 
the scanning transmission electron microscopy (STEM) was applied. A lipophilic 
fluorescent probe was incorporated into the protein microspheres and analysed 
by confocal microscopy, providing a refined data set and, ultimately, a more 
precise evaluation of protein arrangement. Additionally, molecular dynamic 
studies were monitored in order to study the protein performance in 
aqueous/organic interface. Finally, microspheres were screened for cytotoxicity 
using a human cancer cell line (RKO) by means of performing a MTT [3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay. 
 MATERIALS AND METHODS V-2.
V-2.1. Preparation and characterization of protein microspheres 
Protein microspheres were prepared according with the method previously 
described in the Chapter II. The proteinaceous microspheres were produced 
using different protein concentrations of BSA (0.1; 0.5; 1.0 and 5.0 g.L-1) and 
SF (1.0; 3.0; 5.0 and 10.0 g.L-1) and different aqueous/organic ratios [60/40; 
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80/20 and 95/5 (%)]. The organic solvent used in all these experiments was 
the n-dodecane. The procedure for the further characterization is detailed also 
in Chapter II, namely: yield of microspheres formation; size and its distribution; 
zeta-potential, morphology (STEM technique), conformational assessment 
(FT-IR), confocal analysis, molecular dynamic simulations and stability 
studies. The cytotoxicity evaluation is described below. 
V-2.2. In vitro cytotoxicity screening of protein microspheres 
In order to evaluate the effect of the produced proteinaceous microspheres 
on cells, human colon carcinoma (RKO), from American type culture collection 
(ATCC), was used. The microspheres were previously sterilized via UV radiation 
during 2 h. 
Cells were grown in Dulbecco's modified Eagle's medium (DMEM) with 10% 
(v/v) fetal bovine serum (FBS) supplemented with 1.0 mM sodium pyruvate, 
1.5 g.L-1 sodium bicarbonate and 1% (v/v) penicillin/streptomycin (Gibco, 
Invitrogen Corp., San Diego, California, USA). Cultures were maintained at 37 ºC 
in a humidified atmosphere containing 5% CO2. The culture cells were seeded for 
48 h prior to all experiments. Once reached ≈ 90% confluency, cells were 
detached using 0.05% trypsin/ethylenediaminetetraacetic acid (EDTA) and 
counted by means of hemocytometer. Cells were seeded in 24 well-plates at a 
density of 1x104 cells.mL-1 of medium, for 48 h, after which culture medium was 
removed and replaced by fresh medium. The cultivated cells were then treated 
with different concentrations of BSA microspheres (75, 150, 300, 600 and 
900 mg.L-1), prepared with different ratios of aqueous/organic phase (60/40, 
80/20 e 95/5), for another 48 h. Culture medium alone, containing BSA solution 
and n-dodecane, were used as controls. N-dodecane at high percentage (40%) 
was used as positive control. 
Several methodologies for cytotoxicity assay are described nowadays as 
standardized procedures. Cell viability in the presence of microspheres was 
evaluated by the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide] reduction test as previously described [232]. Briefly, culture medium 
was removed and cells were washed twice with 500 μL of phosphate buffered 
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saline solution (PBS). A volume of 0.5 mL MTT (final concentration 0.5 mg.mL-1, 
in PBS medium, pH = 7.4), prepared just before usage and maintained in the 
dark, was added to the RKO cells. Cells were incubated in the dark, for 2 h, at 
37 ºC and 5% CO2. MTT solution was removed and hydrogen chloride 0.04 M in 
isopropanol was then added, followed by incubation for 2 h, in the dark, to 
dissolve the formazan crystals. Finally, 100 μL of each well was transferred to 96 
well-plates, in triplicates, and absorbance was read at 570 nm in a multiplate 
reader (Spectramax 340 PC). The survival of RKO cells was expressed as the 
percentage of absorbance towards control cells (containing only culture medium). 
Data are expressed as means with standard errors of the means. One way 
ANOVA followed by the Tukey´s Multiple Comparison test (GraphPad Prism 5.0 
for Windows) was employed with statistically significant differences when P < 0.05. 
All the experiments were performed in triplicate. 
 RESULTS AND DISCUSSION V-3.
In order to gain further insight into the mechanism and structure of 
proteinaceous microspheres formation, an extensive physico-chemical 
characterization was carried out. In this context, as just referred, two well-known 
proteins, with different contents of a.a. residues, namely BSA, that present higher 
content of Cysteine a.a., and SF, with no Cysteine residues in its structure, were 
used. This study was firstly performed using different protein concentrations and 
different ratios of aqueous/organic phase (water/n-dodecane). The ratios of 
aqueous/organic phase (%) used were: 95/5, 80/20 and 60/40, and for each of 
these ratios the following concentrations of BSA were employed: 0.1; 0.5; 1.0 and 
5.0 g.L-1. For SF the following amounts used for each ratio were: 1.0; 3.0; 5.0 and 
10.0 g.L-1. 
SF concentrations used were higher than BSA concentrations, once that with 
SF concentrations below to 3.0 g.L-1 we could not achieve microspheres. This 
result can be related with the micellization process, in which the polymers tend to 
self-assemble into geometric (disks, spheres, cylinders) shapes and become 
suspended in the solution. However, this phenomenon occurs only when the 
polymer concentration exceeds a threshold known as critical micelle 
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concentration (CMC). Considering this explanation, one may anticipate that the 
proteins would be dispersed in a solution below a critical concentration, and will 
start only to form microspheres at or above that concentration. 
V-3.1. Yield of microspheres 
Firstly, the efficiency of microspheres formation was monitored by Lowry 
assay [191]. The effects of protein concentrations and the different 
aqueous/organic phase ratios used on microspheres formation are shown in 
Figure V-1. From this figure, it is concluded that as the concentration of protein 
increases, the microspheres yield increases. It was reached the maximum yield 
near to 100% at concentration of 5.0 g.L-1 and 10.0 g.L-1 for BSA and SF, 
respectively. Conversely, for lower concentrations the yield obtained was 
significantly different for ratios of 80/20 compared to 95/5. These results, for the 
lower concentrations (0.1, 0.5, and 1.0 g.L-1 for BSA and 3.0, and 5.0 g.L-1 for 
SF), can be explained by the low frequency of the collision of BSA and SF 
molecules and the density of the microparticle membrane, which in turn 
decreases the yield of microsphere obtained. The influence of the n-dodecane 
volume fraction on the microspheres formation yield becomes remarkable only 
when lower protein concentrations are used. For these amounts a higher content 
of n-dodecane promotes higher efficiency of particles formation. This assay 
further suggests that for the more concentrated protein solutions the yield was 
approximately 100% for all the ratios tested. 
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Figure V-1: Yield of BSA (a) and SF (b) microspheres formation using different 
aqueous/organic ratios (%; 60/40; 80/20 and 95/5) and different protein 
concentrations (0.1; 0.5; 1.0; 5.0 g.L
-1
 for BSA and 3.0; 5.0; 10.0 g.L
-1
 for SF). 
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In order to study the different behaviour of microspheres formation for each 
protein, the initial protein concentration was plotted versus levels of protein 
included in microspheres, suggesting a saturation level relationship as described 
in Equation V-1. k is a partition constant indicating the tendency of protein to be 
located at the oil (n-dodecane) interface and obviously dependent on the 
aqueous/oil ratio, and c is the initial protein concentration.  max is the maximum 
amount of protein adsorbed as c increases, and this value was fixed at 100%. In 
all tested aqueous/n-dodecane concentrations potentially 100% of protein tends 
to stabilize the microspheres. 
ck1
ck
esmicrospherinoteinPr% max


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Equation V-1: Saturation level relationship of protein microspheres formation. 
The plot concentrations of protein in microspheres as a function of initial 
protein concentration in solution are shown in Figure V-2. 
0 2 4 6
0
50
100
150
60/40
80/20
95/5
Initial protein concentration (g.L
-1
)
P
ro
te
in
 i
n
 m
ic
ro
s
p
h
e
re
s
 (
%
)
a) 
0 5 10 15
0
50
100
150
60/40
80/20
95/5
Initial protein concentration (g.L
-1
)
P
ro
te
in
 i
n
 m
ic
ro
s
p
h
e
re
s
 (
%
)
b) 
Figure V-2: Saturation curves of BSA (a; 0.1; 0.5; 1.0; 5.0 g.L
-1
) and SF (b; 3.0; 5.0; 
10.0 g.L
-1
) in the microspheres formation. The curve represents the best fit 
to Equation V-1. 
A nonlinear regression fit of Equation V-1 to the experimental data yielded 
values of k for BSA and SF (Table V-1). In Figure V-2 all isotherms show a sharp 
initial rise and then reach maximum adsorption amounts (plateau). 
The data in Table V-1 indicate that the k values increase when higher amount 
of organic phase is added. Thus, the present results demonstrate a higher 
adsorption of protein when 60/40 of aqueous/organic ratio was used, which 
corroborate the yield of microspheres formation. 
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The k values for SF particles present a significant difference when compared 
with BSA k values. This difference of values can be due to the chemical structure 
of SF and BSA protein. As just referred, BSA is a globular protein with high 
content of Cysteine residues and charged a.a.. The use of ultrasound will allow 
the interactions of charged a.a. with the aqueous phase and the hydrophobic a.a. 
with the organic phase. Additionally, the presence of Cysteine residues led to the 
formation of robust bonds (disulphide bonds), which can explain the higher 
protein adsorption on microspheres formation. On the other hand, in a SF 
aqueous solution the hydrophobic segments and hydrophilic segments are 
supposed to disperse randomly [233, 234]. Therefore, the SF molecules have the 
ability for self-assembly under specific conditions, such as ultrasound conditions. 
However, the chemical and physical stimulus promoted by ultrasound was not 
sufficient to obtain higher protein adsorption when compared with BSA 
microspheres. 
Table V-1: Adsorbed protein in microspheres obtained for: BSA (0.1; 0.5; 1.0 and 
5.0 g.L
-1
) and SF (3.0; 5.0 and 10.0 g.L
-1
) 
Aqueous/organic  
ratios (%) 
Adsorbed protein  
in microspheres (L.g-1) 
BSA SF 
95/5 4 ± 0.5 0.4 ± 0.09 
80/20 7 ± 0.4 0.6 ± 0.09 
60/40 95 ± 6.0 2 ± 0.3 
 
V-3.2. Fourier transform infrared (FT-IR) analysis of proteinaceous 
microspheres - Conformational assessment 
The conformational changes in secondary structure for BSA and SF 
microspheres were explored. Infrared spectroscopy is a well-established method 
for the analysis of protein secondary structure. Characteristic bands found in the 
infrared spectra of proteins and polypeptides include the Amide I, Amide II and 
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Amide III. These arise from the amide bonds (-CONH-) that link the a.a.. The 
absorption associated with the Amide I vibrational band is assigned to 
stretching vibrations of the C=O bond of the Amide and it is detected in the 
range of 1700-1600 cm-1. Absorption associated with the Amide II band, which 
falls in 1540-1520 cm-1 region, is attributed to the N-H bending and C-H 
stretching vibrations [235, 236]. 
In this work it was carried out a deeper study on Amide I band to probe the 
microspheres‟ secondary structure. Studies with proteins of known structure have 
been used to correlate systematically the shape of the Amide I band to secondary 
structure providing a powerful tool in the analysis of the secondary structure of 
proteins in aqueous solutions [237, 238]. The Amide I band of proteins typically 
consists of many overlapping component bands that represent different structural 
elements such as α-helices, β-sheets, turns and non-ordered or irregular 
structures. Therefore, the individual component bands cannot be resolved in the 
experimental spectra. The Fourier deconvolution procedure, sometimes referred 
as “resolution enhancement” involves narrowing the widths of infrared bands, 
allowing increased separation of the overlapping components present within the 
broad band envelope [237-239]. 
BSA has a globular protein and its secondary structure consists of mainly 
α-helices [155, 240-242]. For SF untreated samples Silk I (Random coil) 
conformation is confirmed by intense bands at 1411, 1380, 1334 cm-1, which are 
considered marker bands for this structure [184]. Table V-2 presents the 
detailed information of Amide I deconvolution for BSA and SF microspheres 
obtained. In this approach, the Amide I band was transformed to yield a fitted 
self-deconvoluted set of bands from which the secondary structure was 
determined. BSA microspheres presented the same content of α-helix in their 
structure and the microspheres synthesis by sonochemical method did not 
disturb the integrity of the protein structure. On the other hand, for SF the 
deconvolution resulted in an increase of β-sheet content. This data indicates that 
through microspheres formations, SF acquires mainly a β-sheet conformation, 
induced by the ultrasound radiation. As a consequence of the sonochemical 
process, the molecular chains became closer increasing the interactions of side 
chain groups promoting a higher cristallinity in the microspheres formation. 
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The FT-IR results show that the secondary structure of fibrous proteins was 
changed, while globular proteins retain their secondary structure upon the 
sonication treatment. 
Table V-2: Results from the curve fitting of Amide I range of the FT-IR spectrum of 
proteinaceous microspheres prepared with 5.0 g.L
-1
 of BSA and 10.0 g.L
-1
 of 
SF, using 60/40 of aqueous/organic ratio 
 
BSA SF 
Untreated[a] Micropshere Untreated[b] Micropshere 
β-Sheet 48-32% 39% 29% 59% 
α-Helix 52-68% 61% - - 
Random 
coil/Silk I 
- - 43% 15% 
Turns and 
bends 
- - 27% 25% 
[a] Based on literature values [155, 240, 241].  
[b] Based on previous published results of our work group [184]. 
V-3.3. Particle size and its distribution 
The influence of the two different parameters previously considered 
(aqueous/organic ratios and protein concentrations) was also analysed in terms 
of size and its distribution for both proteins. 
The results are presented in Figure V-3. Data show that particle size is 
directly related with protein concentration and aqueous/organic ratio. 
Figure V-3 highlights the fact that when lower quantity of organic phase and 
higher protein concentrations are used it is possible to obtain a narrower size 
distribution of proteinaceous microspheres with a smaller size (nanometre level). 
An increase of the protein concentrations in the solution, promotes the formation 
of less polydisperse particles with a smaller size, which can be explained by 
higher concentration of protein that can wrap the formed microspheres and 
prevent the growth more easily [243]. However, when the sizes obtained for BSA 
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and SF microspheres were compared it was found that smaller sizes were 
achieved for BSA microspheres. 
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Figure V-3: Particle size (Z-average; nm) and PDl for BSA (a) and SF (b) microspheres, 
using different aqueous/organic ratios (%; 60/40; 80/20 and 95/5) and 
different protein concentrations (0.1; 0.5; 1; 5.0 g.L
-1
 for BSA and 3.0; 5.0; 
10.0 g.L
-1
 for SF). 
According with the results from literature, the formation of the disulphide 
bonds is the main explanation for BSA microspheres formation, as well as for all 
proteins containing Cysteine a.a. in their composition [44]. Contrariwise, SF, as 
just referred, is a fibrous protein and is essentially composed by hydrophobic a.a. 
with the capacity for self-assembly. Additionally, the secondary structure of SF 
microspheres shows the formation of crystalline regions that encourage an 
increase on molecular interactions. However, these hydrophobic interactions 
were not sufficient to promote the decrease of size. The dimensions and shapes 
of the supramolecular structure formed from such assemblies depend on a 
variety of factors, such as geometry of polar head group, and also the shape and 
the position of each molecule in the protein microsphere [231]. 
The results obtained can support the idea that the linearity of sizes is 
directly related to the protein structure, protein concentration and the fraction of 
n-dodecane used. Therefore, it can be concluded that all these parameters 
considered can affect the microspheres sizes to a certain extent. 
V-3.4. Surface charge determinations 
The measurement of the surface charge of microspheres showed that 
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independently of aqueous/organic ratio and concentrations used, they present 
negative surface charge. Their zeta-potential values varied around -45 mV and  
-38 mV for the suspension of the BSA and SF, respectively. In most 
circumstances, the higher the absolute value of the zeta-potential of the 
microspheres, the larger the amount of charge on their surface, which produces 
stronger repellent interactions among the microspheres dispersed in the 
buffer/water and thus resulting in higher stability [230]. 
V-3.5. Morphology 
Figure V-4 shows the STEM photographs obtained for the BSA and SF 
microspheres. This figure illustrates that these proteinaceous microspheres are 
clearly spherical homogeneous particles with smooth surfaces. The morphology 
of spherical shape would offer the highest potential for controlled release and 
protection of incorporated drugs, as they provide minimum contact with the 
aqueous environment, as well as the longest diffusion pathways. Comparing 
particles with any other shape, spherical particles also require the smallest 
amount of surface-active agent for stabilization, because of their small specific 
surface area [187]. Moreover, our findings are also consistent with PCS results, 
since similar sizes were obtained. 
 a)  b) 
Figure V-4: STEM photographs (x50000 magnification) of proteinaceous microspheres: 
BSA (a) and SF (b) obtained using an aqueous/organic ratio (%) of 95/5 and 
with a protein concentration of 5.0 g.L
-1
 and 10.0 g.L
-1
 for BSA and SF, 
respectively. 
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V-3.6. Microspheres stability 
On microspheres research, suspension stability is other important parameter 
in materials characterization. Since those colloidal particles can suffer 
aggregation over time [244], it was made an evaluation of particle size for four 
months, to assess their physical stability. The zeta-potential was also determined, 
since this parameter of colloidal particles, due to degradation of some 
components, can also change over storage time [245]. The data obtained 
demonstrate a high stability for microspheres using the highest protein 
concentration. Figure V-5 shows the particle size and the zeta-potential values for 
BSA and SF microspheres prepared with 5.0 g.L-1 and 10.0 g.L-1, respectively 
using different aqueous/organic ratios (60/40; 80/20 and 95/5). Comparing the 
different fraction of organic phase it can be seen that the microspheres obtained 
with 5 and 20% of n-dodecane, aggregate after three months of storage. It was 
observed an increase in microspheres sizes distribution and also a tendency of 
zeta-potential to attain lower negative zeta-potential values. 
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Figure V-5: Particle size (Z-average; nm) and zeta () -potential (mV), over four months, 
for BSA (a) and SF (b) microspheres prepared with 5.0 g.L
-1
 and 10.0 g.L
-1
, 
respectively, for different aqueous/organic ratios (%; 60/40; 80/20 and 95/5). 
For BSA concentrations range between 0.1-1.0 g.L-1 and SF with 3.0-5.0 g.L-1 
the particle stability is lower for all ratios used. However, considerable 
differences between these two proteins were obtained. Figure V-6 shows that 
after two weeks of storage it was observed an increase on size distribution and 
the zeta-potential was near to zero, for SF microspheres (5.0 g.L-1). Conversely, 
BSA microspheres (1.0 g.L-1) instigated signs of instability only after one month of 
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storage. This difference can be explained by disulphide bonds present on BSA 
that forms a robust interaction promoting an increase on microspheres stability. 
Although, SF can be organized into a well-defined and stable macroscopic 
structure, due to their hydrophobic interactions that is rather weak when 
compared with covalent bonds, mainly, when lower protein concentration is used. 
Considering these results, it is possible to conclude that microspheres prepared 
with 60/40 of aqueous/organic phase and with highest amount of protein (5.0 g.L-1 
and 10.0 g.L-1 for BSA and SF, respectively) are stable for at least four months. 
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Figure V-6: Particle size (Z-average; nm) and zeta () -potential (mV) over two months 
for BSA (a) and SF (b) microspheres prepared with 1.0 g.L
-1
 and 5.0 g.L
-1
, 
respectively for different aqueous/organic ratios (%; 60/40; 80/20 and 95/5). 
V-3.7. Confocal analysis 
The confocal analyses allow us to predict the microspheres structure. For 
that two set experiments were performed. In the first set, proteins were 
labelled with fluorescein isothiocyanate (FITC; 495 nm/521 nm) and  
1,1'-dioctadecyl-3,3,3',3'-tetramethylindodicarbocyanine perchlorate (DID), which 
is an hydrophobic probe with markedly red-shifted fluorescence excitation and 
emission spectra. In the second set, the Nile red was chosen because of its 
capacity of getting a range of fluorescent signals depending of chemical 
environment. Hydrophobic environments have signals at 489/509 nm (using the 
green fluorescent protein filter) and less hydrophobic have signals at 550/573 nm 
(using the rhodamine red dye filter). However, highly hydrophilic signals cannot 
be seen due to the lower partition coefficient in water [193, 194]. The Imaris 
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program enabled us to “cut” the microspheres into different planes, allowing us to 
locate the lipophilic probe in the particles. 
Figure V-7 clearly demonstrate that the protein stay at aqueous phase (green 
colour), while the DID dye remains on the n-dodecane phase (red colour). 
 a)  b) 
Figure V-7: Three dimension photographs of microspheres prepared with BSA-FITC 
and with DID, using 60/40 of aqueous/organic ratio (%): a) side view and b) 
top view. The green colour represents the BSA-FITC and the red colour 
corresponds to DID. The BSA protein forms the microspheres walls and the 
DID is entrapped inside the liquid-filled proteinaceous microspheres. 
Furthermore, the results with Nile red emphasize the protein behaviour at 
aqueous/organic interface, presenting a green sign in a less hydrophobic 
medium, while in a polar solvent acquires red sign (Figure V-8 and Figure V-9). 
These results are also in agreement with the morphology studies. 
  
Figure V-8: Photograph of microspheres prepared with BSA and with Nile red, using 
60/40 of aqueous/organic ratio (%): fluorescent signs of Nile red in different 
medium (in organic solvent Nile red present green colour while in polar 
solvent acquires red colour). 
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a) 
b) 
Figure V-9: Photograph of microspheres prepared with BSA and with Nile red, using 
60/40 of aqueous/organic ratio (%): a) Red sphere (in the polar solvent) and 
b) Green sphere (in the organic solvent), cutting in the middle. 
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V-3.8. Molecular studies of protein behaviour on biphasic system 
To assess the behaviour of a globular protein, BSA, through ultrasound 
system, a molecular modelling study was performed by using GROMACS 
software [246] with the GROMOS (ffG53A6) force-field [247]. 
The sonication process was not easily simulated, but to obtain some realistic 
model, the n-dodecane molecules were added randomly and the empty space 
was filled with water. The procedure, where all the components are randomly 
distributed through space, seems to be the best way to simulate the sonication 
process. 
The number of n-dodecane molecules was chosen so that the final solution is 
equivalent to a 1:1 mixture of water/n-dodecane (v/v). All the simulations were 
made at 300 K. The results represent 50 ns of simulated time. 
Figure V-10 shows BSA in the interface between water and n-dodecane. The 
protein retains some water molecules in the surface interacting with n-dodecane, 
however, demonstrate a preferential orientation in the interface. 
 
Figure V-10: Molecular dynamic simulation results of BSA in a 1:1 (v:v) mixture of 
water/n-dodecane. BSA (green) in the interface water (red and white)/n-
dodecane (not shown). The BSA portion that is visible is interacting with 
n-dodecane. 
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Figure V-11 illustrate the differences between the surfaces of BSA in terms of 
potential. It is clear that the surface interacting with n-dodecane is more 
hydrophobic (the surface potential is near zero). In contrast, the surface 
interacting with water clearly has a negative surface potential. 
 
Figure V-11: Representation of the potential surface in vacuum: a) on the surface of BSA 
facing the water phase; b) on the surface of BSA that lies on the interface 
water/n-dodecane. The potentials were calculated using Pymol. 
V-3.9. Proposed mechanism of microspheres formation 
Proteins are considered as natural polymers that contain both hydrophobic 
and hydrophilic segments that could self-assemble in aqueous solution to form 
distinct structures, such as micelles, vesicles and tubules [248, 249]. SF 
amorphous regions are composed of a.a. with bulk side groups that have poor 
orientation, but the repeat a.a. sequence -(Glycine-Alanine)n- tend to form a well 
oriented β-sheet crystalline regions. The polypeptide chains of BSA can be 
arranged into a compact globular form, due to the optimization of free energies of 
many noncovalent and disulphide bonds. Furthermore, a globular protein typically 
b) a) 
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consists of relatively straight runs of secondary structure joined by stretches of 
polypeptides that abruptly can change directions [227]. 
The mechanism of BSA microspheres formation has been described and as 
a direct result of S-S bonds formation between Cysteine residues of the protein in 
an oxidative environment promoted by sonochemical method [44]. Moreover, 
other chemical interactions are involved in this mechanism of proteinaceous 
microspheres formation, in particular when Cysteine residues are lacking in the 
protein sequence. 
The higher shear forces produced by ultrasound will drive the orientation of 
polar and nonpolar groups in a biphasic system. The polar and charged side 
chains, and the polypeptides groups, will be able to form hydrogen bonds with 
water, but the nonpolar sides chains cannot. This side chains will tend to clump 
together in the oil droplet surface. This hydrophobic effect - the clustering of 
hydrophobic side chains from diverse parts of protein sequence - causes protein 
compactness. The “compactness” produces two favourable results: it minimizes 
the total hydrophobic surface area in contact with water, and brings the 
hydrophobic groups close to each other, allowing the van der Waals interactions 
between them. The hydrophobic interactions in proteins sum up to a substantial 
energetic contribution, promoting the formation and stabilization of spherical 
particle. Polar chains do not need to be protected from the solvent, because they 
can form hydrogen bond with water so they will tend to be distributed on the 
microspheres surface (Figure V-12). 
 
Figure V-12: Schematic representation of the different energy fields involved in 
formation and stabilization of proteinaceous microspheres, obtained by 
sonochemical method: I) hydrophobic interaction; II) hydrophilic 
interaction; III) protein-protein interactions. 
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V-3.10. Cytotoxicity evaluation 
An important parameter that has to be evaluated for biomaterials to be used 
in medical applications is the cytotoxicity level. This was assessed to our 
materials through the use of human colon carcinoma (RKO). A RKO cell line was 
exposed to different concentrations of BSA microspheres, over a period of 48 h 
(Figure V-13). 
Assessment of cell membrane integrity is one of the most common procedures 
to measure cell viability and cytotoxic effects. In our particular case it was 
performed by the use of MTT, which can be quantified spectrophotometrically. 
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Figure V-13: Effect of BSA microspheres, applying different concentrations, on viability 
of the human cell line RKO, after 48 h of treatment (*used to compare all 
the controls: BSA solution, n-dodecane at lower and higher concentration, 
with the control cells and $ used to compare all concentrations with 
controls = significantly different from all the other tested conditions, P < 
0.05). 
The different microspheres concentrations (75, 150, 300, 600 and 900 mg.L-1) 
were tested and the $ symbols were used to compare all concentrations with 
controls. Results indicate that BSA particles at concentrations of 75 and 
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150 mg.L-1 do not induce any toxicity for the investigated culturing time. However, 
at concentrations ranges of 300 and 900 mg.L-1, after 48 h, the viability of the 
RKO cells decreased in the presence of BSA particles, which suggests moderate 
cytotoxic effects. In Figure V-13 the * symbol was used to compare all the 
controls (BSA solution, n-dodecane at lower and higher concentration) with the 
control cells (only cells and medium). As can be seen only n-dodecane at the 
highest concentration is toxic, which is in agreement with previous studies [61]. 
 CONCLUSIONS V-4.
This study pretended to highlight the effects of ultrasound in two different 
proteins microspheres development. Results show that it is possible to conclude 
that for the particles formation and stabilization there is not essential the 
presence of disulphide bonds, but the presence of hydrophobic and hydrophilic 
interactions. Furthermore, the results obtained show that ultrasound source 
promote the rearrangement of chains in a regular array to some extent, that can 
lead to a conformational change, resulting in a more rigid and compact structure. 
In this study, it was established that the amount of protein and the  
n-dodecane volume fraction are essential to form and stabilize the proteinaceous 
microspheres and also to tune their size distribution. Moreover, all these 
parameters should take into account the protein structure, and the knowledge of 
this allows a design of different microparticle template. 
Further studies are underway in order to use these proteinaceous 
microspheres as delivery systems (DS) that can be applied in different areas, 
such as medicine. 
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Chapter VI 
Chapter VI -  Mechanism of the formation of proteinaceous microspheres - 
Highlights from peptide size and sequence** 
ABSTRACT 
The use of ultrasound for the formation of microspheres from protein 
aqueous solutions and hydrophobic solvents/oil has been widely reported. The 
previous Chapter (V) demonstrated that there are several factors that should be 
taken into account, alongside with the amino acid composition of proteins, to 
obtain structured microspheres. Using a wide range of peptides with variable 
sizes and sequences with a tailored hydrophilic/hydrophobic ratio, it was 
elucidated the fundamentals on microspheres formations. The results have 
shown that the larger peptides with separated and clear hydrophobic and 
hydrophilic areas lead to more stable and small spheres. 
The work presented in this Chapter set the rational to choose certain 
protein/peptide sequences for designing stable devices for a wide range of 
application areas. 
 
 
                                            
**
 This chapter is based on the following publication: 
Silva R, Ferreira H, Azoia N, Rollet A, Angel U, Güebitz G, Gedanken A, Cavaco-Paulo A, 
Mechanism of the formation of proteinaceous microspheres – Highlights from peptide size 
and sequence, submitted. 
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 INTRODUCTION VI-1.
The growing interest in nanotechnology has stimulated the discovery and 
development of new materials that can self-assemble into well-ordered structures 
at the nanometre scale [250, 251]. Micro and nanoparticles have found diverse 
and important applications, ranging from the encapsulation of dyes, flavours, and 
fragrances, to drug delivery systems and to the study of membrane structure, 
function and reactivity [252-254] . Many molecular components can be used in 
particle manufacturing, and the ability to combine them into designed 
architectures containing significant complexity, remains a challenge. Additionally, 
there are several methods in the literature about the preparation of the different 
devices [23, 131, 164]. The selection of an appropriate method determines the 
success or failure of microstructured materials synthesis, because physical 
properties and applications of micro and nanostructured materials are heavily 
dependent of preparation method. The importance of choosing a proper 
procedure in designing these structured materials has been a driving force for the 
development of new methodologies for several decades. Among a variety of 
approaches, the utilization of ultrasound has been extensively examined over 
many years, and is one of the most powerful tools in micro and nanoparticles 
synthesis. The sonochemical micro and nanosynthesis at the engineered 
interface of a cavitation microbubble is a combination of physical and chemical 
effects [15, 23]. 
The extreme conditions, produced by high intensity ultrasound, at the 
interface between the gaseous interior of the cavitation microbubble and the 
surrounding liquid medium can be utilized for carrying out various physical 
transformations and/or chemical reactions leading to the formation of spherical 
shells containing either gas or liquid in their inner cavity. Suslick and co-workers 
have been able to produce stable microspheres from aqueous solutions of 
proteins and organic solvents using high intensity ultrasound [44-48]. The 
mechanisms of the formation of these particles have been the subject of much 
discussion and could stem from the chemical and mass transport effects of 
ultrasound on an aqueous medium [44, 72]. It was proposed that the particles are 
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held together by disulphide bonds between protein Cysteine residues, and that a 
superoxide radical (O2
•-), sonochemically produced by acoustic cavitation, is the 
cross-link agent. Other studies have shown that microspheres can be formed with 
proteins/peptides that did not contain any Cysteine residues indicating that mass 
transport effects seem to be the major cause of microsphere formation [51]. 
In this study, it was used a wide range of peptides with variable sequences, 
sizes and hydrophilic/hydrophobic ratio in order to investigate the proteinaceous 
microparticle formation, and achieve a rationale on peptides and proteins for 
microsphere formation. 
The motivation to select peptides is based on the fact that they can be readily 
designed and synthesized for specific applications unlike large and complex 
proteins. Instead of studying a protein as a whole for a particular function, one 
may investigate small sections of peptides chains of the same protein to achieve 
the same goal and at the same time to go deeper into the chemical structure. 
This approach has been used to gain a better understanding of microspheres 
formation mechanism via ultrasound sources allowing the resemblance of some 
situation found in well-studied protein. 
 MATERIALS AND METHODS VI-2.
VI-2.1. Peptide development 
The sequence of the peptides is described by a one-letter code, which is the 
symbol commonly used to represent the amino acids (a.a.) residues. The peptide 
sequences were synthesized by JPT Peptide Technologies GmbH (Berlin, 
Germany). These peptides were supplied as a lyophilized material. They were 
analysed by high performance liquid chromatography (HPLC) and mass 
spectrometry (MS), and their purity was over 70% (HPLC, 220 nm, C18, linear 
gradient). 
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VI-2.2. Preparation and characterization of peptide microspheres 
Peptide microspheres were prepared according with the method previously 
described in the Chapter II. The peptide microspheres were produced using a 
fixed ratio (%) of 60/40 of aqueous/organic phase (n-dodecane) and 100 µM was 
the concentration of peptide aqueous solution used in the assays. The procedure 
for the further characterization is detailed in Chapter of materials and methods, 
namely: yield of microspheres formation; size and its distribution; zeta-potential, 
scanning transmission electron microscopy (STEM), confocal microscopy, 
molecular dynamic simulations and stability studies. 
 RESULTS AND DISCUSSION VI-3.
This work was firstly performed using ten different hexapeptides with the 
general sequence of GXGXGX, where G is Glycine and X can be Alanine, 
Serine, Leucine or Aspartic Acid. The aim was the evaluation of the effects of the 
chemical environment on microsphere formation in this small peptide. The results 
proved that only the peptide with highly hydrophobic residues, like Leucine, form 
microspheres (approximately 900 nm in diameter and with a polydispersity index, 
PDI, of 0.8 ± 0.05, presenting a 60% of yield and a negative charge). Alanine 
restricts the small hexapeptide ability to form microspheres at the solvent-water 
interface, because it was not hydrophobic enough. Alanine has a smaller side 
chain when compared with Leucine. 
The design of the peptide motifs with a variety of sizes, charges and 
hydrophobicity was based on the fatty acid model, which has a charged/polar 
head and an hydrophobic tail. The peptides had the general formula of 
[D]xAA[GAAAA]y with 8-31 residues, with the N-terminus linked to Aspartic Acid 
(represented as D; 1-4 residues) and a tail of hydrophobic amino acid (Alanine 
corresponds to A; 6-22 residues), which is interspersed with G for increased 
flexibility (Glycine corresponds to G). 
The data of Table VI-1 show that the amount of Aspartic Acid at the  
N-terminal leads to an increase in the yield of microsphere formation, to smaller 
sizes and to high charged microspheres. It is known that highly charged particles 
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can produce more stable devices, due to their inter-negative repulsive 
interactions. Furthermore, the increased size of the hydrophobic tail of the 
GAAAA motif also promotes the enhancement of the yield of microsphere 
formation, a decrease in size values and high monodispersed fractions. These 
results indicate that the peptides with concentrated charged areas and clear 
larger hydrophobic regions lead to smaller sizes and high surface charges, thus 
improving the microsphere formation yield and microsphere stability. 
Table VI-1: Yield (%), Z-average (nm), PDI and zeta-potential (mV) of microspheres 
obtained for the engineered peptides based on fatty acid model 
Peptide  
(N→C-terminus) 
Yield  
(%) 
Z-average  
(nm) 
PDI 
Zeta-potential  
(mV) 
[D] AA[GAAAA] 49 ± 9 672 ± 37 0.6 ± 0.03 -14 ± 1 
[D]2AA[GAAAA] 60 ± 4 620 ± 36 0.5 ± 0.03 -26 ± 2 
[D]3AA[GAAAA] 68 ± 4 633 ± 32 0.6 ± 0.07 -37 ± 1 
[D]4AA[GAAAA] 70 ± 3 533 ± 17 0.6 ± 0.06 -39 ± 1 
[D]AA[GAAAA]5 89 ± 4 469 ± 15 0.4 ± 0.04 -38 ± 3 
[D]4AA[GAAAA]5 98 ± 1 455 ± 14 0.4 ± 0.04 -47 ± 4 
In the next set of experiments it was used peptide motifs based on the 
primary sequence of a secretory leukocyte protease inhibitor (SLIPI) that has in 
common the potential inhibitory capacity of the human neutrophil elastase (HNE) 
[255]. To maintain the size of the peptide it was replaced the four Cysteine 
residues with a range of hydrophilic and hydrophobic residues. Therefore, in each 
peptide motif, the four Cysteine residues (PCyst) were replaced by Serine (PSer), 
Tyrosine (PTyr), Histidine (PHis), Phenylalanine (PPhe) or Leucine (PLeu). 
The results reported in Table VI-2 indicate higher levels of efficiency in 
microsphere formation, presenting slightly differences in the yield. With this, it 
was confirmed that Cysteine is not needed for microspherization and that mass 
transfer is the major cause for microsphere formation. The peptide with a higher 
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moiety of hydrophobic a.a. displays an increase in the yield of microsphere 
formation. The insertion of polar and basic residue in a peptide segment 
interferes with the balance of hydrophobic/hydrophilic character leading to an 
increase in the size of the microspheres. The peptide with Histidine presents 
positive values due to the high quantity of basic Histidine residue in the sequence. 
Table VI-2: Yield (%), Z-average (nm), PDI and zeta-potential (mV) of microsphere of the 
engineered peptides, based on SLPI, with fourteen a.a. residues 
Peptide[a]  
(N→C-terminus) 
Yield  
(%) 
Z-average  
(nm) 
PDI 
Zeta-potential  
(mV) 
KRCCPDTCGIKCLD 84 ± 2 380 ± 20 0.5 ± 0.01 -26 ± 3 
KRSSPDTSGIKSLD 78 ± 1 971 ± 28 0.8 ± 0.01 -16 ± 2 
KRYYPDTYGIKYLD 77 ± 0.4 829 ± 25 0.8 ± 0.02 -24 ± 1 
KRHHPDTHGIKHLD 76 ± 0.9 840 ± 13 0.7 ± 0.06 +23 ± 3 
KRFFPDTFGIKFLD 92 ± 0.6 310 ± 15 0.5 ± 0.03 -20 ± 1 
KRLLPDTLGIKLLD 91 ± 1 300 ± 8 0.4 ± 0.04 -26 ± 3 
[a] changed a.a. are underline 
Figure VI-1 shows the STEM photographs obtained for the peptide 
microspheres. Figure VI-1 a), b) and c) present spherical particles with smooth 
surfaces. Although, PSer [Figure VI-1 d)] exhibits a heterogeneous population of 
microspheres, it did not produce a regular spherical shape when compared with 
the others peptides. The same behaviour was observed for the microspheres of 
PHis and PTyr. The inclusion of polar and basic residues may cause different 
shape assemblies than the other peptides. Furthermore, the photographs 
obtained for the [D]4AA[GAAAA]5 and [D]2AA[GAAAA] peptides [Figure VI-1 a) 
and b)] also present differences in their sizes. After the self-assembly process 
induced by the sonochemical method, the peptides may form different structures, 
because packing of the hydrophobic side chains depends on the size of their 
corresponded van der Waals surface area. It is clear that the decrease in the 
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hydrophobic tail favours the increase in size of the microspheres. The 
morphology of spherical shape obtained for the majority of the peptide 
microspheres would offer the highest potential for the controlled release and 
protection of incorporated drugs, as they provide minimum contact with the 
aqueous environment, as well as the longest diffusion pathways. Compared with 
other particle shape, spherical ones will require the smallest amount of a 
surface-active agent for stabilization, because of their small specific surface area 
[187]. Additionally, our findings are also consistent with photon correlation 
spectroscopy (PCS) results, since the particle size distribution was very similar. 
 a)  b) 
 c)  d) 
Figure VI-1: STEM images (x50000 magnification) of peptide microspheres: a) 
[D]4AA[GAAAA]5; b) [D]2AA[GAAAA]; c) KRFFPDTFGIKFLD; d) 
KRSSPDTSGIKSLD. 
A lipophilic fluorescent probe was incorporated into peptide microspheres and 
analysed by confocal microscopy, providing a refined data set and, ultimately, a more 
precise evaluation of peptide arrangement. Nile red is a dye that exhibits 
solvatochromism and its absorption band varies in spectral position, shape and 
intensity with the nature of the solvent. The dye is highly fluorescent in organic 
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solutions, and increasing the polarity of the solvent leads to an enhancement of 
emission and excitation maxima, when the fluorescent spectra is measured [193, 194]. 
Figure VI-2 emphasizes the peptide behaviour at an aqueous/organic 
interface, presenting a green colour in a less hydrophobic medium, while in a 
nonpolar solvent it acquires a red colour. The results clearly demonstrate the 
peptide arrangement in microsphere formation, suggesting a more hydrophobic 
core in its structure. This figure also presents some differences between 
[D]4AA[GAAAA]5 and [D]2AA[GAAAA], attributed to the decrease in the number of 
hydrophobic residues in peptide motifs that lead to an increase of particles size 
and to a decrease of peptide microspheres stability. Figure VI-2 b) indicates that 
this peptide has a tendency to coalesce. 
    a) 
    b) 
Figure VI-2: Confocal images of peptide microspheres: a) [D]4AA[GAAAA]5; b) 
[D]2AA[GAAAA], prepared with Nile red (green colour shows the more 
polar regions excitated with laser line of 532 nm and the red colour 
shows the more nonpolar regions excitated with laser line of 488 nm). 
The three-dimensional (3-D) images evidence the peptide behaviour at an 
aqueous/organic interface, presenting a green colour in a less hydrophobic 
medium, while in a nonpolar solvent it acquires a red colour, suggesting a 
more hydrophobic core in its structure. 
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In order to simulate the formation of the microspheres, GROMACS software 
[246] with a GROMOS (ffG53A6) force-field was used [247]. The sonochemical 
method is not easily simulated, but to obtain a realistic model it was used fifty 
peptide molecules randomly distributed in space. Next, the n-dodecane 
molecules were added randomly, and finally, the empty space was filled with 
water. It was considered that this procedure, where all the components are 
randomly distributed through space, is the paramount manner in which simulates 
the sonication process. The number of n-dodecane molecules was chosen so 
that the final solution will be equivalent to a 1:1 mixture of water/n-dodecane 
(v:v). In all of these simulations it was possible to notice that the peptides have 
some affinity to the interface between the solvents. Figure VI-3 shows that the 
highly polar groups at the interface interact with the water and that the nonpolar 
residues interact with the n-dodecane. 
a) b) 
Figure VI-3: Molecular studies of microspheres obtained with peptide [D]4AA[GAAAA]5: 
a) peptide stays at the interface, with the polar head (red) towards the water 
(not shown) and the nonpolar tail (white) facing the n-dodecane (brown); b) 
the peptide in water (not shown) tends to form aggregates, with the polar 
heads (red) interacting with each other. 
The evaluation of the suspension stability of microspheres was performed by 
measuring the particle size, the surface charge and observing the macroscopic 
aspect, over four months. Since these colloidal particles can aggregate over time, 
particularly when stored in an aqueous dispersion, an evaluation of the particle 
size was done for four months, aimed at evaluating their physical stability [244]. 
The zeta-potential was also determined, since this parameter of colloidal particles 
can also change over storage time, due to the degradation of some components 
[245]. 
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The stability results showed that the peptides based on fatty acid molecules 
model, can form microspheres with high stability. The degree of hydrophobicity of 
peptide motifs can significantly affect these data. When hydrophobic residues 
increase (y=5), the molecules have a tendency to assemble and form peptide 
matrices with enhanced strength. The [D]AA[GAAAA]5 and [D]4AA[GAAAA]5 
peptides revealed the same behaviour over four months. The size distribution 
and the zeta-potential values were very similar and there was no change in the 
macroscopic appearance (Figure VI-4). In contrast, the other peptides presented 
an enhancement in the values of size distribution. Additionally, the zeta-potential 
values tend to zero, exhibiting instability. The results indicated that the 
longer is the peptide segment, the greater is the tendency to self-assemble 
into well-defined and stable microstructures. 
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Figure VI-4: Increase of Z-average (nm) (a) and zeta () -potential (mV) (b) over four 
months for the peptide microspheres based on fatty acid model. 
The stability results for microspheres of PSer, PHis and PTyr, derived from 
SLIPI, were evaluated and an increase in the particle size was observed after 
one month of storage (Figure VI-5). Additionally, the zeta-potential value, in the 
same period of time, was more closer to zero, indicating the tendency of the 
particles to aggregate. Conversely, for the microspheres of PPhe and PLeu, the 
values obtained for particle size and zeta-potential, during four months, were very 
similar. 
The results achieved are mainly due to the presence of Cysteine and 
hydrophobic residues. The Cysteine allows the disulphide bonds between those 
residues in adjacent peptides to induce robust covalent bonds. Furthermore, the 
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hydrophobicity of Phenylalanine and Leucine groups prove to be sufficient to 
promote stable devices. 
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Figure VI-5: Increase of Z-average (nm) (a) and zeta () -potential (mV) (b) over four 
months for the peptide microspheres based on SLIPI structure. 
To confirm the influence of different poly(amino acids) on microsphere 
formation poly(Lysine); poly(Serine); poly(Proline); and poly(Alanine) were tested. 
Table VI-3 shows that only poly(Lysine) did not form microspheres. The polarity 
and the positive charge of Lysine could compromise microsphere formation. The 
best result was obtained with poly(Proline) followed by poly(Alanine). They are 
both hydrophobic, although, the side chain of poly(Proline) is larger than the 
Alanine side chain. The yield achieved for poly(Serine) microspheres was the 
lowest. All poly(amino acids) tested present a negative charge. 
Table VI-3:  Yield (%), Z-average (nm), PDI and zeta-potential (mV) of microspheres 
obtained for the different poly(amino acids) 
Poly  
(amino acid) 
Yield  
(%) 
Z-average  
(nm) 
PDI 
Zeta-potential  
(mV) 
Poly(Serine) 29 ± 8 796 ± 27 1 ± 0.02 -11 ± 0.8 
Poly(Proline) 60 ± 2 690 ± 16 0.9 ± 0.03 -31 ± 0.5 
Poly(Alanine) 50 ± 2 676 ± 36 0.8 ± 0.02 -26 ± 1 
Poly(Lysine) - - - - 
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 CONCLUSIONS VI-4.
In this study, it can be concluded that the microsphere formation is mainly 
due to the intrinsic properties of a.a. residues and their arrangements in peptides. 
The higher shear forces produced by ultrasound will drive the orientation of polar 
and nonpolar groups in a biphasic system (Figure VI-6). This orientation is highly 
dependent on the positioning of the individual residues in the peptide motif and 
also on the side chain of each residue. The degree of hydrophobicity is also an 
important parameter to control, since that higher degree leads to an 
enhancement of van der Waals interactions between peptide molecules 
promoting a peptide microsphere compactness and, consequently, higher 
stabilization. 
This work provides the groundwork for the design of sequences for peptides 
and proteins to reach the stable and controlled size of the microspheres and to 
improve their physico-chemical properties. Moreover, it is possible to build 
desired supramolecules with specific properties that can be applied in different 
research fields. 
 
Figure VI-6: Potential packing pathway of peptide microsphere formation: 1) peptide in 
solution; 2) microspheres at the interface of aqueous/organic phase; 3) 
peptide arrangement showing the hydrophilic residues (blue colour) 
interacting with water and the hydrophobic residues (red colour) interact 
with the organic phase. The ultrasound sources promote an enhancement 
of hydrophilic and hydrophobic interactions and form a close ring. 
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Chapter VII 
Chapter VII -  Sonochemical proteinaceous microspheres for wound 
healing†† 
ABSTRACT 
In this Chapter a novel approach is proposed using proteinaceous 
microspheres of bovine serum albumin (BSA), human serum albumin (HSA) and 
silk fibroin (SF), based on the previously described sonication conditions, 
(Chapter V). Different organic solvents, namely n-dodecane, mineral oil and 
vegetable oil, were used as organic phase on microspheres production stage. 
The ability of these devices to inhibit human neutrophil elastase (HNE) was 
evaluated using porcine pancreatic elastase (PPE) solution as a model of wound 
exudates. The results obtained indicated that the level of PPE activity can be 
tuned by changing the organic solvent present on different protein devices, thus 
showing an innovative way of controlling the elastase-antielastase imbalance 
found in chronic wounds. Furthermore, these proteinaceous microspheres were 
shown to be important carriers of elastase inhibitors causing no cytotoxicity in 
human skin fibroblasts in vitro, making them suitable for biomedical applications, 
such as chronic wounds. 
 
 
 
                                            
††
 This chapter is based on the following publication: 
Silva R, Ferreira H, Vasconcelos A, Gomes AC, Cavaco-Paulo A, Sonochemical 
proteinaceous microspheres for wound healing, submitted. 
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 INTRODUCTION VII-1.
A wound is the result of disruption of normal anatomic structure and function. 
Based on the nature of the repair process, wounds can be classified as acute or 
chronic wounds [180, 256]. Acute wounds are usually tissue injuries that heal 
completely, with minimal scarring, within the expected time frame, usually 8-12 
weeks. Chronic wounds, on the other hand, arise from tissue injuries that heal 
slowly, that is not healed beyond 12 weeks and often reoccur [180, 256]. Chronic 
wounds are thus defined as wounds which have failed to proceed through an 
orderly and timely process to produce anatomic and functional integrity or went 
through the repair process without establishing a sustained anatomic and 
functional result. Non-healing chronic wounds, such as decubitis ulcers (bedsores or 
pressure sores) and leg ulcers (venous, ischaemic or of traumatic origin) and other 
delayed wounds, are an important and persistent problem in dermatology [257, 258]. 
Acute wounds have low levels of protein-degrading enzymes, whereas 
exudates from non-healing chronic wounds contain elevated levels of 
proteases, like matrix metalloproteinases (MMP) and human neutrophil elastase 
(HNE) [258-263]. The overproduction of proteolitic enzymes in wound exudates 
leads to reduced concentrations of growth factors, fibronectin and endogenous 
levels of protease inhibitors, resulting in imbalance between degradation and 
remodeling processes [257, 260, 264]. Thus, it has been postulated that lowering 
protease levels in the chronic wound to levels normally found in acute wounds 
may accelerate healing in the chronic wound [261, 263, 265]. Due to its 
involvement in such process, there is extensive literature exploring the different 
types of inhibitors or inhibitors formulations that may restore the normal levels of 
these enzymes in the above diseases [266]. The use of fatty acids is known to 
decrease HNE activity on a chronic wound fluid [267]. The release of oleic acid 
albumin formulations from derivatized cotton wound dressings had also shown 
the promotion of wound healing [265, 268]. Nevertheless, several challenges 
remain that need to be taken into consideration in developing novel wound 
healing delivery formulations. Even so, there are few studies on the release of 
oils from protein microspheres to promote the inhibition of high levels of HNE 
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found on chronic wounds exudate. 
The work presented here evaluated the capacity of three different organic 
solvents (n-dodecane, mineral oil and vegetable oil) to inhibit HNE in order to 
evaluate their ability to be used as a part of a wound management strategy. 
However, these organic solvents are insoluble in aqueous environments and 
would require a vehicle to promote the elastase inhibition in the wound 
environment. For the delivery of such compounds to the target area, 
proteinaceous devices, based on bovine serum albumin (BSA), human serum 
albumin (HSA) and silk fibroin (SF) have been used. Serum albumin is one of the 
most extensively studied and applied proteins in this research field because of its 
availability, low cost, stability, unusual ligand binding properties and is recognized 
as the principal transport protein for fatty acids and others lipids that would 
otherwise be insoluble in the circulating plasma [227, 265, 268, 269]. On the 
other hand, SF has a long history of use in clinical applications [140]. More 
recently, this protein has been bioengineered for use in biomaterials as films, 
three-dimensional (3-D) porous scaffolds, electrospun fibers, hydrogels and 
microparticles [140, 158, 184, 185, 233, 270-272]. These materials provide 
mechanical toughness, biocompatibility and biodegradability [141]. 
In this work, microspheres are produced by means of ultrasonication of a 
two-phase starting mixture, consisting of protein solution (BSA, HSA or SF) and 
organic solvent. 
The preparation was followed by an extensive physico-chemical 
characterization. The ability of proteins to form microspheres was performed by 
quantifying the protein concentration on the supernatant, after ultrasound treatment 
[191]. Particle size, as well as the polydispersity index (PDl) of microspheres was 
evaluated by photon correlation spectroscopy (PCS). In addition to the size 
distribution determination, the zeta-potential was also determined by 
electrophoretic laser Doppler anemometry, to assess particles surface potential. 
Both size and zeta-potential, as well as macroscopic aspect observation, were 
determined every week in order to evaluate their physical-stability over time. The 
scanning transmission electron microscopy (STEM) was employed to 
characterize the overall structure and shape of particles. Furthermore, the 
inhibitory activity of these protein microemulsions containing different organic 
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solvents was tested using porcine pancreatic elastase (PPE) solution as a model 
of wound exudates. Finally, these devices were screened for cytotoxicity using a 
human cell line monitored with a metabolic test. 
 MATERIALS AND METHODS VII-2.
VII-2.1. Preparation and characterization of protein microspheres 
Protein microspheres were prepared according with the method previously 
described in the Chapter II. The protein devices were produced using a fixed 
ratio (%) of 60/40 of aqueous/organic phase and 5.0 g.L-1 of BSA and HSA and 
10.0 g.L-1 of SF were the concentrations of proteins aqueous solution used in the 
assays. Three different organic phases were tested: n-dodecane, mineral and 
vegetable oil. The procedure for the further characterization is detailed in Chapter 
II, namely: yield of microspheres formation; size and PDl; zeta-potential, 
morphology (STEM technique). The assay to determine the activity loss of PPE 
as well as the cytotoxicity screening is described below. 
VII-2.2. In vitro determination of porcine pancreatic elastase (PPE) activity 
loss over time in presence of proteinaceous microspheres 
The activity of PPE was measured according to a method previously reported 
with some modifications [273]. In brief, 30 μL of enzyme was mixed with 900 μL 
of reaction buffer 100 mM tris(hydroxymethyl)aminomethane hydrochloride 
(Tris-HCl), pH 8.0. The reaction was started with the addition of 70 μL of 4.4 mM 
of succinyl-alanine-alanine-p-nitroanilide (Suc-Ala-Ala-Ala-p-nitroanilide), a 
synthetic substrate for PPE. The reaction was carried out for 5 min, at 25 °C, 
and the cleavage of the substrate was monitored spectrophotometrically at 
410 nm using a Heλios γ ThermoSpectronic spectrophotometer (Unicam). One 
unit is defined as the amount of enzyme that will hydrolyse 1.0 μmol of 
Succinyl-alanine-alanine-p-nitroanilide (Suc(Ala)3-pNA) per minute at 25 °C, pH 
8.0. To examine the inhibitory activity of the organic solvents, different 
concentrations of proteinaceous microspheres were added to a fixed amount of 
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PPE solution. The protein microspheres used for these studies are the following: 
BSA; HSA and SF. The incubation was carried out at 25 °C and, at determined 
time points, aliquots were collected to monitor the decrease in elastase activity. 
Measurements were recorded in triplicate and the results were expressed as 
mean value ± standard deviation. 
VII-2.3. Cytotoxicity screening 
The cytotoxicity of microspheres prepared from different proteins was evaluated 
using murine embryonic fibroblasts cells (MEFs), isolated from E13.5 embryos and 
normal human skin fibroblasts (BJ5ta), from American type culture collection (ATCC). 
The BJ5ta cell line (normal human skin fibroblasts) was maintained according 
to ATCC recommendations (4 parts Dulbecco's modified Eagle's medium 
(DMEM) containing 4 mM L-glutamine, 4.5 g.L-1 glucose, 1.5 g.L-1 sodium 
bicarbonate and 1 part of Medium 199, supplemented with 10% (v/v) of fetal 
bovine serum (FBS), 1% (v/v) of Penicillin/Streptomycin solution and 10 µg.mL-1 
hygromycin B). The cells were maintained at 37 ºC in a humidified atmosphere of 
5% CO2. Culture medium was refreshed every 2 to 3 days. 
Cells were seeded at a density of 10 x 103 cells/100 µL/well on 96-well tissue 
culture polystyrene (TCPS) plates (TPP, Switzerland) in the day before 
experiments and then exposed to different microspheres concentrations, as well 
as to different controls solutions (BSA; HSA and SF solutions; vegetable oil) 
added to fresh culture medium. At 24, 48 and 72 h of exposure, cell viability was 
determined using the alamarBlue® assay (Invitrogen, EUA). AlamarBlue cell 
viability reagent functions as a cell health indicator by using the reducing power 
of living cells to quantitatively measure the proliferation of various human and 
animal cell lines, allowing to establish relative cytotoxicity of agents within various 
chemical classes. When cells are alive, they maintain a reducing environment 
within the cytosol of the cell. In this assay, viable cells continuously convert 
resazurin (blue and non-fluorescent) to resorufin (red and highly fluorescent), 
increasing the overall fluorescence and colour of the media surrounding cells. 
10 µL of alamarBlue compound were added to each well containing 100 µL of 
culture medium. After 4 h of incubation at 37 ºC the absorbance at 570 nm, using 
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600 nm as a reference wavelength, was measured in a microplate reader 
(Spectramax 340PC). 
The quantity of resorufin formed is directly proportional to the number of 
viable cells. Data are expressed as means with standard errors of the means. 
Two-way ANOVA followed by post hoc Bonferroni test (GraphPad Prism 5.0 for 
Windows) was employed with statistically significant differences when P < 0.05. 
The samples were tested at least in triplicates per two independent 
experiments. 
 RESULTS AND DISCUSSION VII-3.
In this work, devices based on proteins, such as BSA, HSA and SF, to 
delivery oils were developed and characterized. Therefore, this study presents an 
original system to control high levels of elastase found on chronic wounds. 
VII-3.1. Characterization of proteinaceous microspheres 
The characterization of the microspheres obtained with these different 
proteins was focused in the study of microspheres formation yield, particle size, 
PDl, zeta-potential and morphology. All the experiments were done with three 
different organic solvents and, while n-dodecane present twelve carbons linked 
by saturated bonds, mineral oil and vegetable oil present different degrees of 
saturated and unsaturated fats. 
Firstly, to determine the successful yield of protein that forms microspheres 
with different organic solvent, the Lowry procedure was used. 
Table VII-1, Table VII-2 and Table VII-3 show the results obtained for BSA, 
HSA and SF microspheres, respectively. The proteinaceous microspheres 
evidence a high yield on particles formation independently of the organic 
solvent used. However, these devices exhibit a slight difference of the mean 
size (Z-average) when vegetable oil and mineral oil were applied, relatively to the 
microspheres obtained with n-dodecane. It is known that certain properties of 
fatty acid residues in the molecule of triacylglycerol have significant effects on the 
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fluidity of the oil. The "zig-zag" organization of single bonds enables the chains to 
be lined up close to each other and intermolecular interactions, such as van der 
Waals interactions, can take place promoting the size reduction, which explain 
the results obtained for n-dodecane. This system inhibits fluid flow, resulting in 
the relatively high viscosity of the oils. On the other hand, the presence of double 
bonds, can produce "kinks" in the geometry of the molecules. This prevents the 
chains becoming close to form intermolecular contacts, which results in an increased 
capability of the fluid to flow and, consequently, a highest size was achieved. 
This assay further suggests that the SF present the highest Z-average values 
when compared with BSA and HSA. According with our previous studies 
(Chapter V) [72] this is mainly due to the differences that exist in the 
macromolecular structures of proteins. 
The PDl values were similar, without significant changes, in the presence of 
different organic solvents and proteins. Moreover, there was no difference on the 
yield of particles formation, particle sizes and PDl, when the proteinaceous 
microspheres were prepared in phosphate buffered saline solution (PBS) medium 
or in deionized water (H2O). 
Another characteristic of polymeric microspheres that is of extreme interest is 
zeta-potential, which is a function of the surface charge of the particles [274]. The 
proteinaceous particles, prepared with the three different organic solvents, 
present a negative charge on their surfaces (Table VII-1, Table VII-2 and 
Table VII-3). Negligible changes in zeta-potential values were observed between 
different organic solvents used. However, the results show that the zeta-potential 
value dropped significantly when protein microspheres are prepared with PBS 
solution (pH 7.4). Studies of current literature suggest that the zeta-potential is 
related to both surface charge and the local environment of the particle 
(composition of the surrounding solvent, the environmental pH value and ions in 
the suspension) [275-277]. Nevertheless, the zeta-potential is not an actual 
measurement of the individual molecular surface charge; rather, it is a 
measurement of the electric double layer produced by the surrounding ions in 
solution (i.e. counter ions). The effect of pH on the zeta-potential of the protein 
particles is explainable by considering that the surfaces of these materials contain 
pH-dependent ionisable functional groups, both acidic and basic, that can undergo 
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dissociation and protonation [278]. The results advise that the use of deionized water 
(H2O, pH 5.5) augmented the negative charge on the particles surfaces. 
Table VII-1: Effect of organic phase (40%) on the yield value (%), Z-average (nm), PDI 
and zeta-potential (mV) on the formulation of BSA prepared in different 
dispersing medium (H2O and PBS) 
Organic 
phase 
Yield 
(%) 
Z-average  
(nm) 
PDl 
Zeta-potential (mV) 
H2O PBS 
n-dodecane 100 ± 0 960 ± 186 0.5 ± 0.07 -43 ± 2 -15 ± 1 
Mineral oil 100 ± 0 1203 ± 141 0.6 ± 0.02 -40 ± 0 -16 ± 1 
Vegetable 
oil 
100 ± 0 1382 ± 551 0.5 ± 0.04 -42 ± 1 -18 ± 1 
 
Table VII-2: Effect of organic phase (40%) on the yield value (%), Z-average (nm), PDI 
and zeta-potential (mV) on the formulation of HSA prepared in different 
dispersing medium (H2O and PBS) 
Organic 
phase 
Yield  
(%) 
Z-average  
(nm) 
PDl 
Zeta-potential (mV) 
H2O PBS 
n-dodecane 99 ± 1 1117 ± 111 0.4 ± 0.01 -41 ± 2 -16 ± 1 
Mineral oil 97 ± 0 1608 ± 114 0.6 ± 0.06 -39 ± 2 -13 ± 1 
Vegetable 
oil 
94 ± 0 1676 ± 275 0.5 ± 0.08 -42 ± 4 -13 ± 1 
 
Table VII-3: Effect of organic phase (40%) on the yield value (%), Z-average (nm), PDI 
and zeta-potential (mV) on the formulation of SF prepared in different 
dispersing medium (H2O and PBS) 
Organic 
phase 
Yield  
(%) 
Z-average  
(nm) 
PDl 
Zeta-potential (mV) 
H2O PBS 
n-dodecane 98 ± 1 1505 ± 193 0.6 ± 0.07 -37 ± 3 -12 ± 0 
Mineral oil 88 ± 2 1930 ± 159 0.7 ± 0.04 -39 ± 2 -12 ± 0 
Vegetable 
oil 
90 ± 1 2006 ± 125 0.6 ± 0.08 -39 ± 2 -14 ± 3 
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Suspension stability is another important parameter for materials 
characterization in microemulsion research. Nevertheless, stability studies were 
performed over four months analyzing the macroscopic aspect and measuring 
the size distribution and zeta-potential, in order to evaluate their physical stability 
(Figure VII-1). An increase in size is observed over time when aggregation of 
particles occurs. Size of proteinaceous devices did not otherwise change over 
four months. 
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Figure VII-1: Z-average (nm) and zeta () -potential (mV) over time frame of four months 
for different protein formulations prepared in PBS medium: a) BSA (5.0 g.L
-1
) 
b) HSA (5.0 g.L
-1
) and c) SF (10.0 g.L
-1
). 
For a suspension system, zeta-potential is also an important index, which 
reflects the intensity of repulsive force among particles and the stability of 
dispersion. The reduced net charge on the surface and the accompanying 
reduction in repulsive forces between particles led to aggregation. However, after 
the time storage of proteinaceous devices, no noticeable aggregates or obvious 
changes in zeta-potential were observed when microspheres were prepared in 
H2O or PBS medium. The electrostatic repulsive forces present in these 
emulsions were sufficient to promote the stability over the time frame of storage. 
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The use of electron microscopy can provide valuable information on particle 
size, shape and structure. STEM is an important technique to depict particle 
morphology and surface features. Figure VII-2 evidences the spherical shape of 
proteinaceous particles. The spherical shape would offer the highest potential for 
controlled release and protection of incorporated drugs, as they provide minimum 
contact with the aqueous environment, as well as the longest diffusion pathways. 
Comparing particles with any other shape, spherical particles also require the 
smallest amount of surface-active agent for stabilization, because of their small 
specific surface area [187]. The STEM photographs are also consistent with PCS 
results, once that the particle size distribution was very similar. 
 a)  b) 
 c) 
Figure VII-2: STEM images (x50000 magnification) of proteinaceous microspheres 
prepared with vegetable oil: a) BSA (5.0 g.L
-1
) b) HSA (5.0 g.L
-1
) and c) SF 
(10.0 g.L
-1
). 
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VII-3.2. Inhibitory activity 
The major goal of this work is the development of proteinaceous devices with 
a specific biological functionality: the inhibition of elastase in chronic wounds. For 
this purpose, it was important to determine the inhibitory activity of the different 
organic solvents incorporated into protein devices. 
Figure VII-3 depicts the activity loss obtained with the highest concentration 
of proteinaceous microspheres used (5.0 g.L-1 for BSA and HSA and 10.0 g.L-1 
for SF), after 5 min of incubation with PPE. It can be observed that after 5 min it 
was achieved more than 40% of activity loss for all the proteinaceous 
microspheres prepared with different solvents. Nevertheless, both mineral and 
vegetable oil present higher activity loss than n-dodecane, specially when SF 
was used as carrier. This result can be due to the presence of monounsaturated 
and polyunsaturated fatty acids in different ratios on mineral and vegetable oil, 
when compared with n-dodecane, which is composed by saturated chains. Oleic 
acid, for example, has been shown to be effective in the wound healing process 
[265, 268] . Additionally, a survey of the literature reveals the importance of chain 
length in the inhibitory capacity, indicating that a minimal chain length of fatty 
acids is a prerequisite [267, 279]. 
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Figure VII-3: Activity loss of PPE obtained after 5 min of incubation at 25 ºC with BSA 
(5.0 g.L
-1
), HSA (5.0 g.L
-1
) and SF (10.0 g.L
-1
) microspheres prepared with 
different organic phases: n-dodecane, mineral and vegetable oil. 
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Considering all the mentioned aspects, the vegetable oil was used as 
standard conditions for all subsequent preparations. 
The controlled release of vegetable oil present in proteinaceous 
microspheres was also assessed. To determine the inhibitory activity of 
vegetable oil, decreasing protein microspheres amounts were incubated with 
PPE solution, at 25 ºC. At determined time points, aliquots were taken to 
determine the residual activity. From the results obtained (Figure VII-4) it is 
evident that for high protein microspheres concentrations, PPE activity rapidly 
decreases, suggesting a promising system to modulate elastase activity. For 
lower protein microspheres concentrations, the decrease in activity of PPE was 
not so pronounced. This leads to the conclusion that the decrease in PPE activity 
is dependent on protein devices concentration, once that higher concentrations of 
proteinaceous microspheres lead to a higher content of the entrapped vegetable 
oil. 
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Figure VII-4: Activity loss of PPE, obtained after 24 h of incubation, at 25 ºC, in the 
presence of different concentrations of BSA (a: 75, 150, 300 and 600 mg.L
-1
), 
HSA (b: 75, 150, 300 and 600 mg.L
-1
) and SF (c: 150, 300, 600 and 1500 mg.L
-1
) 
microspheres incorporating vegetable oil. 
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It is noteworthy that when SF is used as a carrier, a faster decrease of PPE 
activity is observed, revealing that the PPE solution is rapidly in contact with 
vegetable oil encapsulated into the SF microspheres. The data obtained can be 
related with the cristallinity degree of SF induced by ultrasound which was not 
sufficient to promote a more rigid structure, leading to an easier degradation or 
even the formation of cracks, allowing a rapidly diffusion out of vegetable oil. 
The results obtained for albumin microspheres can be related with their 
concentration in the devices. Previous reports indicated that albumin can 
increase enzyme activity [265, 280]. Recently, the use of oleic acid/BSA 
formulations showed acceleration of the elastase activity, while requiring 
increased oleic acid concentrations to override the elastase activation properties 
of the albumin [265, 280]. A possible explanation is that higher concentrations of 
BSA may stabilize the enzyme, by promoting aggregation or association of the 
albumin protein, which in turn may hinder the enzymatic turnover of available 
substrate. An alternative explanation is that the higher albumin concentration 
serves as an additional substrate for elastase hydrolysis and thereby decreases 
the level of enzyme available for chromophoric peptide substrate analysis [265, 
268]. 
These results further suggest differences between the two albumin proteins, 
bovine albumin and human albumin, in their capacity to inhibit PPE enzyme. The 
primary structures of HSA and BSA are homologous by 80% [155]. The 
difference between these two proteins is mainly due to the replacement of some 
hydrophobic amino acids (a.a.) in their sequence and this replacement can 
promote different affinities to fatty acids [155, 227]. Spector and co-workers [281] 
reported the affinity of BSA and HSA to several fatty acids, showing that the 
unsaturated fatty acids were bound more tightly to HSA than to BSA. This fact 
can explain the highest activity loss when HSA is used as a device. 
VII-3.3. Cytotoxicity evaluation 
The biocompatibility of proteinaceous devices incorporating the vegetable oil 
was assessed through the use of fibroblast in vitro cultures. A preliminary 
screening was made using murine embryonic fibroblasts cells (MEFs) as a 
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measure of global cytotoxicity. In this study, a wide range of protein 
concentrations (from 75 to 5000 mg.L-1 for BSA, HSA and from 150 to 
10000 mg.L-1 for SF) used for inhibition assays was evaluated and no toxicity was 
observed for the range concentrations of 75-300 mg.L-1 and 150 to 600 mg.L-1 for 
BSA and SF, respectively. The results obtained with MEFs were then confirmed 
with human skin fibroblasts (BJ5ta), testing the range protein microspheres 
concentrations that did not promote any damage to the MEFs. 
The effect of all tested conditions over BJ5ta was evaluated after 24, 48 and 
72 h (Figure VII-5). Results indicate that neither protein solutions (BSA, HSA and 
SF), nor vegetable oil induced any toxicity in this time frame (P > 0.05). 
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Figure VII-5: BJ5ta cell viability at 24, 48 and 72 h of culture with different materials 
solutions and different concentration of BSA (a), HSA (b) and SF (c) 
microspheres incorporating vegetable oil. Values for tested samples are 
presented as a function of the control (cells cultured with culture medium, 
scored 100%). Statistically significant differences are observed. The results 
obtained were compared among each other and with the control: * P <0.05, 
*** P <0.001. 
It is possible to observe in Figure VII-5 that the range concentrations of  
75-300 mg.L-1 of BSA microspheres containing the vegetable oil did not affect the 
viability of human skin fibroblasts cells for a period of 72 h, suggesting that 
microspheres can be safely applied to the skin at these concentrations. Similar 
data is displayed for the viability of BJ5ta cells, in the presence of HSA particles, 
which further provides the evidence of no cytotoxic effects after 72 h. However, 
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the use of 600 mg.L-1 of SF microspheres on human fibroblasts cells is 
statistically different when compared with control cells (* P < 0.05), which 
suggests a mild cytotoxicity. 
 CONCLUSIONS VII-4.
In this study, a promising microemulsion system was characterized and 
selected microemulsions were explored for their ability as potential elastase 
inhibitors. 
This work outlines the feasibility of using different organic solvents to produce 
proteinaceous devices. The choice of organic phase interferes with the 
characteristics of the microspheres and such knowledge allows the design of 
materials with specific properties. After their production and subsequent 
characterization, the inhibitory activity was evaluated against PPE solution and it 
was found that vegetable oil presents higher inhibitory efficiency. Furthermore, 
the effective nature of protein should be considered, once that SF demonstrated 
to be more capable of transferring vegetable oil in an aqueous solution under 
conditions of pH properties mimicking wound fluid. 
The cytotoxicity screening indicated that the developed protein particles are 
not cytotoxic in a wide range of concentrations (75 to 300 mg.L-1 for BSA and 
HSA and 150 to 300 mg.L-1 for SF) over 72 h of exposure. However, for those 
proteinaceous microspheres concentrations, the highest value attained for the 
inhibitory activity of PPE was achieved for HSA and BSA. Therefore, it is 
necessary to find a compromise between the ability to inhibit the elastase and 
their cytotoxicity, when formulations are developed. 
The results presented here strongly demonstrate the value of in vitro 
experiments with respect to the influence of proteinaceous devices to study 
single factors in the wound healing process. Nevertheless, it must be kept in mind 
that wound healing is rather complex, although the understanding of these 
properties may help to support the further refinement of protein devices for 
improved wound healing. 
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Chapter VIII 
Chapter VIII -  Protein microspheres as suitable devices for piroxicam 
release‡‡ 
ABSTRACT 
Bovine serum albumin-piroxicam (BSA-piroxicam) and human serum 
albumin-piroxicam (HSA-piroxicam) -piroxicam microspheres were 
sonochemically prepared and characterized based on the previous results 
achieved in the Chapter V [95/5 (%) of aqueous/organic phase]. The use of 
polyvinyl alcohol (PVA) lead to an improvement of formulation characteristics, 
including smaller size, lower polydispersity index (PDl), higher entrapment 
efficiency and higher stability. The release kinetics of these proteinaceous 
microspheres was determined in presence of protease, indicating an anomalous 
drug transport mechanism (diffusion and polymer degradation). In presence of 
higher protease concentration, BSA microspheres exhibit Case II transport, 
leading to zero order release (polymer degradation). These proteinaceous 
devices did not show cytotoxicity against human skin fibroblasts in vitro, for range 
concentrations below to 300 mg.L-1, greatly supporting their potential application 
in the treatment of inflammatory diseases. 
 
 
                                            
‡‡
 This chapter is based on the following publication: 
Silva R, Ferreira H, Carvalho A, Gomes AC, Cavaco-Paulo A, Protein microspheres as 
suitable devices for piroxicam release, submitted. 
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 INTRODUCTION VIII-1.
Non-steroidal anti-inflammatory drugs (NSAIDs) are the most widely used 
drugs in the treatment of inflammatory diseases, such as rheumatic disease, but 
are also being increasingly used for non-rheumatic conditions, including acute 
and chronic pain, biliary and ureteric colic, dysmenorrheal inflammation and fever 
[282]. The mechanism of action of NSAIDs is mediated by its capacity to inhibit 
cyclo-oxygenase (COX) activity. The COX enzyme can be divided into two 
isoforms - a constitutive isoform (COX-1), which is responsible for maintaining 
normal function in the gastrointestinal and renal tracts, for example, and an 
inducible isoform (COX-2), which is found in areas of inflammation and in the 
brain [283]. It has been suggested that the anti-inflammatory actions of NSAIDs 
are due to the inhibition of COX-2, whereas the unwanted side-effects are due to 
the inhibition of COX-1 [284-286]. The vast majority of NSAIDs currently available 
are not selective for COX-2 and can thus cause the adverse reactions so 
commonly seen during NSAIDs treatment [284-286]. Therefore, the entrapment 
in microspheres of the NSAIDs, such as piroxicam, which are not selectively 
targeting COX-2, could be useful to minimize their adverse reactions. 
Various types of macromolecular substances, such as synthetic and natural 
polymers have been used in drug delivery research, as they can effectively 
deliver the drug to target the action site and thus increasing the therapeutic 
benefit, while minimizing the side effects [9, 148, 287-289]. Recently, protein 
microspheres have been shown efficacy as biodegradable and biocompatible 
carrier, which can incorporate a variety of drugs in relatively non-specific fashion 
[61, 66, 69, 70, 75]. 
Albumin is a promising material and has been extensively investigated as 
drug delivery system (DDS), because of its biodegradability and low toxicity [134, 
137]. In addition, albumin proteins has a functionality for transporting different 
macromolecules in the bloodstream to target organs making it a potential 
macromolecular carrier for the site-directed delivery of drugs [227]. Previous 
studies demonstrate that 3 min of sonication promote high entrapment efficiency 
of anti-cancer drugs in bovine serum albumin (BSA) microspheres [61, 66]. 
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In this work, a sonochemical method was used to produce microspheres of 
BSA and human serum albumin (HSA) and to incorporate piroxicam into them. 
The production was followed by an extensive physico-chemical characterization 
of microspheres. Moreover, further miniaturization of the microspheres, to 
improve their colloidal stability, was performed via different stabilizers: polyvinyl 
alcohol (PVA), pluronic acid F68 (pluronic F68) and tween 80. The ability of 
proteins to form microspheres was evaluated by quantifying protein concentration 
with the Lowry assay on the supernatant after ultrasound treatment [191]. Particle 
size, as well as the polydispersity index (PDl), of microspheres, was evaluated by 
photon correlation spectroscopy (PCS). It is well known that the particle size can 
significantly affect the microspheres properties and is important for their 
interaction with the biological environment [187]. Particle size values are thus 
crucial in the development and optimization of preparation process. In addition 
the zeta-potential of microspheres was also evaluated by electrophoretic laser 
Doppler anemometry, to obtain an indication of surface potential. The scanning 
transmission electron microscopy (STEM) has been employed to characterize the 
overall structure and shape of the microspheres. The entrapment efficiency of 
piroxicam in microspheres was assessed and the release profile was evaluated in 
the presence of a protease. 
Finally, microspheres were screened for cytotoxicity using a metabolic assay 
on a human cell line. 
 MATERIALS AND METHODS VIII-2.
VIII-2.1. Preparation and characterization of protein microspheres 
Protein microspheres were prepared according with the method previously 
described in the Chapter II. The protein devices were produced using a fixed ratio 
(%) of 95/5 of aqueous/organic phase (vegetable oil), 3000 µM of drug 
(piroxicam) and 5.0 g.L-1 was the concentration of protein aqueous solution used 
in the assays. 
The procedure for the characterization of microspheres obtained is detailed in 
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the Chapter of materials and methods, namely: yield of microspheres formation, 
entrapment efficiency of piroxicam into protein microspheres, size and its 
distribution, zeta-potential, morphology (STEM technique) and stability studies. 
The procedure used to study enzymatic degradation and the drug release 
kinetics, as well as the cytotoxicity evaluation is described below. 
VIII-2.2. In vitro enzymatic degradation studies 
The enzymatic degradation of the developed carrier systems was 
investigated by incubating the microspheres in phosphate buffered saline solution 
(PBS, 0.01 M, pH = 7.4) with different concentrations of protease, subtilisin from 
Bacillus sp. (E.C.3.4.21.62), (0.075, 0.50 and 3.0 U.mL-1). The selected enzyme 
was used to mimicking the enzymatic environment of the human body and as a 
trigger for drug release. 
The microspheres were incubated at room temperature under constant 
shacking (50-60 rpm). At determined time points, aliquots were taken and the 
piroxicam release was monitored by absorbance measurements at wavelength of 
353 nm using a Heλios γ ThermoSpectronic spectrophotometer (Unicam). The 
quantification of the release was established by a standard absorbance curve. All 
the release experiments were carried out in triplicate and for a period of 6 days. 
Results are reported as average ± standard deviation. 
VIII-2.3. Drug release kinetics 
The release behaviour of compounds from polymeric systems can be 
determined by fitting the release data to the empirical relationship given by the 
Ritger-Peppas equation (Equation VIII-1). Mt/M is the fractional drug release at 
time t, t is the release time; k is the kinetic constant, and n is the diffusion 
exponent characteristic of the release mechanism. 
nt tk
M
M

  
Equation VIII-1: Ritger-Peppas equation. 
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To determine n values for proteinaceous microspheres, Equation VIII-1 is 
transformed in Equation VIII-2, and n is determined from the slope of the plot of 
log (% release) versus log t. 
  tlognklog
M
M
logreleased%log t 






  
Equation VIII-2: Modified Ritger-Peppas equation. 
VIII-2.4. Cytotoxicity screening 
The cytotoxicity of BSA and HSA microspheres, containing piroxicam, was 
evaluated using murine embryonic fibroblasts cells (MEFs), isolated from E13.5 
embryos and normal human skin fibroblasts (BJ5ta), from American type culture 
collection (ATCC). 
The BJ5ta cell line (normal human skin fibroblasts) was maintained according 
to ATCC recommendations (4 parts Dulbecco's modified Eagle's medium 
(DMEM) containing 4 mM L-glutamine, 4.5 g.L-1 glucose, 1.5 g.L-1 sodium 
bicarbonate and 1 part of Medium 199, supplemented with 10% (v/v) of fetal 
bovine serum (FBS), 1% (v/v) of Penicillin/Streptomycin solution and 10 µg.mL-1 
hygromycin B). The cells were maintained at 37 ºC in a humidified atmosphere of 
5% CO2. Culture medium was refreshed every 2 to 3 days. 
Cells were seeded at a density of 10 x 103 cells/100 µL/well on 96-well tissue 
culture polystyrene (TCPS) plates (TPP, Switzerland), in the day before of 
experiments, and then exposed to different microspheres concentrations, as well 
as to different controls solutions (BSA and HSA solutions, vegetable oil; PVA 
solution; piroxicam solution) added to fresh culture medium. At 24, 48 and 72 h of 
exposure, cell viability was determined using the alamarBlue® assay (Invitrogen, 
EUA). AlamarBlue cell viability reagent functions as a cell health indicator by 
using the reducing power of living cells to quantitatively measure the proliferation 
of various human and animal cell lines, allowing to establish relative cytotoxicity 
of agents within various chemical classes. When cells are alive, they maintain a 
reducing environment within the cytosol of the cell. In this assay, viable cells 
continuously convert resazurin (blue and non-fluorescent) to resorufin (red, highly 
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fluorescent), increasing the overall fluorescence and colour of the media 
surrounding cells. 10 µL of alamarBlue compound were added to each well 
containing 100 µL of culture medium. After 4 h of incubation at 37 ºC the 
absorbance at 570 nm, using 600 nm as a reference wavelength, was measured 
in a microplate reader (Spectramax 340PC). 
The quantity of resorufin formed is directly proportional to the number of 
viable cells. Data are expressed as means with standard errors of the means. 
Two-way ANOVA followed by post hoc Bonferroni test (GraphPad Prism 5.0 for 
Windows) was employed with statistically significant differences when P < 0.05. 
The samples were tested at least in triplicates per two independent 
experiments. 
 RESULTS AND DISCUSSION VIII-3.
VIII-3.1. Influence of stabilizer addition in protein microspheres 
characterization parameters 
In this work, matrices based on BSA and HSA proteins, were produced and 
characterized. To ensure microspheres suitability for the intended type of 
application and to enable a focused development of dispersions with specific 
properties, the characteristics of the dispersions have to be known in detail. 
In a previous study [72] (Chapter V) it was demonstrated that smaller sizes 
are obtained with 95/5 (%) of aqueous/organic phase. Based on these results, 
the addition of different stabilizers, namely PVA, tween 80 and pluronic F68, on 
formulations was evaluated. 
Firstly, the efficiency of microspheres formation was monitored with the 
Lowry assay [191]. The addition of stabilizer for the production of protein devices 
did not affect the yield of microspheres formation (≈ 100%). 
The effect of stabilizers on microspheres size was then evaluated. In this 
experiment, PVA was the first adopted stabilizer and BSA microspheres of 
different sizes were successfully prepared controlling PVA amount (Table VIII-1). 
Results show that when PVA quantity is increased, the size of proteinaceous 
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microspheres becomes much smaller. From Table VIII-1, it is possible to verify 
that not only the size of BSA microspheres gets effectively smaller, within a 
certain range, with the increasing of PVA amount, but also the particle size 
distribution, determined as PDl, becomes narrower. There are two main 
explanations for these observations. Firstly, the tiny particles make wavy 
movement and collide each other in an emulsion leading to particles aggregation. 
The polymerization degree of PVA used in the experiment can change the 
viscosity of an aqueous solution decreasing the wavy movement speed and the 
collision of the tiny particles. Secondly, the adsorption of PVA on the surface of 
proteinaceous microspheres can lower the surface energy and further 
agglomeration of proteinaceous microspheres [165, 290]. 
Table VIII-1: Effect of PVA on Z-average (nm), PDI and zeta-potential (mV) values of BSA 
microspheres 
PVA amount 
(%) 
Z-average 
(nm) 
PDl 
Zeta-potential 
(mV) 
0 402.9 ± 65.1 0.44 ± 0.03 -15.6 ± 1.5 
2 392.7 ± 20.1 0.35 ± 0.01 -4.7 ± 0.3 
4 378.1 ± 40.6 0.18 ± 0.08 -3.9 ± 0.6 
6 340.4 ± 15.6 0.15 ± 0.06 -3.8 ± 0.2 
8 257.9 ± 5.90 0.06 ± 0.04 -3.9 ± 0.1 
10 259.1 ± 4.20 0.06 ± 0.06 -3.7 ± 0.3 
 
Besides PVA, others macromolecular stabilizers have been tested, namely, 
pluronic F68 and tween 80 (Table VIII-2). However, PVA, when compared with 
pluronic F68 and tween 80, presented a high ability to reduce the particle sizes 
and, at the same time, decrease the PDl, promoting a monomodal distribution of 
BSA microspheres. The optimization of stabilizer amount was achieved at 8%, as 
higher percentages of PVA did not represent significant change in microspheres 
size. This ratio was used as standard conditions for all subsequent preparations. 
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Apart from size determination, zeta-potential was also evaluated to obtain an 
indication of microspheres surface potential. The surface potential of the particles 
cannot be measured directly, the zeta-potential (electrical potential at the surface 
of hydrodynamic shear around the colloidal particle) is usually determined as a 
characteristic parameter for the particle charge [229, 291]. The BSA 
microspheres possess a zeta-potential around -15 mV, suggesting the presence 
of negative charge on the microspheres surfaces (Table VIII-1). Nevertheless, the 
zeta-potential of the particles decreased significantly in the presence of 
stabilizers (Table VIII-1 and Table VIII-2). 
Table VIII-2: Effect of different stabilizers, PVA (8%), pluronic F68 (8%) and tween 80 
(8%), on Z-average (nm), PDI and zeta-potential (mV) values of BSA 
microspheres 
Stabilizers 
(8%) 
Z-average 
(nm) 
PDl 
Zeta-potential 
(mV) 
PVA 247.9 ± 5.9 0.060 ± 0.04 -3.9 ± 0.1 
Pluronic F68 392.1 ± 60.1 0.29 ± 0.05 -2.9 ± 0.4 
Tween 80 386.3 ± 17.1 0.28 ± 0.06 -3.5 ± 0.1 
 
A survey of the literature reveals that the measurement of zeta-potential 
allows predict about the stability for colloidal dispersion [275, 276, 278]. In 
general, particle aggregation of charged particles (high zeta-potential) is less 
likely to occur, due to electric repulsion. However, this rule cannot be strictly 
applied to the systems containing steric stabilizers, because the adsorption of the 
steric stabilizers will decrease the zeta-potential, due to the shift in the shear 
plane of the particle [109]. 
HSA was also tested in this work and the data presented on Table VIII-3 
substantiate that HSA contributed to a small increase on the Z-average value, 
when compared with BSA. In spite of the 80% of homology, present on the 
primary structures of the two proteins, the replacement of some hydrophobic 
amino acids (a.a.) by others (e.g. HSA has a single Tryptophan amino acid while 
BSA holds two Tryptophan‟s in its sequence [155, 227], can explain this 
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difference on the size obtained, once that, the properties of each amino acid 
demonstrated to be essential in the physico-chemical parameters of 
microspheres [72, 73]. Conversely, the zeta-potential of HSA microspheres is 
very similar to BSA microspheres. 
Table VIII-3: Effect of PVA on Z-average (nm), PDI and zeta-potential (mV) values of HSA 
microspheres 
PVA amount 
(%) 
Z-average 
(nm) 
PDl 
Zeta-potential 
(mV) 
0 451.8 ± 14.6 0.47 ± 0.02 -17.1 ± 1.6 
8 296.9 ± 1.3 0.070 ± 0.01 -3.9 ± 1.1 
 
VIII-3.2. Piroxicam entrapment 
The entrapment efficiency of piroxicam into BSA and HSA microspheres was 
assessed spectrophotometrically. Entrapment efficiency refers to the ratio of 
quantity entrapped/adsorbed drug in relation to the total (theoretical) amount of 
drug used for microspheres production. 
Figure VIII-1 shows that PVA proved to be successful in enhancing drug 
incorporation efficiency in both types of proteinaceous devices prepared. 
Piroxicam entrapment efficiency is an important factor, once that the release 
rate is usually dependent on drug concentration gradient [132]. Furthermore, 
higher levels of drug incorporation lead to a wider concentration gap between the 
polymeric/protein microspheres and the release medium and can cause a higher 
diffusion rate. 
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Figure VIII-1: Effect of PVA (8%) on the entrapment efficiency of piroxicam (initial 
concentration of 3000 µM) into BSA (5.0 g.L
-1
) and HSA (5.0 g.L
-1
) 
microspheres. 
As previously demonstrated, the PVA addition led to a submicron size and a 
relatively narrow particle size distribution. The drug incorporation in microspheres 
resulted in a slightly bigger particles with similar PDl values (Figure VIII-2). 
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Figure VIII-2: Z-average (nm) and PDl of different formulations, prepared with BSA 
(5.0 g.L
-1
) and HSA (5.0 g.L
-1
), piroxicam (3000 µM), with or without PVA 
(8%). 
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The zeta-potential results (Figure VIII-3) evidence that the presence of 
piroxicam did not affect significantly the surface charge of proteinaceous 
microspheres. 
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Figure VIII-3: Zeta () -potential (mV) of different formulations prepared with BSA (5.0 g.L
-1
) 
and HSA (5.0 g.L
-1
), piroxicam (3000 µM), with or without PVA (8%). 
VIII-3.3. Stability studies 
Since those colloidal particles can suffer destabilization over time [244], 
particularly when stored in an aqueous dispersion, particle size was monitored 
for two months after preparation in order to evaluate their physical stability. The 
zeta-potential was also determined, since this parameter can change over time, 
due to degradation of components of the colloidal particles [245]. In an 
electrostatically stabilized dispersion, charges generated on the surface of 
particles prevent or control agglomeration. Steric stabilization takes place when 
large molecules adsorb onto the surface of particles, thus introducing physical 
barriers between them [276]. A combination of electrostatic and steric 
mechanisms produces electrosteric stabilization preventing microspheres 
agglomeration. 
Figure VIII-4 demonstrates that the presence of PVA increases microspheres‟ 
stability, as the size and zeta-potential measurements were roughly stable over 
time. Conversely, the entrapment of piroxicam without PVA leads to an increase 
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on Z-average values and decrease zeta-potential values (≈ 0 mV), after one 
week of storage. Furthermore, the stabilization of microemulsion with PVA is 
attributed to the adsorbed chain molecules of PVA on the surface, which have 
ceaseless thermal motion, resulting in dynamically rough surface preventing 
coalescence by repulsive entropic force. 
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Figure VIII-4: Z-average (nm) and zeta () -potential (mV) over a timeline of two months for 
different formulations prepared with BSA (5.0 g.L
-1
) and HSA (5.0 g.L
-1
), 
piroxicam (3000 µM), with or without PVA (8%). 
VIII-3.4. Morphology 
STEM photographs, in Figure VIII-5, illustrate that the obtained BSA 
microspheres are clearly spherical homogeneous particles with smooth surfaces. 
It was possible to verify that the use of stabilizers (PVA) promoted some 
restrictions on visualization of microspheres, due to their surface tension. The 
morphology of HSA microspheres was also evaluated and presents a similarly 
spherical shape. This morphology would offer the highest potential for controlled 
release and protection of incorporated drugs, as they provide minimum contact 
with the aqueous environment, as well as the longest diffusion pathways. 
Comparing particles with any other shape, spherical particles also require the 
smallest amount of surface-active agent for stabilization, because of their small 
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specific surface area [187]. These results are also in agreement with PCS results, 
once that the particle size distribution was very similar. 
 a)  b) 
 c)  d) 
Figure VIII-5: STEM images (x50000 magnification) of protein microspheres: a) BSA 
(5.0 g.L
-1
) + Piroxicam (3000 µM); b) BSA (5.0 g.L
-1
) + PVA (8%) + Piroxicam 
(3000 µM); c) HSA (5.0 g.L
-1
) + Piroxicam (3000 µM); d) HSA (5.0 g.L
-1
) + PVA 
(8%) + Piroxicam (3000 µM). 
VIII-3.5. In vitro release profile 
The two developed systems in this study aimed to be used as carriers of an 
anti-inflammatory molecule are: BSA-piroxicam microspheres and HSA-piroxicam 
microspheres. One important and desired property is biodegradation when 
designing DDS. Biodegradable polymers are able to release the entrapped drug 
as their degradation take places. Thus, by controlling the degradation rate of 
polymeric materials the drug release can be identically monitored. 
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The release profile of BSA and HSA-based particles, prepared with 5.0 g.L-1 
of protein, 8% of PVA and with 3000 µM of piroxicam, in the presence of protease 
enzyme are presented in Figure VIII-6. The release can be divided into two 
phases: an initial burst in the first hours and a continuous release over the 
remaining time. 
The burst release of piroxicam is associated with those piroxicam molecules 
dispersing close to microspheres surface, which diffuse out in the initial 
incubation time. 
There are several factors that affect the release of the entrapped drug. It was 
possible to verify that BSA particles display a faster release of piroxicam, 
compared with the release obtained with HSA microspheres. This result can be 
attributed to the fact that smaller particles have a larger surface area, therefore, 
most of the associated drug would be at or near the particle surface leading to a 
fast drug release. On the other hand, the observed higher sizes of HSA particles, 
can explain the longer sustained release compared to smaller particles. 
Different concentrations of protease (0.073, 0.50 and 3.0 U.mL-1) were used 
for piroxicam release trigger on protein devices and the results of Figure VIII-6 
evidence that the higher concentration lead to the most rapid diffuse out of drug. 
A number of mathematical models have been proposed to describe the 
mechanisms of drug release from polymeric devices. The Higuchi [292], 
Korsmeyer [293] and Peppas [294, 295] equations are the most widely used to 
date and are mainly based on the Fickian diffusion equation. 
In order to analyse the release mechanism of piroxicam from the 
proteinaceous microspheres and the effect of the protease concentrations over 
the release behaviour, the obtained data was processed using the empirical 
expression proposed by Ritger-Peppas [294] presented in the previously point of 
materials and methods. 
For a sphere, a Fickian diffusion of first-order is observed when n has the 
limiting value of 0.43; if n = 0.85 occurs Case II transport (polymer 
relaxation/degradation), leading to zero-order release. Finally, when n lies 
between 0.43 and 0.85, Anomalous transport is observed coupling Fickian 
diffusion and polymer degradation [294, 295]. 
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Figure VIII-6: In vitro release profile of piroxicam from BSA (a) and HSA (b) microspheres 
incubated with different concentrations of protease (0.073, 0.50 and 
3.0 U.mL
-1
) and with PBS buffer solution (control). The first 24 h of release is 
enlarged for all the conditions. 
In HSA microspheres (Table VIII-4), the drug transport mechanism obtained 
for all experimental conditions was Non-Fickian diffusion or Anomalous 
(indication of the superposition of both extreme phenomena: drug diffusion and 
macromolecular chain relaxation/degradation). This result indicates that neither 
absolute Fickian diffusion (as result of pure drug diffusion) nor Case II-zero order 
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(because of polymer chain relaxation/degradation) was the predominant 
mechanism in this case. Therefore, it can be concluded that the protease 
concentration does not significantly influences the drug transport mechanism, 
affecting solely the diffusion coefficient value. 
In Table VIII-4 is possible to observe that BSA microspheres in the 
presence of higher protease concentrations present a higher n value indicating 
the Case II-zero order nature, which means that the piroxicam release is mainly 
due to the macromolecular chain relaxation indicating the degradation of BSA 
microspheres. 
The proteins chemical nature reveal a significant influence in the drug 
transport mechanism (Anomalous and Case II-zero order nature), when higher 
enzyme concentrations are used, affecting the diffusion coefficient value. 
Moreover, correlation coefficient “R2” is above the permissible range, that is, 
0.95, further supporting the validity of the results. 
Table VIII-4: Piroxicam release kinetic data obtained from fitting experimental release 
data to Ritger-Peppas Equation VIII-2, where “n” is the diffusion exponent 
and R
2
 is the correlation coefficient 
Protease 
(U.mL-1) 
BSA HSA 
n R2 n R2 
0.073 0.568 0.987 0.529 0.988 
0.50 0.699 0.994 0.526 0.996 
3.0 0.859 0.987 0.544 0.993 
 
VIII-3.6. Cytotoxicity evaluation 
The biocompatibility of the piroxicam entrapped on proteinaceous devices 
was assessed in fibroblast cultures. A preliminary screening was made using 
murine embryonic fibroblasts cells (MEFs), as a measure of global cytotoxicity. In 
this study, a wide range of protein concentrations (from 75 to 5000 mg.L-1) used 
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for inhibition assays was evaluated and no toxicity was observed for the range 
concentrations of 75-300 mg.L-1. 
The results obtained with MEFs were then confirmed with human skin 
fibroblasts, testing the range protein concentrations (75-300 mg.L-1) that did not 
induced any damage to MEFs cells. 
The effect of all tested conditions on BJ5ta was evaluated after 24, 48 and 
72 h of culture, in order to establish the effect of drug entrapped in proteinaceous 
microspheres (BSA and HSA) on exposed BJ5ta (Figure VIII-7 and Figure VIII-8). 
Results indicate that neither protein solutions (BSA and HSA), PVA solution 
(PVA Sol.) nor vegetable oil induce any toxicity for the investigated culture times 
(P > 0.05). However, it is clear that the effect of piroxicam, in a concentration of 
0.5 mM, on human fibroblasts cells is statistically different when compared to 
control cells (*** P < 0.001) and with the other tested samples (••• P < 0.001). 
In Figure VIII-7 it is possible to verify that after 72 h of exposure to 300 mg.L-1 
of BSA microspheres containing piroxicam, the viability of BJ5ta decreased, 
suggesting moderate cytotoxicity effects when compared with cells control  
(** P < 0.01). Comparisons of different concentrations of BSA microspheres, 
containing piroxicam, with the other tested samples were also performed and 
statistically significant differences were obtained for the 300 mg.L-1 
concentration, after 72 h (+ symbol: BSA Sol. Vs 300 mg.L-1 BSA; # symbol: 
Vegetable oil Vs 300 mg.L-1 BSA; δ symbol: 150 and 75 mg.L-1 BSA Vs 
300 mg.L-1 BSA, P < 0.05). 
In Figure VIII-8, similar data is displayed for the viability of BJ5ta cells in 
contact with HSA microspheres, containing piroxicam, which further provides the 
evidence of cytotoxic effects after 72 h, when 300 mg.L-1 of HSA microspheres 
concentration is used (+ symbol: BSA Sol. Vs 300 mg.L-1 BSA; # symbol: 
Vegetable oil Vs 300 mg.L-1 BSA; δ symbol: 150 and 75 mg.L-1 BSA Vs 
300 mg.L-1 BSA, P < 0.05 and ** symbol: Cells Vs 300 mg.L-1 BSA P < 0.01). 
Statistically, it is possible to observe that the range concentrations of  
75-150 mg.L-1 of proteinaceous microspheres containing piroxicam, did not 
significantly affect the viability of human skin fibroblasts cells for a period of 72 h, 
indicating that microspheres can be safely applied at these concentrations. 
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Figure VIII-7: BJ5ta cell viability at 24, 48 and 72 h of culture with different solutions and 
different concentrations of BSA microspheres containing piroxicam (75, 150 
and 300 mg.L
-1
). Values for tested samples are presented in relation to the 
control (cells cultured with culture medium scored 100% of viability). 
Statistically significant differences are indicated. * = significantly different 
from cells control; • = significantly different from other tested conditions; 
+ = significantly different from BSA Sol.; # = significantly different from 
Vegetable oil; δ = significantly different from 75, 150 and 300 mg.L
-1
 of BSA 
microspheres. 
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Figure VIII-8: BJ5ta cell viability at 24, 48 and 72 h of culture with different solutions and 
different concentrations of HSA microspheres containing piroxicam (75, 150 
and 300 mg.L
-1
). Values for tested samples are presented in relation to the 
control (cells cultured with culture medium scored 100% of viability). 
Statistically significant differences are indicated. * = significantly different 
from cells control; • = significantly different from other tested conditions; 
+ = significantly different from HSA Sol.; # = significantly different from 
Vegetable oil; δ = significantly different from 75, 150 and 300 mg L
-1
 of HSA 
microspheres. 
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 CONCLUSIONS VIII-4.
The present study demonstrates the ability of proteinaceous microspheres to 
entrap the anti-inflammatory drug piroxicam. BSA and HSA microspheres were 
produced with predictable and reproducible size by a sonochemical method. 
Furthermore, the incorporation of PVA into the prepared formulations resulted in 
improved characteristics, including smaller size, lower size distribution, higher 
stability and higher entrapment efficiency of piroxicam. 
The kinetics of piroxicam entrapped in BSA or HSA microspheres release 
mechanism was shown to be dependent on the protein and on protease 
concentration. The fast release is achieved when the drug is entrapped into BSA 
microspheres and in the presence of high protease concentration (3.0 U.mL-1). 
However, if it is necessary a slower release the piroxicam should be incorporated 
in HSA microspheres. 
This fact, along with the cytocompatibility observed with human skin 
fibroblasts, indicates that these proteins may potentially be used as potential 
bioactive carriers for treatment of inflammatory diseases. In this sense, such drug 
carriers with a specific size range can be invaluable therapeutic tools for other 
pathologies where the NSAIDs can be useful, such as cancer, Alzheimer and 
artherosclerosis [282, 296-298]. 
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Chapter IX 
Chapter IX -  Cotton and nonwoven gauzes bandages: A support for 
proteinaceous microspheres§§ 
ABSTRACT 
The use of active ingredients in wound management have evolved alongside 
the pharmaceutical agents and dressings used to deliver them. However, the 
development of gauzes dressings with specific properties still remains a 
challenge for several medical applications, thus the search for the new gauzes 
bandages. 
Being protein microspheres production process optimized, it was 
considered pertinent their application onto a textile support. Thus, bovine serum 
albumin-piroxicam (BSA-piroxicam) microspheres were attached onto cotton and 
nonwoven gauzes using two different methodologies (incubation and 
sonochemical methodology). The attachment of proteinaceous microspheres 
using sonochemical radiation, promotes the binding onto cotton and nonwoven 
gauzes by a one-step process. In fact, the short time ultrasound treatment (3 min) 
proved to be the more efficient methodology, due to the increase of mass 
transport effects. 
The results also demonstrated that the previous activation of surface gauzes, 
with the cationic product, led to an enhancement of proteinaceous microspheres 
attached onto cotton and nonwoven gauzes and, consequently, to a higher 
piroxicam release. Furthermore, these protein devices show extraordinary ability 
to delivery piroxicam, greatly supporting their potential application in the 
biomedical fields. 
 
                                            
§§
 This chapter is based on the following publication: 
Silva R, Ferreira H, Cavaco-Paulo A, Cotton and nonwoven gauzes bandages: A support 
for proteinaceous microspheres, submitted. 
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 INTRODUCTION IX-1.
The use of textiles in medicine has a long tradition. An important field of 
application is in wound care and prevention of chronic wounds [180]. Among the 
long list of textile materials, bandages and wound dressings gained great 
popularity [178]. The exploit of textile materials was supported by availability, 
prices and re-usability [299]. Along with the technology development of functional 
textiles, their use in wound healing and prevention of chronic wounds has 
reached a new quality of interactivity between biological tissues and textiles 
[178]. These fibres were shown to favour wound occlusion, exudate transport, 
and drug dispensation with much reduced distress to the patient [180, 300]. 
Despite the fact that traditional textiles fulfilled primary quality approaches like 
biocompatibility, flexibility, strength, etc., there is an increasing need for specified 
functions [301]. In particular, the controlled release of bioactive molecules to 
counteract the progression of infection and inflammation such as in chronic 
wounds management was considered a step forward in this research area [302]. 
The local delivery of drugs by topical administration or by delivery device may 
enable the maintenance of high local drug concentration for an extended duration 
release without exceeding systematic toxicity. This is an important feature, 
because the use of anti-inflammatory drugs, such as piroxicam that is very useful 
to counteract local inflammation, can be absorbed through blood vessels and 
could originate severe side effects on both the gastrointestinal and kidney [303, 304]. 
Controlled delivery dressings can provide an excellent means of delivering 
drugs to wound sites in a consistent and sustained fashion over long periods of 
time without the need for frequent dressing change [305]. 
There is a need to develop new dressings that can be useful in the treatment 
of local infections, where it may be beneficial to the increase of the local 
concentrations of anti-inflammatory drugs, while avoiding high systemic doses, 
thus reducing patient exposure to an excess of drug beyond that required at the 
wound site [306, 307]. Furthermore, a dressing that will deliver an active 
substance to a wound site in a controlled fashion for a sustained period of about 
a week could help solve or minimize the non-compliance patients. 
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Several biodegradable devices from both natural and synthetic polymers 
have been produced by different processes in recent years, for use as drug 
carriers. Biodegradable polymers can release larger quantities of pharmaceutical 
agents and their degradation properties can be tailored for a specific application 
[8, 148, 308]. Natural polymers such as proteins are attractive, since they exhibit 
superior biocompatibility and biodegradability [69, 140, 309]. 
In the present work, piroxicam, sonochemical entrapped on bovine serum 
albumin (BSA) microspheres was attached onto cotton and nonwoven gauzes in 
order to produce a functionalized biomaterial with the ability to deliver the 
pharmaceutical agent in a control manner. 
 MATERIALS AND METHODS IX-2.
IX-2.1. Preparation and characterization of protein microspheres 
containing piroxicam 
Protein microspheres were prepared according with the method described 
previously in Chapter II. The protein devices were produced using a fixed ratio 
(%) of 95/5 of aqueous/organic phase (vegetable oil), 8% of polyvinyl alcohol 
(PVA), 3000 µM of piroxicam and 5.0 g.L-1 was the concentration of protein 
aqueous solution used in the assays. The procedure for the further 
characterization is detailed in Chapter II. The methodologies used to attach the 
proteinaceous devices onto cotton and nonwoven gauzes as well as the 
evaluation of piroxicam release are described below. 
IX-2.2. Chemical activation of gauzes 
IX-2.2.1. Cationization of cotton and nonwoven gauzes 
The gauzes were cationized using the exhaust method already described 
[310]. The cationization was performed in sealed, stainless steel pots of 120 cm3 
capacity in a laboratory scale dyeing machine (AHIBA Spectradye, from 
Datacolor International) with infrared temperature control. 
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The treatment was carried out using a material: liquor ratio of 1:20, 10% 
(on weight of the fabric) of poly(diallyldimethylammonium chloride) (PDDA) 
(Figure IX-1) and 5.0 g.L-1 of sodium hydroxide (NaOH) over 60 min at 50 ºC. 
Then the gauzes were washed thoroughly with deionized water. 
 
Figure IX-1: Chemical structure of poly (diallyldimethylammonium chloride). 
IX-2.2.2. Determination of the cationization efficiency on the gauze surface 
The cationization at the surface of gauzes (cotton and nonwoven) were 
analysed by staining of treated samples and controls (cotton and nonwoven 
gauzes without cationization treatment) with a Comassie brilliant blue G250 (Acid 
Blue 90; C.I. 42655). The staining was executed in AHIBA machine, previously 
referred, using 1 g.L-1 of Comassie dye, at 60 ºC for 60 min. After staining, the 
samples were washed with deionized water until no more dye could be detected 
in the washing solution. The colour measurements were determined using a 
spectrophotometer (illuminant D65 at 600 nm) (Spectraflash, from Datacolor 
International) coupled to a computer. The colour strength was evaluated as K/S 
(Equation IX-1) at maximum absorption wavelength (600 nm). The ratio between 
absorption coefficient (K) and scattering coefficient (S) is related to reflectance 
data by applying Kubelka-Munk‟s law at each wavelength, and it is proportional to 
dye concentration [311, 312]. R is the light reflection, K is the absorption 
coefficient and S is the scattering coefficient. All the samples were measured 
using at least triplicate samples. 
R
R
S
K



2
1 2
 
Equation IX-1: Determination of K/S using the simplified Kubelka-Munk’s law. 
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IX-2.3. Attachment of proteinaceous microspheres, containing piroxicam, 
onto gauzes bandages 
In order to obtain the attachment of proteinaceous microspheres, containing 
piroxicam, onto gauzes (0.1 g) two sets of experiments were applied, namely 
incubation and sonochemical method. The attachment of microspheres by 
incubation procedure was carried out in two different steps. First, the 
microspheres were produced and submitted to an extensive physico-chemical 
characterization. After, they were incubated with the gauzes in a water shaking 
bath at room temperature (25 ºC) over 24 h under constant shacking (50 rpm). 
Several controls were run simultaneously: a control test with non-cationized 
gauzes (cotton and nonwoven) and a control test with cationized gauzes (cotton 
and nonwoven) without microspheres, incubated with phosphate buffered saline 
solution (PBS, 0.01 M, pH=7.4). After incubation, the samples were removed and 
washed with deionized water. 
The attachment of proteinaceous microspheres via sonochemical method 
was performed in one-step reaction. In this case, the gauzes were added to the 
biphasic system, consisting of protein solution and vegetable oil, applying the 
same conditions described in Chapter II (II-4.2.). The control samples were the 
gauzes (cotton and nonwoven, cationized and non-cationized) in PBS submitted 
to ultrasound treatment in the same conditions. The remaining solution was 
centrifuged, using the centricon tubes, and the protein concentration in the 
supernatant and the amount of piroxicam entrapped was determined (Chapter II). 
Finally, the samples gauzes were collected and washed with deionized water. 
All measurements were performed using at least duplicate samples. 
IX-2.4. Evaluation of proteinaceous microspheres attached onto gauzes 
based on ninhydrin reaction 
The presence of protein microspheres in the gauzes samples, was evaluated 
using the ninhydrin (2,2-dihydroxyindane-1,3-dione) reagent. Ninhydrin is most 
commonly used to detect, the terminal amines or Lysine residues in peptides and 
proteins [313, 314]. This is a chemical reagent used to detect ammonia or 
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primary and secondary amines. When reacting with these free amines, a deep 
blue or purple colour, known as Ruhemann's purple, is produced (Figure IX-2). 
 
Figure IX-2: Mechanism of reaction of amino acids with ninhydrin to form Ruhemann’s 
purple product (Adapted from Friedman [314]). 
For this assay, the gauzes samples were dried at 60 ºC and then incubated 
with ninhydrin solution (0.5%), at 60 ºC, over 30 min. This test was performed in 
the gauzes samples after proteinaceous microspheres attachment by incubation 
and ultrasound treatment, and in controls gauzes samples (cotton and nonwoven 
cotton samples gauzes, cationized and non-cationized, without microspheres). 
IX-2.5. Quantification of piroxicam released from proteinaceous 
microspheres attached onto gauzes bandages 
The release of piroxicam by the microspheres attached onto gauzes was 
assessed by incubation of the textile samples, and control samples (gauzes 
without microspheres) in deionized water (pH 5.5). The deionized water was used 
to mimic the skin pH (5.5 - 5.6) [315]. At determined time points, aliquots were 
taken, and the piroxicam release was monitored by absorbance measurements at 
wavelength of 353 nm using a Heλios γ ThermoSpectronic spectrophotometer 
(Unicam). The quantification of the piroxicam released was established by a 
standard absorbance curve. The release studies were carried out in in triplicate 
and for a period of 6 days. Results are reported as mean value ± standard 
deviation. 
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 RESULTS AND DISCUSSION IX-3.
In this work, matrices based on BSA protein, were produced and 
characterized. 
In a previous study [76] (Chapter VIII), it was shown that smaller sizes are 
obtained with 95/5 (%) of aqueous/organic phase and with 8% of stabilizer. After 
testing some different stabilizers it was demonstrated that the most competent is 
the PVA. The results evidence high entrapment efficiency (≈ 80%) of piroxicam 
into BSA microspheres. Piroxicam entrapment efficiency is an important factor, 
once that the release rate is usually dependent on drug concentration gradient 
[132]. Furthermore, higher levels of drug incorporation lead to a wider 
concentration gap between the protein microspheres and the release medium 
and can cause a higher diffusion rate. 
These conditions were used as standard conditions for all subsequent tests. 
IX-3.1. Attachment of proteinaceous microspheres, containing piroxicam, 
onto cotton and nonwoven gauzes 
Considering special advantages and high potentialities of the application of 
microstructures materials in textile industry, especially for producing high 
performance textile, this study report the application of microstructured 
proteinaceous material containing an anti-inflammatory drug for biomedical 
application. 
In this work, two different methodologies were used to attach the BSA 
microspheres, containing the anti-inflammatory drug, onto cotton and 
nonwoven gauzes bandages. First, the microspheres were previously 
prepared, characterized and subsequently incubated with gauzes (cationized 
and non-cationized) in shaking water bath, at 25 ºC and 50 rpm. 
In the other set of experiments, the attachment of microspheres was carried 
out in one-step reaction using the ultrasound system. This attachment procedure 
did not present significant differences on physico-chemical characteristics of BSA 
microspheres containing piroxicam. The efficiency of microspheres formation 
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was ≈ 100% and the entrapment efficiency of piroxicam was ≈ 76%. The values 
of zeta-potential were also very similar (-5 ± 0.5 mV), as well as the Z-average 
and polydispersity index (PDl) values (280 ± 10 nm and 0.095 ± 0.001, 
respectively). 
Taking into account that microspheres present negative surfaces charge, our 
aim is the activation of the gauzes surfaces in order to obtain a positive charge. 
Consequently, a higher electrostatic interaction has been expected between the 
negative surface charge of BSA microspheres and the positive surface charge of 
gauzes. The covalent addition of cationizer products to cotton is used extensively 
to improve anionic dye fastness [316]. This study reports not only the 
cationization of cotton gauzes but also the nonwoven gauzes using PDDA. The 
reason to submit the nonwoven gauze to cationization process is due to the 
presence of viscose (67%), containing hydroxyl groups as the cotton fibre. These 
hydroxyl groups acquire a negative charge when they are ionisable, decreasing 
the electrostatic interactions with the BSA microspheres and thus the need for 
cationization process of gauzes. 
The cationized samples and the control samples (cotton and nonwoven 
gauzes no cationized) were dyed with Comassie blue, known as an acid dye, to 
evaluate cationization efficiency. When dyed, ionic bonding with fibre cationic 
sites accounts for fixation of coloured anions in the dyed material. The efficiency 
of cationization process was determined based on colour strength (K/S) and the 
values are given in the Figure IX-3. Comparing the K/S values of the cationized 
and the non-cationized gauzes (cotton and nonwoven) it is possible to conclude 
that Comassie dye has a more affinity for the cationized fibre when compared 
with non-cationized fibre, demonstrating the strong electrostatic interactions 
between the negative charge of dye molecules and the positive charge present at 
the gauzes surfaces. 
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Figure IX-3: K/S values (=600 nm) for the cationized samples (cotton and nonwoven 
gauzes represented as CO Cat and NW Cat, respectively) and the control 
samples (non-cationized cotton and nonwoven gauzes, represented as CO 
control and NW control, respectively) dyed with Comassie brilliant blue 
G250. The K/S was calculated according with the Equation IX-1. 
The proposed methods to attach the BSA microspheres, containing piroxicam, 
onto cotton and nonwoven gauzes bandages (cationized and non- cationized) 
were evaluated using the ninhydrin reagent, which is applied to detect amino 
acids (a.a.) on proteins. When ninhydrin react with amines present on proteins a 
visible purple colour will be developed [313, 314]. 
Figure IX-4 shows the images, after the addition of ninhydrin, being possible 
to verify that all the samples (cationized and non-cationized) present a blue 
colour, correspondent to the presence of protein at gauzes surface. However, the 
results suggest a more pronounced blue colour for the cationized samples, 
evidencing the higher protein attachment onto positively charged surfaces. 
Furthermore, the ultrasound treatment seems to be more efficient once that a 
greater uniformity of the colour was achieved. In this case, the protein transfer 
from solution to gauze surface is improved by ultrasound induction in a more 
uniform manner. 
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a) 
NW control NW cat control NW incubation NW cat incubation NW ultrasound NW car ultrasound 
       
      
b) 
CO control CO cat control CO incubation CO cat incubation CO ultrasound CO car ultrasound 
Figure IX-4: Images of developed colour after 30 min of ninhydrin application on the 
microspheres attached onto cotton (a) and nonwoven (b) gauzes bandages 
by sonication or incubation method (cotton and nonwoven gauzes 
represented as CO and NW, and cotton and nonwoven gauzes cationized 
represented as CO cat and NW cat, respectively). The control samples were 
incubated or sonicated with PBS (non-cationized gauzes: cotton and 
nonwoven without microspheres, symbolized as CO control and NW 
control, respectively; cationized gauzes: cotton and nonwoven without 
microspheres, represented as CO cat control and NW cat control, 
respectively). 
IX-3.2. Morphology of gauzes bandages with microspheres 
The morphological analysis of the fibres was carried out using scanning 
electron microscopy (SEM), which is the most widely used of the surface 
analytical techniques. SEM represents an invaluable tool for studying surface 
topography and failure analysis. The technique, which enables qualitative  
three-dimensional (3-D) imaging of surface features, clearly illustrated that with 
both methodologies, incubation and ultrasound treatment, it was possible to 
attach the BSA microspheres, containing piroxicam, onto the cotton and 
nonwoven gauzes (Figure IX-5 and Figure IX-6).The microphotographs also 
suggest that the presence of positive charges on the gauzes surfaces increment 
the microspheres attachment, being possible to visualise a layer of microspheres 
covering almost completely the surface of the gauze fibres. These data 
corroborate the ninhydrin results. 
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Figure IX-5: SEM microphotography’s (x5000 magnification) of cotton gauzes 
bandages: a) and b) control (cationized and non-cationized without 
microspheres, respectively); c) non-cationized - incubation treatment; d) 
cationized - incubation treatment; e) non-cationized - ultrasound treatment; 
f) cationized - ultrasound treatment. 
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Figure IX-6: SEM microphotography’s (x5000 magnification) of nonwoven gauzes 
bandages: a) and b) control (cationized and non-cationized, without 
microspheres, respectively); c) non-cationized-incubation treatment; d) 
cationized - incubation treatment; e) non-cationized - ultrasound treatment; 
f) cationized - ultrasound treatment. 
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IX-3.3. In vitro release profile of piroxicam from cotton and nonwoven 
gauzes bandages 
The release behaviour of polymeric microspheres is one of the most 
important features of the drug/polymer formulations, because of the proposed 
application in sustained drug delivery. 
The release profile of BSA-based particles was performed in wet gauzes 
bandages (immediately after ultrasound or incubation treatment) and in dried 
gauzes bandages (samples dried at room temperature). 
The release of piroxicam it was observed mainly in the first hours. The burst 
release of piroxicam is associated with those piroxicam molecules dispersing 
close to microspheres surface, which diffuse out in the initial incubation time 
(Figure IX-7 and Figure IX-8).There are several factors that affect the release of 
the entrapped drug in protein microspheres. It was possible to verify that BSA 
particles display a higher release of piroxicam, when they are attached by 
sonochemical methodology [Figure IX-7 b) and Figure IX-8 b)]. This result can be 
attributed to the fact that ultrasound phenomena in liquid media enhance mass 
transports of their constituents in a non-homogeneous fashion allowing the fast 
attachment on the fibres gauzes. 
The beneficial use of the ultrasound is realized through its chemical, 
mechanical or physics effects on the process or product [317]. Conversely, the 
attachment by incubation treatment with a constant stirring is not plentiful to 
promote an efficient treatment, which can explain the longer sustained release of 
piroxicam. The amount of piroxicam release can be related with its microsphere 
entrapped quantity and attached onto fibres surface. 
Incubation and ultrasound treatment with the above characteristics appear 
to have the same behaviour effects on the release of piroxicam in cationized 
gauzes bandages (Figure IX-7 and Figure IX-8). As it was mentioned, the 
cationization process promotes the presence of positive charges on the gauzes 
surfaces that would favour the attachment of the BSA microspheres, which 
presents a negative surface charge, onto the structure of the gauzes material 
(cotton and nonwoven). Therefore, the improvement of electrostatics interactions, 
between the microspheres and the cationized gauzes, can promotes a higher 
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released of piroxicam. These data also suggested that lowest concentration of 
piroxicam released is achieved with gauzes bandages dried. This result can be 
attributed to the fact that the drying process can lead to a premature disruption of 
BSA microspheres and, consequently, a lost in the content of piroxicam. It is also 
necessary to note that in dried samples the hydration of the textile material may 
be more difficult or occurs more slowly and, consequently, can decrease the 
diffusion of piroxicam to the medium. 
0 20 40 60 80 100 120 140 160
0
500
1000
1500
2000
2500
3000
a)
C
u
m
u
la
ti
v
e
 p
ir
o
x
ic
a
m
 r
e
le
a
s
e
d
 (

M
)
Time (h)
 CO wet
 CO cat. wet
 CO dry
 CO cat. dry
0 2 4 6
0
200
400
600
800
1000
1200
1400
 CO wet
 CO cat. wet
 CO dry
 CO cat. dry
 
0 20 40 60 80 100 120 140 160
0
500
1000
1500
2000
2500
3000
b)
C
u
m
u
la
ti
v
e
 p
ir
o
x
ic
a
m
 r
e
le
a
s
e
d
 (

M
)
Time (h)
 CO wet
 CO cat. wet
 CO dry
 CO cat. dry
0 2 4 6
0
200
400
600
800
1000
1200
1400
 CO wet
 CO cat. wet
 CO dry
 CO cat. dry
 
Figure IX-7: In vitro release profile of piroxicam entrapped on BSA microsphere from 
cotton gauzes bandages: (a) incubation treatment (b) sonochemical 
treatment. The first 6 hours of release is enlarged for all the conditions. 
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Figure IX-8: In vitro release profile of piroxicam entrapped on BSA microsphere from 
nonwoven gauzes bandages: (a) incubation treatment (b) sonochemical 
treatment. The first 6 hours of release is enlarged for all the conditions. 
The gauzes porosity nature reveals a significant influence in the attachment 
of BSA microspheres, affecting the drug delivery concentrations. The results 
show that independently of the methodology used to immobilize the BSA 
microspheres, the nonwoven gauze shows a higher concentration of piroxicam 
released over the time. Being more closed and compact than cotton gauzes, this 
type of fibre structure can offer a better support for microspheres‟ attachment. 
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Considering that the assumed application of the product is for one-way used 
only, no fastness tests were included in the investigation plan at this stage. 
 CONCLUSIONS IX-4.
The present study demonstrates the attachment ability of proteinaceous 
microspheres, containing an anti-inflammatory drug, onto different gauzes, cotton 
and nonwoven. The continuous application of shear stress provided by stirring or 
ultrasound waves was able to promote the attachment of BSA-particles onto 
gauze bandages. Furthermore, the chemical activation of gauzes, using the 
PDDA as cationizer reagent, improved the content of BSA microspheres at the 
fibres surfaces and, consequently, a higher concentration of piroxicam was 
released. However, the highest release was achieved when the attachment 
process was performed by sonochemical method. The short time treatment 
(3 min) improves the mass transport effects enhancing the microspheres 
attachment. The capacity of ultrasound to attach the microspheres to gauzes was 
made by one-step reaction, providing a reduction in the products consumption, 
shorter process time and a greater uniformity of the treatment. 
The release of piroxicam entrapped in BSA microspheres was shown to be 
dependent on the gauzes structure. The fastest and highest concentration of 
piroxicam released can be reached when the proteinaceous microspheres were 
attached on nonwoven gauzes. 
The results achieved, indicate that these functionalized gauze bandages may 
potentially be used as powerful bioactive carriers for wound healing. Furthermore, 
such drug carriers can be helpful for several pathologies where the piroxicam can 
be useful. 
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Chapter X 
Chapter X -  General discussion, final remarks and future perspectives 
GENERAL DISCUSSION 
The objective of this dissertation was the development and characterization 
of delivery systems (DS) sonochemically prepared. These systems can be useful 
for entrapment and release of bioactive agents. To accomplish this aim, two 
based materials were selected: phospholipids and proteins. Herein a summary of 
major achievements will be given. 
The general discussion of the research work produced in this thesis, which 
intends from Chapter III to IX, was divided in the following items: 
- Liposomes; 
- Protein microspheres. 
LIPOSOMES 
The feasibility to prepare liposomes with predictable sizes via ultrasound 
sources was demonstrated in the Chapter III. Sonication is a powerful technique 
that can be used to reduce the liposomes size in a relative short time treatment, 
due to their high energy released over treatment. In order to achieve dependable 
and reproducible results, with this technique, several parameters were controlled, 
namely time of treatment, power input and distance of ultrasound tip from the 
base of the vessel. The results obtained demonstrated that the cavitation events 
promoted by sonochemical methodology are directly dependent on the 
parameters previously described and, also, on the wave behaviour. 
The choice of tip placement was based on estimated wavelength of 
77.1 mm, which allows the calculation of the anti-node (/4; 19 mm) and node 
point (/2; 38 mm). The anti-node point is where the maximum of vibration and 
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amplitude of wavelength occurs and, consequently, more pronounced cavitation 
events and the associated phenomena. It was also shown that the behaviour of a 
longitudinal wave should give a constructive interference at anti-nodal point and 
destructive at the nodal point. Thus, the calorimetric and dosimetric procedure 
was employed to characterize the events that occur at the node and anti-node 
points. The results prove that the energy and the hydroxyl radicals (•OH) 
production are higher at 19 mm of depth and using the maximum of amplitude 
(40%). The results for the energy deposition increase with the power input for 
both depths (19 and 38 mm). However, the results for •OH formation showed that 
at 19 mm (/4) position displayed a significant increase in •OH radical production 
at 40% of amplitude. The reason for this fact is that whilst cavitation bubble 
implosion is regarded as necessary for •OH radical formation, and is also a 
contributor of heat, other factors are present which contribute for heat energy to 
the solution when conditions do not favour •OH radical production. 
These parameters were taken into account to verify how they interfere with 
the reduction of liposomes size. The results demonstrated that at 19 mm and with 
40% of amplitude it was possible to obtain smaller sizes and a more 
homogeneous population after few minutes of treatment when compared with the 
results achieved for 38 mm of depth. However, after a total time treatment of 
21 min there was no significant differences on the reduction of liposomes size for 
these two depths. 
The further Chapter (Chapter IV) described the ultrasonic effects on peptides 
incorporated on phospholipids aggregates. In this Chapter it were explored the 
potentialities of liposomes to incorporate two synthetic peptides, linked to 
fluorescent dye, which can be used in the cosmetic field. The treatments with 
ultrasound were carried out at anti-nodal and nodal points, using the lowest 
(20%) and the highest amplitude (40%). According to the previous results, the 
total treatment time necessary to decrease the liposomes sizes was 12 min and 
this time frame was used for the subsequent preparations. The results were in 
agreement with the previously data where the smaller sizes were obtained with 
the 19 mm of tip placement and using 40% of amplitude. The peptide motifs differ 
in the position of the charged group (Lysine; K) in the peptide structure. These 
Chapter X - General discussion, final remarks and future perspectives 
 
187 
changes in the peptide motif lead to changes in the physico-chemical 
characteristics of liposomes. 
The zeta-potential results demonstrate differences on the surface of vesicles 
when these two peptides were incorporated. The peptide with the Lysine residue 
distributed along the sequence (LLLLKLLLLKLLLLKLLLLK) can be located on 
the polar surface of liposomes and consequently promote an enhancement on 
the values of zeta-potential (≈ 7 mV). The incorporation of this peptide on 
phospholipids aggregates leads to an amorphous shape of liposomes. 
Conversely, the peptide with the Lysine residue in the extremity of the peptide 
fragment (LLLLLLCLCLLLKAKAK) allows the location of the others residues 
inside of the core vesicle, due to their hydrophobicity. Consequently, the surface 
of liposomes did not suffer a significant change on the zeta-potential values and 
the morphology studies demonstrate a more homogeneous shape, presenting a 
“rode” shape. 
PROTEINS 
In this dissertation, the other main aim was to fully investigate the mechanism 
of protein microspheres formation by ultrasound sources. The microspheres were 
produced by means of ultrasonication of two-phase starting mixture, consisting of 
protein solution and organic solvent, using the same power input energy, 40% of 
amplitude, which is the maximum of power input to prepare microspheres. The 
use of this condition favours the cavitation events at the aqueous/organic 
interface and, consequently, the mass transport effects. 
Chapter V reported the use of two proteins, specifically bovine serum albumin 
(BSA) and silk fibroin (SF), to produce microspheres. BSA is a soluble globular 
protein, presenting a high content of Cysteine residues, while SF is an insoluble 
fibrous protein without Cysteine residues in its chemical constitution. In this 
Chapter, it was found that the amount of protein and the organic volume fraction 
are essential to form and stabilize the proteinaceous devices and also tune their 
size distribution. The knowledge of this proves to be an important tool to predict 
sizes particles ranging from 300 to 1500 nm. Additionally, the conformation 
assessment, obtained with Fourier transform infrared (FT-IR) analysis after 
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microspheres formation, confirmed a change on the secondary structure leading 
to more ordered structure (enhancement on the β-sheet content), while the 
globular protein (BSA) maintains its secondary structure upon ultrasound 
treatment. This result accomplished with the molecular studies and with the 
confocal analysis, which demonstrates the protein arrangement in a biphasic 
system, allows us to predict that the mass transport effects is the main 
mechanism of protein microspheres formation. This phenomena brings the 
hydrophobic groups close to each other allowing the van der Waals interactions 
between them, summing up to a substantial energetic contribution, favouring the 
formation and stabilization of spherical particle. The polar chains can form 
hydrogen bond with the aqueous phase and will be distributed around 
microspheres surface. Another important characteristic on the microspheres 
characterization is the cytotoxicity. Polymeric materials to be used in medical 
applications should be biocompatible. Cytotoxicity, as initial phase in testing 
biocompatibility, detects cell death or other negative effect of materials on cellular 
functions. The cytotoxicity screening was assessed to our materials through the 
use of human cell line, establishing that the use of high concentrations of 
microspheres (above 300 mg.L-1), accomplished with the high ratio of organic 
phase (40% of n-dodecane), lead to a moderate cytotoxicity effects. 
The followed Chapter (Chapter VI) reported deeper studies on the 
mechanism of the protein microspheres using wide ranges of peptides with a 
variable size and sequence and a tailored hydrophobic/hydrophilic ratio. The 
results proved that larger peptides with a separated clear hydrophobic and 
hydrophilic areas lead to a more stable and small spheres. The formation of 
peptide microspheres show to be dependent of the intrinsic properties of amino 
acids (a.a.) residues and their arrangements in the peptide sequences. The use 
of sonochemical methodology promotes high shear forces driving the orientation 
of polar and nonpolar groups in biphasic system. The proof of the concept was 
attained with molecular dynamic studies and confocal analysis, demonstrating the 
polar residues interacting with aqueous phase and the affinity of hydrophobic 
residues with the n-dodecane. 
Based on the concept of delivery devices, the Chapter VII described a novel 
approach using proteinaceous microspheres of BSA, human serum albumin 
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(HSA) and SF containing different organic solvents, namely, n-dodecane, mineral 
and vegetable oil, to reduce the activity of HNE found in high levels on chronic 
wounds. The inhibitory activity was evaluated against porcine pancreatic elastase 
(PPE), used as a model of wound exudates, and it was found that the vegetable 
oil presents higher inhibitory efficiency. This was explained by the incidence of 
monounsaturated and polyunsaturated fatty acids present in different ratios on 
mineral and vegetable oil when compared with n-dodecane. Moreover, the 
chemical nature of proteins also interferes with the elastase inhibition, once that 
SF demonstrated to be the more capable device for this purpose. Subsequently, 
the in vitro experiments were performed to investigate the effects on cell viability. 
The cytotoxicity screening reveals that the developed microspheres are not 
cytotoxic against human fibroblast in a range concentrations of 75-300 mg.L-1 for 
BSA and HSA, and 150-300 mg.L-1 for SF after 72 h of exposure. However, in 
those concentrations SF is no longer the best device to inhibit the elastase. 
Therefore, there is a need to find a compromise between the ability to inhibit the 
elastase and their cytotoxicity when formulations are developed. 
The Chapter VIII reported the entrapment of piroxicam, which is an  
anti-inflammatory drug commonly used in the treatment of inflammatory diseases, 
into BSA and HSA microspheres. The results have shown that the use of lowest 
ratio of organic phase (5%) led to smallest sizes (≈ 300 nm). However, their sizes 
distribution (measured in term of polydispersity index, PDI) is high. To circumvent 
this drawback it were tested different stabilizers in the BSA and HSA 
microspheres preparation to achieve a monodispersed population (Chapter VIII). 
The results demonstrated that the polyvinyl alcohol (PVA) is the most efficient 
and that 8% is the amount required to achieve a monodispersed population for 
both protein-based devices. The use of PVA led to an increase on the 
entrapment efficiency of piroxicam, as well as the BSA-piroxicam and  
HSA-piroxicam stability over the time. The release kinetics of the protein-based 
devices was determined in the presence of protease, used to mimic the 
enzymatic environment of the human body and as a trigger for the drug release. 
This assay indicates an Anomalous drug transport mechanism (diffusion and 
polymer degradation). Although, the presence of an higher protease 
concentration led to a complete degradation of BSA matrix, exhibiting  
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Case II transport. Concomitantly, the cytotoxicity evaluation in human fibroblasts 
demonstrated that these protein-based devices can be safely applied in the range 
concentrations below 300 mg.L-1. 
Chapter IX, exploited the potential of the combinatorial strategy in  
textile-based wound dressing employing the previous characterized devices. In 
the aforementioned Chapter VIII it was performed the physico-chemical 
characterization of the BSA-piroxicam devices, prepared with PVA, 
demonstrating a negative charge on the microspheres surfaces. Thus, prior to the 
attachment of microspheres, the cotton and nonwoven gauzes were submitted to 
a cationization process in order to acquire the positive charge on their surfaces. 
The cationization of gauzes led to an increase of the electrostatic interactions 
between the protein microspheres and the surfaces gauzes. The attachment of 
proteinaceous devices using sonochemical radiation promotes the binding onto 
cotton and nonwoven gauzes by one-step-process, and an enhancement of this 
device on their surface was observed. The attachment of protein microspheres 
showed to be dependent on the gauzes structure. The fastest and the highest 
concentration of piroxicam released were reached with nonwoven gauzes. This 
type of fibre structure offers a better support for microspheres attachment, once 
that is more closed and compact than cotton gauzes. 
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FINAL REMARKS 
The following points summarize the work carried under the scope of this 
thesis. 
 
SONOPRODUCTION OF PARTICLES… 
 
 It was possible to develop nano and micron size particles, by 
sonochemical method, using two different materials: phospholipids and 
protein-based materials. 
 The sonochemical methodology employed has shown to be adequate to 
produce these systems, which allowed, to some extent, tailor the 
properties of the nano and microparticles, namely their size and its 
distribution, surface charge and morphology. 
 
…FOR DELIVERY PURPOSES 
 
 Liposome-based particles have shown its capacity to entrap different 
synthetic peptides. 
 Protein-based particles were able to entrap and release bioactive agents in 
a sustained fashion. Piroxicam presented high entrapment efficiency, and 
was released with an initial burst, followed by a state of lower release up to 
six days. 
 The devices, based on protein material, containing piroxicam, were 
attached onto cotton and nonwoven gauzes and the release piroxicam was 
achieved, greatly supporting their application for textile-based wound 
dressings. 
As conclusion, these systems present an outstanding potential for delivery 
applications. 
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In the proposed strategy, ultrasound systems aim to fill different roles to 
obtain these DS. Further understanding of intrinsic properties of these developed 
systems allows their optimization in order to enhance their potentialities. When 
gathering all the information from each of the studies, it can be drawn that the 
developed liposomes and protein-based particles present potential to be used as 
carriers for bioactive molecules. 
In summary, the results demonstrate the potential of sonochemical method to 
develop liposomes and protein-based nano and micron size systems for the 
above proposed strategy. This confirms that the milestones for this work were 
achieved. 
FUTURE PERSPECTIVES 
A number of valuable results were obtained in this research project which will 
hopefully be of utility in future investigations. The usefulness of sonochemical 
methodology for the development of an efficient lipidic and proteinaceous delivery 
platforms for the delivery of bioactive agents are the most significant contributions 
of this thesis. The next steps may include the following studies: 
- To undertake in vivo studies to assess the potential of protein 
microspheres to induce wound healing in animal models, as well as the 
potential of anti-inflammatory ability of protein-piroxicam microspheres. 
- To enhanced the site-specific of drug delivery by using receptor-targeting 
ligands. 
- To explore new applications of the developed systems as carriers for 
cosmetics uses. 
- Upgrading the sonoproduction of particles from laboratory scale to a large 
scale-process. 
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